Page last updated: 2024-09-02

tadalafil and Erectile Dysfunction

tadalafil has been researched along with Erectile Dysfunction in 633 studies

*Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction. [MeSH]

Research

Studies (633)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	284 (44.87)	29.6817
2010's	261 (41.23)	24.3611
2020's	88 (13.90)	2.80

Authors

Authors	Studies
Adam, L; Beyer, B; Chong, S; Ferrer, P; He, B; Henwood, A; Humphrey, WG; Krupinski, J; Macor, JE; Mason, H; Normandin, D; Pongrac, R; Seliger, L; Wang, J; Wu, X; Yu, G; Zhang, R	1
Bhattacharjee, S; Guan, J; Haynes-Johnson, D; Jiang, W; John, TM; Kraft, P; Lundeen, S; Macielag, MJ; Qiu, Y; Sui, Z; Zhang, S	1
Asberom, T; Boyle, CD; Chackalamannil, S; Chintala, M; Clader, JW; Greenlee, WJ; Guzik, H; Hu, Y; Hu, Z; Kurowski, S; Lankin, CM; Myers, J; Palamanda, J; Pissarnitski, DA; Skell, J; Stamford, AW; Vemulapalli, S; Wang, P; Wang, Y; Wu, P; Xu, R	1
Ahn, SK; Choi, H; Choi, NS; Han, CK; Hwang, IC; Im, DS; Kim, SJ; Kim, SW; Kim, YH; Lee, HW; Lee, J; Lee, KJ; Lee, SS; Moon, SK; Yoon, JH	1
Ahn, SK; Choi, H; Choi, NS; Hwang, IC; Im, DS; Kim, SJ; Kim, SW; Kim, YH; Lee, HW; Lee, J; Lee, KJ; Lee, SS; Moon, SK	1
Fujishige, K; Hikota, M; Kikkawa, K; Koga, Y; Kotera, J; Matsuki, K; Morimoto, H; Murakami, M; Omori, K; Sakamoto, T; Yamada, K	1
Arora, V; Benjamin, J; Bhardwaj, A; Choudhary, A; Jagdish, RK; Jindal, A; Kamaal, A; Kumar, G; Kumar, M; Maiwall, R; Rajan, V; Sarin, SK; Shasthry, SM	1
Fournaraki, A; Hatzichristou, D; Kalyvianakis, D; Kapoteli, P; Mykoniatis, I; Pyrgidis, N; Zilotis, F	1
Gupta, A; McGraw, T; Nunes, AP; Seeger, JD; Stewart, A	1
Alghobary, MF; Mostafa, T	1
Liu, X; Zhu, ZM	1
Chen, L; Chen, WJ; Cheng, HJ; Huang, YP; Li, L; Lu, MJ; Peng, Y; Wu, ZM; Yang, NQ	1
Gallo, L; Pecoraro, S; Sarnacchiaro, P	1
Abdelwahab, KM; Desoky, E; El-Babouly, IM; Eldery, MS; Saber, S; Seleem, MM; Taha, K	1
Gupta, A; Kloner, RA; Kostis, JB; McGraw, TP; Qiu, C	1
Grossman, E	1
El-Nashaar, AM; Mostafa, T; Osman, IA; Said, SZ; Zaghloul, AS	1
Choi, SH; Chun, SY; Chung, JW; Ha, YS; Jang, SW; Kim, BS; Kim, HT; Kim, SH; Kim, TH; Kwon, TG; Lee, EH; Lee, JN; Yoo, ES	1
Al-Majed, AA; Alshehri, YM; Attwa, MW; Bakheit, AH	1
Antinozzi, C; Aversa, A; Di Luigi, L; Greco, EA; Sgrò, P	1
Blachman-Braun, R; Goberdhan, S; Masterson, TA; Nackeeran, S; Ramasamy, R	1
Altunrende, F; Canat, L; Culha, MG; Ermec, B; Kocak, G; Otunctemur, A	1
Ahmed, MM; Alalaiwe, A; Alali, AS; Aldawsari, MF; Alshehri, S; Alshetaili, A; Anwer, MK; Bukhari, SI; Ghoneim, MM; Mohammed, AA; Soliman, GA; Zafar, A	1
Baran, C; Culha, MG	1
Badagliacca, R; Barbagallo, F; Barbano, B; Caboni, P; Campolo, F; Carbone, I; Catalano, C; Ciolina, F; Defeudis, G; Feola, T; Filardi, T; Francone, M; Galea, N; Gianfrilli, D; Giannetta, E; Isidori, AM; Lenzi, A; Minnetti, M; Pasqualetti, P; Pofi, R; Pozzilli, P; Sesti, F; Venneri, MA; Vizza, CD	1
AbdelRazek, M; Abolyosr, A; Fathi, A; Hassan, A; Mhammed, O; Talaat, M	1
Antonelli, A; Autrán-Gómez, AM; Balzarro, M; Castellani, D; Gemma, L; Gubbiotti, M; Migliorini, F; Pirola, GM; Polykarpova, A; Rubilotta, E; Tafuri, A; Teoh, JY; Tortolero Blanco, L	1
Chung, JW; Jang, SW; Kwon, TG	1
Jiang, X; Liu, Z; Ma, J; Ma, S; Tang, Q; Wu, T; Xue, W	1
Keseroglu, BB; Ozgur, BC	1
Baran, C; Culha, MG; Karakanlı, MÜ; Ötünçtemur, A; Özcan, L	1
Bayar, G; Salman, MY; Yavuz, A; Yıldırım, Ç	1
Abdel-Aal, FAM; Ali, ABH; Mohamed, AI; Rageh, AH	1
Forootanfar, H; Hamzehnejadi, M; Homayouni, F; Jahani, Z; Langarizadeh, MA; Rezaei, M; Tavakoli, MR	1
Ju, B; Li, L; Li, X; Ma, M; Yao, J; Zhang, Y	1
Antunes, E; de Gomes, ET; de Oliveira, MG; Leonardi, GR; Mónica, FZ; Passos, GR; Zapparoli, A	1
Chen, Q; Mao, Y; Tang, S; Zhou, H	1
Dai, X; Hu, Q; Liu, J; Sun, J; Wei, H; Yu, H	1
Abbasi, B; Breyer, BN; Hakam, N; Lui, JL; Shaw, NM	1
Montorsi, F; Salonia, A; Ventimiglia, E	1
Brookman-May, SD; Gratzke, C; von Büren, J; von Büren, M; Wülfing, C	1
Fadaei, S; Forootanfar, H; Jahani, Z; Langarizadeh, MA; Nejad, BG; Salary, A; Tavakoli, MR	1
Can, O; Culha, MG; Ermec, B; Onal, B	1
Armin, A; Khoshdel, AR; Poopak, A; Samzadeh, M; Zahir, M	1
Farhadi, D; Kohandel Gargari, M; Nourian Kafshgari, H; Pourasghary, S; Soleimanzadeh, F; Tahmasbi, F	1
Chen, Y; Han, ZY; Wang, H; Zhang, ZH	1
Blum, A; Konstantinovsky, A; Kridin, K; Kuchersky, N	1
Abo Sief, A; GamalEl Din, SF; Labib, M; Nabil, N; Ragab, MW; Saad, H	1
Fu, Q; Gao, S; Li, KF; Liu, H; Liu, S; Liu, X; Sun, DQ; Zhang, H; Zhang, KQ	1
DU, JG; Li, PC; Sun, ZX; Wei, XX; Zhang, XH; Zhang, ZG	1
Darweish, E; Mohamed, AR	1
Bayraktar, N	1
Geng, LG; He, CB; Wang, YL; Yuan, SY	1
Atan, A; Bulut, EC; Doğan, AE; Polat, F; Tokuçoğlu, H; Ünsal, A; Yeşil, S	1
Kamalov, AA; Nizov, AN	1
Akamatsu, S; Goto, T; Kobayashi, T; Matsubara, K; Matsui, Y; Negoro, H; Ogawa, O; Omura, T; Terada, N; Yamamoto, T; Yonezawa, A	1
Chapple, C; De Nunzio, C; Frizzi, J; Gacci, M; Gravas, S; Kaplan, SA; Maggi, M; McVary, KT; Saleh, O; Sebastianelli, A; Serni, S; Spatafora, P; Tubaro, A; Vignozzi, L	1
Bansal, M; Gupta, NP; Srivastava, GK	1
Fadhly, SF; Felizio, J; Mantiri, BJ; Prasetyo, DT; Rahardjo, HE; Raharja, PAR; Rahman, IA; Ringoringo, DRL; Tambunan, MP	1
Dhaun, N; Farrah, TE; Tzoumas, N; Webb, DJ	1
Chang, D; Li, G; Li, Z; Ma, Z; Ren, F; Shen, Y; You, Y; Yu, X; Zhang, P	1
Rezk, MR; Tantawy, MA; Wadie, M; Weshahy, SA	1
Heydari, R; Khosravifar, M; Navabi, SJ; Navabi, SM	1
Amaro, JL; Cardoso, LEM; Gomes Filho, FF; Guerra, R; Kawano, PR; Pajolli, PIR; Sampaio, FJ; Toledo, AC; Yamamoto, HA	1
Ahn, ST; Jeong, HG; Kim, JW; Lee, DH; Moon, DG; Oh, MM; Park, HS	1
Kaputovskij, AA	1
Baccaglini, W; Corrêa Barros, EA; Glina, S; Monteiro, L; Navas, A; Pazeto, CL; Saad Rached, RY; Timóteo, F	1
Chopra, I; Hassan, TA; Mulhall, JP; Patel, D; Tang, WY	1
Bayatli, N; Gur, S; Kaya-Sezginer, E; Lokman, U; Oztekin, CV; Yilmaz-Oral, D	1
Akkoç, A; Aslan, F; Öktem, Ç; Topcuoğlu, M; Uçar, M	1
Huang, H; Huang, WP; Ye, XT; Zhang, FY	1
Cai, J; Li, CD; Shang, XJ; Wang, QQ; Wu, ZG; Xiao, YB; Zhou, CF	1
Jia, DH; Li, R; Wang, CL; Wang, R; Yang, F; Zhang, TB; Zhang, WX; Zheng, T	1
Cheng, Q; Shi, S; Wu, Y; Zhou, M	1
Cai, Z; Li, H; Ma, C; Xiong, J; Zhang, J	1
Li, C; Moezzi, B; Xu, D	1
Abu El-Hamd, M; Hegazy, EM	1
Jeong, TY; Kim, KS; Moon, HS	1
Ahmad, N; Blair, HC; Gera, S; Gumerova, A; Hadelia, E; Haider, S; Ievleva, K; Iqbal, J; Kim, SM; Korkmaz, F; Kuo, TC; Li, W; Liu, L; Liu, P; Lizneva, D; Mathew, M; Miyashita, H; New, MI; Perez-Pena, H; Ryu, V; Sant, D; Stanley, S; Sun, L; Tamler, R; Taneja, C; Tourkova, I; Yuen, T; Zaidi, M; Zhu, LL	1
Cummings, TH; Hardin, JW; Magagnoli, J; Sutton, SS	1
Borisov, VV	1
Gross, MS; Rezaee, ME	1
Izumi, K; Kadono, Y; Kawaguchi, S; Mizokami, A; Nohara, T; Shigehara, K; Shimamura, M; Shouda, R	1
De Nunzio, C; Lombardo, R; Tema, G	1
Chapple, C; Gacci, M; Gravas, S; Kaplan, S; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L	1
Balbaa, ME; Meftah, AA; Sheweita, MS; Sheweita, SA	1
Machado-Alba, JE; Valladales-Restrepo, LF	1
Chapple, C; Gacci, M; Gemma, L; Gravas, S; Kaplan, SA; Liaci, A; Maggi, M; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L; Zaccaro, C	1
Akinsal, EC; Baydilli, N; Selvi, I	1
Chiba, F; Iwase, H; Nagasawa, S; Saka, K; Torimitsu, S; Yajima, D; Yamagishi, Y; Yamaguchi, R	1
Fujihara, A; Harikai, S; Kanemitsu, N; Narukawa, T; Soh, J; Ukimura, O	1
Ashok, R; Dai, YT; Gao, QQ; Song, T; Sun, GH; Sun, XL; Xu, ZP; Yu, W	1
El Balkhi, S; El Osta, R; Evrard, M; Gillet, P; Humbertjean, L; Pape, E; Petitpain, N; Scala-Bertola, J; Yéléhé-Okouma, M	1
Haga, N; Miyazaki, T; Okabe, Y; Tsubouchi, K	1
Haidich, AB; Hatzichristodoulou, G; Hatzichristou, D; Mykoniatis, I; Ouranidis, A; Pyrgidis, N; Sokolakis, I; Sountoulides, P; van Renterghem, K	1
Çakan, M; Demirci, A; Topçuoğlu, M	1
Kosivtsova, MA; Kostromeev, SA; Statsenko, ME; Turkina, SV; Tyschenko, IA	1
Allazov, SA; Gafarov, RR; Giyasov, SI; Shodmonova, ZR	1
Buchner, A; Gratzke, C; Rodler, S; Schröder, F; Stief, C; von Büren, J; von Büren, M; Wiesenhütter, I; Wülfing, C	1
Selvi, I	1
Cheng, YB; Guo, JL; He, Y; Li, S; Sun, L; Tang, Y; Wang, J; Wang, YL; Xin, Y; Zeng, HQ; Zhang, YP; Zhu, ZH	1
Arcaniolo, D; Celentano, G; Cirino, G; D'Emmanuele di Villa Bianca, R; La Rocca, R; Mirone, V; Mitidieri, E; Napolitano, L; Sorrentino, R; Turnaturi, C; Vanacore, D; Vanelli, A	1
Gamidov, SI; Izhbaev, SK; Ovchinnikov, RI; Popova, AY	1
Brandão, MAF; Ferreira, A; Polonini, HC; Raposo, FJ; Raposo, NRB	1
Dong, Q; Liu, L; Peng, Z; Wei, Q; Yang, B; Yang, L	1
Bertolo, R; De Cillis, S; Fiori, C; Geuna, S; Manfredi, M; Porpiglia, F	1
Gong, B; Huang, J; Huang, Y; Luo, Y; Ma, M; Sun, T; Xie, W; Yang, X	1
Akdeniz, E; Aşcı, R; Bolat, MS; Cinar, O; Özer, İ	1
Ahn, TY; Hyun, JS; Jung, J; Kim, SW; Lee, SW; Min, KS; Moon, DG; Moon, KH; Park, JK; Park, K; Park, NC; Ryu, JK; Son, H; Yang, DY; Yang, SK	1
Amano, T; Earle, C; Imao, T; Kishikage, T; Matsumoto, Y	1
Bansal, UK; Fuller, TW; Jackman, SV; Jones, C; Wessel, C	1
Bian, TS; Chen, Q; Huang, J; Wang, JS; Yang, K; Zeng, MY; Zeng, QQ; Zhu, Y	1
Li, WB; Pan, MA; Zhang, T	1
Bao, Y; Cui, Y; Duan, L; Liu, J; Wang, Y	1
Burgio, G; Calogero, AE; Cannarella, R; Condorelli, RA; La Vignera, S	1
Hassan, TA; Mulhall, JP; Rienow, J	1
Cai, ZK; Guo, JH; Jiang, YQ; Li, WJ; Wang, Z; Xu, MX	1
Akdeniz, E; Aşcı, R; Bolat, MS; Cinar, O	1
Efremov, EA; Kasatonova, EV; Mel'nik, YI; Nikushina, AA	1
Anzanello, MJ; Chaovalitwongse, WA; Ferrão, MF; Fogliatto, FS; Kahmann, A; Marcelo, MCA; Mariotti, KC; Ortiz, RS	1
De Alba, F; Kaja, S; Rosen, SM	1
Bakırdere, S; Özbek, B; Öztürk Er, E	1
Kaplan, SA	2
Dai, Y; Jiann, BP; Li, H; Li, P; Lou, Y; Park, HJ; Viktrup, L; Ye, Z; Zhang, X; Zhang, Z	1
Kitta, T	1
Chien, TM; Li, CC; Lu, YM; Wang, CJ; Wu, WJ	1
Miura, K; Mizushima, A; Watanabe, D; Yamashita, A	1
Han, CH; Kim, BD; Lee, JG; Lee, KK; Yum, KS	1
Anzanello, MJ; de Araújo Gomes, A; de Cassia Mariotti, K; Dos Santos, MK; Ferrão, MF; Kahmann, A; Limberger, RP; Ortiz, RS	1
Comerma-Steffensen, S; Knudsen, JS; Munk, NE; Simonsen, U	1
De Nucci, G; Mónica, FZ	1
Bulygin, KV; Galimov, SN; Galimova, EF; Gaysina, GG; Nikitina, IL; Pavlov, VN	1
Arnold, DG; Oakley, JL	1
Demirci, A; Ozgur, BC	1
El Taieb, M; Hegazy, E; Ibrahim, A	1
Cari, L; Costantini, E; Illiano, E; Kopa, Z; Nocentini, G; Petrillo, MG; Scroppo, FI; Silvani, M; Zucchi, A	1
Calogero, AE; Condorelli, RA; Favilla, V; La Vignera, S; Lotti, F; Maggi, M; Morgia, G; Vicari, E	1
Andersson, KE; Gratzke, C; Herlemann, A; Sievert, KD	1
Angulo, J; Chen, M; Cuevas, P; Fernández, A; González-Corrochano, R; La Fuente, J; Sáenz de Tejada, I	1
Deyo, RA; Dobscha, SK; Donovan, M; Johnson, ES; Morasco, BJ; Petrik, A; Smith, DH; Tillotson, CJ; Yang, X	1
Dotan, G; Krashin-Bichler, I	1
Baye, J; Cantrell, MA; Vouri, SM	1
Borregales, L; Cairoli, C; Reyes, LA; Rubio-Aurioles, E; Sorsaburu, S	1
Al-Mitwalli, K; El-Meliegy, A; Gurbuz, S; Hussein, T; Istarabadi, M; Lei, Y; Mostafa, T; Rabah, D	1
Boehmer, M; Boess, FG; Büttner, H; Buvat, J; Hatzimouratidis, K; Henneges, C; Moncada, I; Vendeira, PA	1
Mohindroo, NK; Negi, PC; Sharma, DR; Thakur, A; Thakur, JS; Thakur, S	1
Giessing, M; Neumann, NJ; Thierling, U; Uche-Holub, E	1
Alei, G; Letizia, P; Massoni, F; Ricci, S; Simeone, C	1
Chadwell, K; Fenkl, EA; Jones, SG; Patsdaughter, CA	1
Callanan, AC; Campbell, N; Clark, JP; Donnelly, BF; Goldstein, I; Kaminetsky, JC; Stecher, VJ; Thomas, JW	1
Du, Q; Gu, LX; Miao, Y; Pan, BC; Song, YS; Wu, B; Xing, X	1
Duan, XG	1
Chen, YB; Huang, CC; Li, GY; Liang, JH; Liang, SK; Song, WR; Wei, GQ; Wei, P; Zhang, X; Zhu, CH	1
Cui, WS; Gao, B; Hong, Q; Peng, J; Song, WD; Xin, ZC; Yuan, YM; Zhang, ZC	1
Brock, GB; Lee, KC	1
Esler, A; Porst, H; Roehrborn, CG; Secrest, RJ; Viktrup, L	1
Erdem, SR; Keskin, U; Peskircioglu, CL; Toksoz, S	1
Dong, Y; Han, C; Hao, L; Shi, Z; Wang, G; Zhang, Z	1
Artemiadis, AK; Chrousos, G; Darviri, C; Kalaitzidou, I; Konstadinidis, K; Venetikou, MS	1
Burns, PR; Goldfischer, ER; Kim, ED; Ni, X; Seftel, AD	1
Gan, Y; He, LY; Jiang, XZ; Tang, YX; Yang, JF; Zhang, XB; Zhu, XS	1
Bi, JB; Gong, DX; Kong, CZ; Zhang, YX	1
Althof, SE; Ni, X; Rosen, RC; Sontag, A	1
Borhan, A; Jamshidian, H; Kooraki, S	1
Bottalico, M; Marino, F	1
Gao, L; Hong, K; Jiang, H; Liu, DF; Ma, LL; Mao, JM; Qiao, J; Tang, WH; Yang, Y; Zhang, J; Zhao, LM; Zhuang, XJ	1
Huang, CC; Li, GY; Liang, JH; Liang, SK; Meng, ZB; Shen, SL; Song, WR; Wei, GQ; Zhang, X; Zhu, CH	1
He, Q; Jiang, X; Jin, J; Li, J; Shen, J; Terrett, NK; Tian, G; Wang, Z; Wu, H; Yang, B; Yang, X; Zhu, D	1
Brock, G; Broderick, G; Roehrborn, CG; Viktrup, L; Wong, D; Xu, L	1
Brock, GB; Donatucci, C; McVary, KT; Ni, X; Roehrborn, CG; Viktrup, L; Watts, S; Wong, DG	1
Boess, F; Büttner, H; Gacci, M; Henneges, C; Porst, H	1
Litman, HJ; Ni, X; Rosen, RC; Sontag, A; Yang, M	1
Mandal, AK; Mete, UK; Singh, DV; Singh, SK	1
Brock, G; Büttner, H; Chevallier, D; Dickson, R; Henneges, C; Krajka, K; Moncada, I; Montorsi, F; Mulhall, J; Patel, HR; Stolzenburg, JU	1
Cai, YH; Feng, LJ; Huang, YY; Li, X; Li, Z; Luo, HB; Wu, Y	1
Bechara, A; Casabe, A; Cobreros, C; Rodriguez Baigorri, G	1
de la Rosette, JJ	2
Burnett, AL	2
Ioakeimidis, N; Kostis, JB	1
Brock, G; Büttner, H; Henneges, C; Montorsi, F; Mulhall, J	1
Carson, CC; Kissel, J; Rosenberg, M; Wong, DG	1
Bretsztajn, L; Eardley, I; Mohee, A; Storey, A	1
Liu, KF	1
Cui, H; Deng, Y; Fang, J; Liu, B; Song, Z; Wang, H; Wang, Z; Zhang, S	1
Liu, Y	1
Cai, ZK; Dai, JC; Li, P; Li, Z; Wang, YX; Wang, Z; Zhang, W; Zheng, JH	1
Huang, YR; Jiang, ZX; Li, P; Li, Z; Liu, YF; Ma, M; Shen, ZJ; Tian, RH; Wang, GM; Wang, JL; Wang, YX; Wu, M; Yang, NQ; Zhong, S; Zhou, W	1
Akbal, C; Cadirci, S; Cevik, O; Erşahin, M; Reiter, RJ; Sener, G; Sener, TE; Tavukçu, HH; Tinay, I	1
Arcaniolo, D; La Rocca, R; Mirone, V; Verze, P	1
Das, D; Lobo, A; Panigrahi, PK; Roy, R; Saurabh, K	1
Althof, S; Goldfisher, E; Hayes, RP; Rosen, RC; Seftel, AD; Shen, W; Sontag, A	1
Bruner, DW; Buyyounouski, MK; Greenberg, RE; Kachnic, LA; Mowat, RB; Pervez, N; Pisansky, TM; Pugh, SL; Raben, A; Reed, DR; Rosenthal, SA	1
Davies, KP; Martinez, LR; Nosanchuk, JD; Tar, MT	1
Baygani, SK; Burns, PR; Goldfischer, ER; Kim, ED; Seftel, AD	1
Chen, G; Fu, J; Huang, XJ; Lü, BD; Yang, KB; Zhang, SG	1
de Boer, MK; Knegtering, H; Oolders, JM; Schoevers, RA; van den Heuvel, ER; Wiersma, D	1
Angulo, J; Cardoso, J; Cuevas, P; Fernández, A; La Fuente, JM; Martínez-Salamanca, JI; Wright, HM	1
Abdel Aziz, MT; Ahmed, HH; Atta, HM; Fouad, H; Rezq, AM; Sabry, D; Yehia, HM; Zaahkouk, AM	1
Albano, G; Altieri, V; Castaldo, L; D'Agostino, M; Del Forno, D; Ferro, M; Giallauria, F; Lucci, R; Mancini, M; Maresca, L; Torella, G; Vigorito, C; Vitelli, A	1
Boess, FG; Büttner, H; Buvat, J; Gehchan, N; Hatzichristou, D; Henneges, C; Porst, H	1
Büttner, H; de Bethencourt, FR; Henneges, C; Lledó-García, E; Martinez Salamanca, JI; Moncada, I; Romero-Otero, J; Turbi, C	1
Elhenawee, M; Hashem, H; Ibrahim, AE	1
Lampl, Y; Lorberboym, M; Makhline, E	1
Benigni, F; Briganti, A; Buono, R; Castiglione, F; Freschi, M; Hedlund, P; La Croce, G; Montorsi, F; Moschini, M; Villa, L	1
Hsu, JC; Lu, CY; Tang, DH	1
Büttner, H; Esen, A; Glina, S; Henneges, C; Plekhanov, A; Roehrborn, CG; Sorsaburu, S; Viktrup, L	1
Athyros, V; Doumas, M; Katsiki, N; Lazaridis, A	1
Becher, EF; Garrido, G; Mazza, ON; Muschietti, L; Redko, F; Sambrotta, L; Ulloa, J	1
Baygani, S; Burns, P; Goldfischer, E; Kim, E; Seftel, A	1
Büttner, H; Graefen, M; Henneges, C; Kriegel, C; Manning, M; Martin Morales, A; Michl, U; Pommerville, PJ; Schostak, M; Stolzenburg, JU	1
Baygani, SK; Burns, PR; Dunn, M; Perelman, MA; Rosen, RC	1
Atış, G; Canat, L; Çaşkurlu, T; Güner, B; Gürbüz, C	1
Cho, DY; Kim, JJ; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yeo, JK	1
Cui, Y; Gao, Z; Liu, X; Shi, L	1
Iannino-Renz, R; Mager, D	1
Albino, G; Buonomo, AF; Corvasce, A; Leonetti, T; Marucco, EC	1
Agrawal, S; Jayant, K; Kumar, S; Mavuduru, RS; Roat, R	1
Büttner, H; Buvat, J; d'Anzeo, G; Hamidi, K; Hatzichristou, D; Henneges, C; Porst, H; Rossi, A	1
Singman, EL; van Landingham, SW	1
Capra, R; Cordioli, C	1
Hu, T; Kang, M; Qu, X; Song, Q; Yang, L; Zhang, D; Zhao, Y	1
Angulo, J; Carballido, J; Castela, A; Costa, C; Fernández, A; Martínez-Salamanca, E; Martínez-Salamanca, JI; Vaquero, J; Zurita, M	1
Egan, KB; Miner, MM; Ni, X; Roehrborn, CG; Rosen, RC; Wong, DG	1
Brock, G; Büttner, H; d'Anzeo, G; Henneges, C; Montorsi, F; Mulhall, JP; Oelke, M; Rossi, A; Salonia, A	1
Baygani, S; Brock, GB; Donatucci, CF; Glina, S; Maggi, M; Mulhall, JP	1
Brock, G; Büttner, H; d'Anzeo, G; Fode, M; Henneges, C; Mulhall, JP; Oelke, M; Probst, KA; Rossi, A	1
Aydın, M; Balcı, MB; Bozkurt, A; Çakan, M; Hirik, E; Karabakan, M; Nuhoglu, B; Onuk, Ö	1
Barry, J; Brock, G; D'Souza, D; Mulhall, J; Ni, X; Oelke, M; Rosenberg, M; Seftel, A	1
Calogero, AE; Condorelli, RA; Di Mauro, M; La Vignera, S; Mongioì, LM; Morgia, G; Russo, GI	1
Huang, C; Lan, H; Li, G; Liang, J; Zhang, C	1
Gillatt, D; Goonewardene, SS; Persad, R	1
Bindayi, A; Kucuk, EV; Onol, FF; Tahra, A	1
Seftel, AD	3
Echeverría-García, F; García-Perdomo, HA; Tobías, A	1
Deng, L; Han, P; Liu, L; Qiu, S; Tang, Z; Wei, Q; Yang, L	1
Aversa, A; Cortese, A; Francomano, D; Ilacqua, A; Inghilleri, M; Lenzi, A; Tartaglia, G	1
Hassan, M; Sheweita, SA; Wally, M	1
Egberts, TC; Heerdink, ER; Janssen, DG; Vermetten, E	1
Angulo, J; Carballido, J; Fernández, A; La Fuente, JM; Louro, N; Martínez-Salamanca, E; Martínez-Salamanca, JI; Pepe-Cardoso, AJ	1
Mostafa, T	1
Aydinlar, A; Baran, I; Güllülü, S; Keçebaş, M; Kiliçarslan, H; Özdabakoğlu, O; Sağ, S; Şentürk, T; Tütüncü, A	1
Fallah-Karkan, M; Hassanzadeh-Hadad, A; Karami, H	1
Aversa, A; Bimonte, VM; Crescioli, C; Di Luigi, L; Fittipaldi, S; Francomano, D; Greco, EA; Lenzi, A; Migliaccio, S	1
Genovese, A; Manzoni, GC; Russo, M; Taga, A; Torelli, P	1
Akhvlediani, ND; Matyukhov, IP	1
Kocaaslan, R; Onen, E; Otunctemur, A; Ozbek, E; Ozcan, L; Polat, EC	1
Gozal, D; Lei, Z; Nozdrachev, AD; Rao, CV; Shah, ZA; Soukhova-O'Hare, GK	1
Allam, A; Belger, M; El Khiat, Y; Ghazi, S; Khawaja, M; Kopernicky, V; Tamer, M	1
Chen, HC; Chuang, SH; Wang, CS; Wang, CY	1
Imaoka, T; Uenaka, K; Yamaguchi, T	1
Srámková, T; Sutorý, M	1
Lundberg, GD	1
Ali, ST	1
Bechara, A; Casabé, A; Dedola, P; Haime, S; Hernández, C; Rey, H; Romano, S	1
Cocco, G	1
Elion-Mboussa, A; McVary, KT; Roehrborn, CG; Viktrup, L	1
Antonialli, MM; Freitas, VM; Menezes, FG; Nascimento, JW	1
Cornelius, V; Hazell, L; Shakir, SA; Wilton, LV	1
Deng, SM	2
Donatucci, CF; Dowsett, SA; Giuliano, F; Glina, S; Sorsaburu, S; Watts, S; Wong, DG	1
Akcin, S; Duman, T; Gorur, S; Guven, O; Melek, IM; Okuyucu, EE; Yilmazer, S	1
Belgrano, E; Bucci, S; De Giorgi, G; Liguori, G; Maio, G; Ocello, G; Ollandini, G; Pomara, G; Trombetta, C; Vecchio, D	1
Cecconi, F; Del Popolo, G; Lombardi, G; Macchiarella, A	2
De Berardis, G; Franciosi, M; Morelli, P; Nicolucci, A; Pamparana, F; Pellegrini, F; Tognoni, G	1
Buhse, LF; Gryniewicz, CM; Kauffman, JF; Reepmeyer, JC	1
Fusco, F; Mirone, V; Montorsi, F; Rossi, A; Sicuteri, R	1
Baldo, OB; Cartledge, J; Eardley, I; Storey, A; Taylor, J	1
Althof, S; Buvat, J; Fugl-Meyer, A; Paget, MA; Sotomayor, M; Stothard, D	1
Belger, M; Heidler, H; Perimenis, P; Roos, E; Roumeguere, T; Schmitt, H	1
Goda, Y; Haishima, Y; Hasegawa, T; Ishii, T; Kawahara, N; Kurihara, M; Nagata, T; Saijo, M; Takahashi, K	1
Brock, G; Glina, S; Kopernicky, V; Moncada, I; Watts, S; Wolka, A; Xu, L	1
Carini, M; Chavalmane, A; Fibbi, B; Filippi, S; Forti, G; Maggi, M; Mancina, R; Marini, M; Morelli, A; Silvestrini, E; Vannelli, GB; Vignozzi, L	1
Chan, CL; Dalan, R; Gardner, D; Kao, SL; Lee, KO; Lee, M; Lim, CC; Pratt, E; Tan, B	1
Hauzeur, C; Roumeguère, T; Schulman, C; Vanhaeverbeek, M; Wespes, E; Zouaoui Boudjeltia, K	1
Bai, WJ	2
Calenda, G; Davies, KP; Lowe, D; Melman, A; Siragusa, J; Tar, M; Tong, Y	1
Chiang, HS; Choi, HK; Guo, YL; Kopernicky, V; Shen, W; Viswanathan, VP; Yip, AW	1
Volpe, A	1
Elion-Mboussa, A; McVary, KT; Montorsi, F; Porst, H; Sutherland, P; Viktrup, L; Wolka, AM	1
Gillatt, D; Gulur, DM; Mevcha, A; Persad, R	1
McGill, J; Sorsaburu, S; Strawbridge, A; Wong, D; Wrishko, R	1
Wang, X	1
Burns, P; Kim, ED; Porst, H; Rosen, RC; Rubio-Aurioles, E; Wong, DG; Zeigler, H	1
Aguilar-Shea, AL; Sierra-Santos, L	1
He, XY	1
Dinsmore, W	2
Fusco, F; Haro, JM; Imbimbo, C; Kontodimas, S; Mirone, V; Rossi, A; Sicuteri, R	1
Katz, A	2
Auerbach, SM; Elion-Mboussa, A; Kaminetsky, JC; Montelongo, RM; Roehrborn, CG; Viktrup, L	1
Badani, KK; Cheetham, P; Lee, DJ	1
Belger, M; Bitton, A; Roumeguère, T; Schmitt, H; Verheyden, B	1
Li, F; Li, TQ; Mao, XM; Zhou, QZ; Zou, YG	1
Notz, HJ	1
Rosenzweig, EB	1
French, DD; Margo, CE	1
Gonenc, F; Ozgur, BC; Yazicioglu, AH	1
Chen, XW; Rui, WB	1
Heidelbaugh, JJ	1
Kopa, Z; Romics, I	1
Brock, GB; Broderick, GA; Elion-Mboussa, A; Roehrborn, CG; Viktrup, L; Watts, SD	1
Althof, SE; Burns, P; Kingsberg, S; Rubio-Aurioles, E; Wong, DG; Zeigler, H	1
Chen, Y; Dai, YT; Sun, C; Xu, ZP	1
Martinac, AI; Milcić, N; Sokolić, M; Tomić, S	1
Bajramovic, S; Dzelaludin, J	1
Del Popolo, G; Lombardi, G; Macchiarella, A	1
Allmen, Hv; Chang, LL; Harper, K; Henderson, SC; Hornbuckle, K; Ma, M	1
Bassi, P; Bonanni, G; Cella, G; De Bon, E; Saggiorato, G	1
Demirtas, A; Ekmekcioglu, O; Gökçe, A; Halis, F	1
Perelman, MA	1
Ding, L; Huang, Z; Wang, M; Yan, H; Zhang, Y; Zhu, S	1
Fusco, F; Imbimbo, C; Mirone, V; Razzoli, E; Rossi, A; Verze, P	1
Glina, S; Porst, H; Ralph, D; Wong, DG; Woodward, B; Zeigler, H	1
Yuang, RQ	1
Cerqueira, J; Machado, A; Ribeiro, M; Rodrigues, M; Soares-Fernandes, J	1
Buvat, J; Colson, MH; Cuzin, B; Dean, JD; Eardley, I; Kaipia, A; Maggi, M; Martin-Morales, A; Meuleman, E; Moncada, I; Montorsi, F; Porst, H; Shabsigh, R; Yassin, A	1
Shindel, AW; Washington, SL	1
Csupor, D; Hohmann, J; Kecskeméti, A; Micsinay, A; Szekeres, A; Szendrei, K; Vékes, E; Veres, K	1
Jang, YM; Kim, CS; Kwon, SW; Lee, BJ; Lee, HM	1
Choi, SB; Jeon, JH; Kang, KK; Kim, SH; Lee, SW; Park, JK; Zhao, C	1
Conaglen, HM; Conaglen, JV; McCabe, MP; O'Connor, EJ	1
Burns, P; Dula, E; Goldfischer, E; Kim, ED; Seftel, A; Zeigler, H	1
Kamenov, ZA	1
Chen, Y; Dai, YT; Sun, C; Xu, ZP; Zhu, WD	1
Bianco, E; Colpi, GM; Guazzi, M; Mancini, M	1
Bian, J; Deng, CH; Gao, Y; Huang, YP; Liu, GH; Sun, XZ; Yao, FJ; Ye, YL; Zhang, YD; Zheng, FF	1
Bai, WJ; Gu, XE; Wang, XF; Xiao, F; Yan, ZA	1
Barras, C; Cornish, KS	1
Jackson, G	2
Alma, E; Evliyaoğlu, Y; Kobaner, M; Saygılı, M; Yelsel, K	1
Aksoy, N; Altunkol, A; Celik, H; Ciftci, H; Gulum, M; Oncel, H; Savas, M; Verit, A; Yeni, E	1
Guo, WB; Li, F; Li, JP; Liu, CD; Mao, XM; Tan, WL; Zheng, SB; Zhou, QZ	1
Hong, K; Jiang, H; Liu, DF; Ma, LL; Zhao, LM; Zhu, JC	1
Hwang, EC; Kim, SO; Park, K	1
Chen, B; Chen, Z; Hu, JL; Huang, YR; Ma, Y; Wang, HX; Wang, YX; Xia, JG; Yang, Y	1
Bergamasco, L; Gualà, L; Maselli, G; Pace, G; Silvestri, V; Vicentini, C	1
Bian, W; Fu, Q; Zhang, MY	1
Guigou, S; Nadeau, S; Nguyen, F	1
Engel, JD	1
Aversa, A; Barker, C; Moncada, I; Montorsi, F; Perimenis, P; Porst, H; Shane, MA; Sorsaburu, S	1
Badellino, S; Ciammella, P; Filippi, AR; Gontero, P; Guarneri, A; Moretto, F; Munoz, F; Ragona, R; Ricardi, U; Rondi, N; Tizzani, A; Valentino, F	1
Goldstein, I; Khera, M	1
Ji, JT; Liu, ZY; Lu, X; Piao, SG; Sheng, X; Xu, CL; Xu, WD; Ye, HM	1
Gong, BS	1
Calogero, AE; Condorelli, R; D'Agata, R; La Vignera, S; Vicari, E	1
Allen, KR; Araujo, AB; Ni, X; Rosen, RC	2
Beardsworth, A; Bolyakov, A; Paduch, DA; Watts, SD	1
Fan, Y	2
Auerbach, S; Costa, P; Egerdie, RB; Esler, AL; Garza, MS; Roehrborn, CG; Secrest, RJ; Wong, DG	1
Albersen, M; Lue, TF	1
Costabile, RA; Lowe, G	1
Cao, ZG; Ja, RP; Liu, J; Qi, MJ; Su, JH; Xu, LW; Xu, Z	1
Creta, M; Fusco, F; Imbimbo, C; Mirone, V; Palmieri, A; Verze, P	1
Helfand, BT; Mazur, DJ; McVary, KT	1
Hubanks, JM; Karnes, RJ; Myers, RP; Umbreit, EC	1
Aliferis, K; Farpour, B; Matter, MA; Petropoulos, IK; Safran, AB	1
Brock, GB; Chung, E; DeRogatis, LR; Jannini, EA	1
Gokce, Mİ; Güleç, S; Gülpınar, Ö; Öztürk, E; Yaman, Ö	1
Lameijer, CM; Tielliu, IF; van Driel, MF; Zeebregts, CJ	1
Du, Q; Li, ZT; Pan, BC; Song, YS; Wu, B; Xing, X	1
Cox, D; Giuliano, F; Mirone, V; Oelke, M; Viktrup, L; Xu, L	1
Wyllie, MG	2
Carini, M; Corona, G; Gacci, M; Kaplan, SA; Maggi, M; McVary, KT; Mirone, V; Roehrborn, CG; Salvi, M; Serni, S; Vignozzi, L	1
Burns, P; Būttner, H; Hackett, G; Huynh, NN; Kim, ED; Kopernicky, V; Lenero, E; Montorsi, F; Morales, AM; Porst, H; Rubio-Aurioles, E; Stuckey, B; West, TM	1
de Kaste, D; Venhuis, BJ	1
Kotb, K; Mostafa, T; Rashed, L; Taymour, M	1
Chen, Y; Dai, YT; Gao, J; Li, XX; Lin, HC; Qiu, XF; Wang, R	1
Andersen, ML; Cavalheiro, EA; Matos, G; Scorza, FA; Tufik, S	1
Fujishige, K; Inoue, H; Kikkawa, K; Kobayashi, T; Kojima, K; Kotera, J; Mochida, H; Noto, T; Omori, K; Sasaki, T; Yamada, Y; Yee, S	1
Büttner, H; Hell-Momeni, K; Porst, H	1
He, LY; Jiang, XZ; Li, DJ; Peng, SL; Tang, YX; Zhou, HB	1
Li, J; Li, WX; Luo, L; Wang, S; Wang, XK	1
Burnett, AL; Day, WW; DiDonato, K; Heller, WH; Kikkawa, K; Kotera, J; Omori, K; Peterson, CA; Wang, R; Yee, S	1
Barret, E; Cathala, N; Cathelineau, X; Djavan, B; Galiano, M; Giuliano, F; Jaffe, J; Kazzazi, A; Mombet, A; Prapotnich, D; Rozet, F; Sanchez-Salas, R; Vallancien, G	1
Araujo, AB; Litman, HJ; Ni, X; Rosen, RC; Sontag, A	1
Bae, JH; Kim, JJ; Kim, JW; Moon, DG; Oh, MM; Park, JY; Park, MG	1
Curran, MP	1
Burns, PR; Kim, ED; Ni, X; Seftel, AD; Shabsigh, R	1
Bozkurt, Y; Çaça, I; Murat, M; Şahin, A; Türkcü, FM; Yüksel, H	1
Shaeer, O	1
Goldstein, I; Scranton, RE; Stecher, VJ	1
Amato, B; Iacono, F; Illiano, E; Prezioso, D; Romeo, G; Ruffo, A	1
Burns, PR; Kim, ED; Ni, X; Samuels, SM; Seftel, AD; Shinghal, R	1
Gkialas, I; Megas, G; Moschonas, D; Ntoumas, K; Papadopoulos, G; Stathouros, G	1
Brock, G; Burnett, A; Ghanem, H; Giuliano, F; Glina, S; Hellstrom, W; Martin-Morales, A; Porst, H; Salonia, A; Sharlip, I	1
Cox, D; Giuliano, F; Hatzimouratidis, K; Jungwirth, A; Oelke, M; Viktrup, L; Watts, S	1
Asadolahzade, A; Esmaeili, S; Farzan, A; Hamidi Madani, A; Mokhtari, G; Shahrokhi Damavand, R	1
Wyllie, M	1
Bolyakov, A; Paduch, DA; Polzer, PK; Watts, SD	1
Miller, MS	1
Chen, Q; Ding, H; Lee, J; Liu, Y; Mao, C; Qin, X; Ren, Z; Tang, J; Tian, J; Yang, Z; Yuan, J; Zhang, R	1
Kumon, H; Nagai, A	1
Rotella, DP	2
Gould, M	1
Anglin, G; Brock, GB; Chen, KK; Costigan, T; McMahon, CG; Shen, W; Watkins, V; Whitaker, S	1
Gleiter, CH; Gresser, U	1
Brock, G; Kuan, J	1
Anglin, G; Emmick, JT; Knight, JR; Sáenz de Tejada, I	1
Satyanarayana, R; Vickers, MA	1
Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C	1
Brock, GB	1
Holmes, S	1
Jünemann, KP	1
McKenna, KE; Rosen, RC	1
Anglin, G; Giuliano, F; Padma-Nathan, H; Porst, H; Rosen, R; Varanese, L	1
Mason, RG	1
Kuthe, A	1
Josefson, D	1
Curran, M; Keating, G	1
Gaines, KK	2
Kalsi, JS; Minhas, S; Ralph, DJ	1
Meuleman, EJ	1
Kostis, JB; Rosen, RC	1
Padma-Nathan, H	1
Emmick, JT; Kloner, RA; Mitchell, M	2
Brindis, RG; Cheitlin, MD; Kloner, RA; Kuritzky, L; Miller, TA; Padma-Nathan, H; Rosen, RC	1
Bella, AJ; Brock, GB	1
Denne, J; Emmick, JT; Hutter, AM; Jackson, G; Kloner, RA; Mitchell, MI	1
Ahuja, S; Denne, J; Govier, F; Kaufman, J; Kovalenko, P; Potempa, AJ	1
Costigan, T; Murphy, A; Ströberg, P	1
Sohn, W	1
Naughton, K	1
Casabé, A; Denne, J; Jünemann, KP; Knight, J; Meuleman, E; Moncada, I; Montorsi, F; Pacheco, C; Segal, S; Valiquette, L; Verheyden, B; Watkins, VS	1
Beasley, CM; Costigan, T; Denne, J; Emmick, JT; Lockhart, D; Murphy, A; Rajfer, J; Segal, S; von Keitz, A	1
Salama, N	1
Romics, I	1
Kirkpatrick, P; Neumeyer, K	1
Briganti, A; Gallina, A; Montorsi, F; Rigatti, P; Salonia, A; Suardi, N	1
Abrams, J	1
Carrier, S; Carson, CC; Cordell, WH; Denne, JS; Eardley, I; Rajfer, J; Shen, W; Walker, DJ	1
Larsen, A	1
Ahuja, S; Knapp, PM; Seftel, AD; Shin, J; Wang, WC; Wilson, SK	1
Del Popolo, G; Li Marzi, V; Lombardi, G; Mondaini, N	1
Lo, V; Masood, A; Noviasky, JA	1
Basson, BR; Breza, J; Calomfirescu, N; Chen, J; Kopernicky, V; Kula, K; Skoumal, R	1
Ahuja, S; Brock, GB; Broderick, G; Hoover, A; McCullough, A; Montorsi, F; Murphy, A; Nathan, HP; Novack, D; Varanese, L; Whitaker, S	1
Gibson, L	1
Brandetti, F; Carosa, E; Di Stasi, SM; Jannini, EA; Lenzi, A; Lombardo, F; Martini, P	1
Fox, PD; Peter, NM; Singh, MV	1
Allerheiligen, SR; Forgue, ST; Mackie, A; Rapado, J; Staab, A; Tillmann, C; Trocóniz, IF	1
Austoni, E; Beardsworth, A; Eardley, I; Gentile, V; Hackett, G; Lembo, D; Wang, C	1
Schmitt, H; Schulman, CC; Shen, W; Stothard, DR	1
Berzas Nevado, JJ; Castañeda Peñalvo, G; Mora Diez, N; Rodríguez Flores, J	1
Kloner, RA	2
Keil, TU	1
McCullough, A	1
Wooten, JM	1
Denne, J; Fonseca, V; Fredlund, P; Seftel, A	1
Aversa, A; Fabbri, A; Fini, M; Rosano, GM; Spera, G; Vitale, C	1
Hogan, MJ	1
Goldstein, I; Lewis, JH; Rosen, R	1
Carson, C; Fredlund, P; Kuepfer, C; Murphy, A; Segal, S; Shabsigh, R	1
Perimenis, P	1
Doggrell, SA	1
Anghelescu, I; Urbanek, C	1
Campbell, HE	1
Escaravage, GK; Givre, SJ; Wright, JD	1
Bollinger, K; Lee, MS	1
Fredlund, P; Jesudason, DR; Lording, DW; Lowy, MP; McMahon, CG; Murphy, A; Palmer, NR; Shin, J; Stuckey, BG; Sutherland, PD; Wittert, GA	1
Whitehill, D	1
Chan, M; Cordell, WH; Costa, P; Damber, JE; Holmes, S; Lembo, D; Mirone, V; Moncada, I; Van Ahlen, H; Varanese, L; Wespes, E	1
Takahashi, Y	1
Bettella, A; Caretta, N; Ferlin, A; Foresta, C; Garolla, A; Palego, P; Selice, R	1
Adomat, H; Eberding, A; Fleshner, N; Guns, E; Harvey, M; Hersey, K; Wood, C	1
Hallock, M; King, SH; Strote, J; Wessells, H	1
Hatzichristou, DG; Hatzimouratidis, K	1
Bakhtyari, A; Beasley, CM; Bedding, AW; Cantilena, LR; Costigan, TM; Dmitrienko, AA; Emmick, JT; Kloner, RA; Mitchell, MI; Ruskin, JN; Shen, W; Turik, MA; Warner, MR	1
Gupta, M; Kovar, A; Meibohm, B	1
Basson, BR; Hatzichristou, D; Kopernicky, V; Papp, G; Pushkar, D; Vardi, Y	1
Ahuja, S; Burnett, AL; Eardley, I; Ellsworth, PI; Garcia, CS; Natanegara, F; Shabsigh, R; Sharlip, ID	1
Hackett, GI	1
Huang, YR; Jin, W	1
Brandetti, F; Carosa, E; Jannini, EA; Lombardo, F; Martini, P	1
Carson, CC	2
Barbieri, L; Briganti, A; Deho', F; Montorsi, F; Rigatti, P; Salonia, A; Zanni, G	1
Beardsworth, A; Eardley, I; Kell, P; Mirone, V; Montorsi, F; Ralph, D; Warner, MR; Zhao, Y	1
Brown, M; Lambert, SM; Masson, P; Shabsigh, R	1
Kuritzky, L; Rosen, RC; Shabsigh, R; Sides, GD; Wang, WC	1
Hayreh, SS	1
Ficorelli, CT; Weeks, B	1
Burhani, S; Harnett, JP; McLaughlin, TP; Mulhall, JP; Russell, D; Scott, B	1
Casariego, J; Chan, M; Damber, JE; Mirone, V; Moncada, I; Varanese, L; Wespes, E	1
Anglin, G; Beasley, CM; Brock, GB; Carrier, S; Pommerville, PJ; Shin, J; Whitaker, S	1
Broderick, G; Cameron, A; Lockhart, D; Rosen, R; Shabsigh, R; Swindle, R	1
Ahuja, S; Eardley, I; Lewis, RW; O'Leary, M; Sadovsky, R; Seftel, A; Shen, W; Walker, DJ; Wang, WC; Wong, DG	1
McMahon, C	2
Corbin, J; Montorsi, F; Phillips, S	1
Costigan, TM; Emmick, JT; Jackson, G; Kloner, RA; Warner, MR	1
Padma-Nathan, H; Pullman, W; Rosen, RC; Saikali, K; Shabsigh, R; Watkins, V	1
Chen, KK; Costigan, TM; Emmick, JT; Huang, ST; Jiann, BP; Ju-Ton, H; Lee, SS; Lin, JS; Su, CK; Wang, CJ	1
Pomeranz, HD	1
Hall, TA; McGwin, G; Owsley, C; Vaphiades, MS	1
Briganti, A; Gallina, A; Montorsi, F; Montorsi, P; Rigatti, P; Saccà, A; Salonia, A	1
Dyachkova, Y; Gatchalian, E; Glina, S; Kopernicky, V; Markey, C; Sotomayor, M; Yaman, O	1
Oguz, H; Verit, A	1
Diede, HE; Saad, F; Yassin, AA	1
Agarwal, A; Nandipati, KC; Raina, R; Zippe, CD	1
Hedelin, H; Ljunggren, C; Ströberg, P	1
Bekos, A; Hatzichristou, D; Hatzimouratidis, K; Ioannidis, E; Moysidis, K; Tsimtsiou, Z	1
Elkin, S	1
Wolfe, SM	1
Hou, P; Koh, HL; Low, MY; Zou, P	1
Ambrosini, S; Crescioli, C; Donati, S; Filippi, S; Forti, G; Luconi, M; Maggi, M; Mirone, V; Morelli, A; Vannelli, GB; Vignozzi, L; Zhang, XH	1
Ahuja, S; Barada, J; Donatucci, C; Garcia, CS; Morgentaler, A; Natanegara, F; Niederberger, C; Wong, DG	1
Bradley, JD; Carson, CC; Fischer, CJ; Florio, VA; McMahon, CG; Wang, WC	1
Buvat, J; Chan, M; Kuepfer, C; Schmitt, H; van Ahlen, H; Varanese, L	1
Bivalacqua, TJ; Burnett, AL; Champion, HC; Musicki, B	1
Casariego, J; Cassinello, A; Lledó García, E; Mo, D; Rajmil, O; Rodríguez Vela, L	1
Fang, JJ; Li, FY; Zhu, XW	1
Chan, M; Costigan, TM; Hutter, AM; Jackson, G; Kloner, RA; Mittleman, MA; Vail, GM; Warner, MR	1
Casabé, AR; Elion-Mboussa, A; Giuliano, F; Glina, S; Porst, H; Ralph, D; Shen, W; Whitaker, JS	1
Cappelleri, JC; Sobel, RE	1
Chartier-Kastler, E; Denys, P; Previnaire, JG; Soler, JM	1
Abramson, DH; Folberg, R; Lin, A; Odell, P; Rollins, IS	1
Chan, M; Cheong, NF; Ding, Q; Guo, YL; Lim, E; Pan, TM; Shen, W; Venugopalan, M; Wang, YX; Zhu, JC	1
Beardsworth, A; Dean, J; Gentile, V; Hackett, GI; Pirozzi-Farina, F; Rosen, RC; Warner, MR; Zhao, Y	1
Ahuja, S; Broderick, GA; Donatucci, CF; Hatzichristou, D; Loughney, K; Sides, GD; Torres, LO; Valiquette, L; Zhao, Y	1
Aversa, A; Bruzziches, R; Corona, G; Greco, EA; Pili, M; Spera, G	1
McMahon, CG	1
Beheiry, A; Esen, A; Kadioglu, A; Khalaf, I; Kopernicky, V; Saylan, M; Shoair, KZ; Wang, WC	1
Kim, SC	1
Chiang, HS; Kopernicky, V; Li, MK; Mendoza, JB; Tan, HM; Wang, WC; Yip, WC	1
Bedding, AW; Forgue, ST; Jewell, H; Mitchell, MI; Patterson, BE; Payne, CD; Phillips, DL; Wrishko, RE	1
Wooltorton, E	1
Prisant, LM	1
van Driel, MF	1
Brock, G; Chan, J; Chan, M; Dickson, R; Gagnon, R; Krisdaphongs, M; Lee, J; Mehta, P; Pommerville, P	1
Campaña, JMC; Ciutat, LF; Miranda, EF; Tolrà, JR	1
Hatzichristou, D; Hatzimouratidis, K	1
Hop, WC; Incrocci, L; Slagter, C; Slob, AK	1
Gopalakrishanan, G; Tharyan, P	1
Ahuja, S; Althof, SE; Brock, GB; Dunn, ME; Eid, JF; Natanegara, F; Talley, DR; Tomlin, ME	1
Koh, HL; Low, MY; Oh, SS; Zou, P	1
Ahuja, S; Deeley, MC; Garcia, CS; Giuliano, F; Porst, H; Rosen, RC; Seftel, AD; Shabsigh, R	1
Ishii, N; Kamidono, S; Kimoto, Y; Marumo, K; Nagao, K; Tsujimura, A; Vail, GM; Watts, S	1
Belger, M; Berglund, O; Eliasson, T; Fugl-Meyer, AR; Fugl-Meyer, KS; Stothard, D; Toll, A	1
Casariego García-Lubén, J; Cassinello Hervás, A; Chan, M; Cruz Navarro, N; Martín-Morales, A; Moncada Iribarren, I; Sanz Terrada, B	1
Beardsworth, A; Bertsch, J; Haro, JM; Kontodimas, S; Martin-Morales, A	1
Fujimoto, K; Imaoka, T; Marumo, K; McGill, J; Stothard, D; Watts, S	1
Buvat, J; Costa, P; Hamidi, K; Holmes, S; Petto, H; Varanese, L; Weitckus, S	1
Bocchio, M; Desideri, G; Ferri, C; Francavilla, F; Francavilla, S; Mihalca, R; Necozione, S; Passaquale, G; Pelliccione, F	1
Brock, G; Carrier, S; Chan, J; Chan, M; Dickson, R; Gutkin, S; Horner, R; Klein, AH; Lang, C; Salgado, L	1
Gustafsson, LE; Hallén, K; Wiklund, NP	1
Chen, B; Hu, JL	1
Calogero, AE; Cannizzaro, MA; Condorelli, R; La Vignera, S; Noto, Z; Vicari, E	1
Dickson, RA; Lee, J; Segraves, RT; Stevenson, R; Walker, DJ; Wang, WC	1
Chan, M; Jungwirth, A; Moncada, I; Schmitt, H; Varanese, L; Wespes, E	1
Ahuja, S; Goldstein, I; Kim, E; Natanegara, F; Pryor, JL; Steers, WD; Wilde, DW; Wong, DG	1
Kukreja, RC	1
Nini, A; Vardi, M	1
Boshier, A; Harris, S; Hazell, L; Shakir, SA; Wilton, LV	1
Bridge, S; Harnett, JP; Hvidsten, K; Kell, PD; Morant, SV	1
Fusco, F; Imbimbo, C; Longo, N; Mirone, V; Rossi, A; Sicuteri, R; Valle, D	1
Hackett, G	1
Beardsworth, A; Chan, ML; Eardley, I; Jackson, G; Loughney, K; Mirone, V; Montorsi, F; Vail, GM	1
Aversa, A; Bruzziches, R; Letizia, C; Menghi, G; Merla, A; Proietti, M; Rossi, C; Salsano, F; Spera, G	1
Antonijević, N; Dabetić, M; Dimitrijević-Srecković, V; Dordević, P; Gostiljac, D; Matanović, D; Milić, G; Nale, D; Nisić, T; Popović, S; Vujović, S	1
Chodorowski, Z; Korolkiewicz, RP; Kozłowska-Boszko, B; Roszkowska-Kranc, K; Sein Anand, J; Tajanko, E	1
Barbieri, L; Briganti, A; Dehò, F; Gallina, A; Guazzoni, G; Montorsi, F; Rigatti, P; Saccà, A; Salonia, A; Suardi, N; Zanni, G	1
Casariego, J; Cruz, N; Dahl, P; Del Popolo, G; Elion-Mboussa, A; Giuliano, F; Leriche, A; Löchner-Ernst, D; Lombardi, G; Reichert, S; Sanchez-Ramos, A	1
Beardsworth, A; Belger, M; Bertsch, J; Haro, JM; Hatzichristou, D; Martin-Morales, A; Riley, A; von Keitz, A; Wolka, AM	1
Chan, AY; Lai, CK; Lam, YH; Mak, TW; Poon, WT	1
Bocchio, M; Ciociola, F; Francavilla, F; Francavilla, S; Mihalca, R; Necozione, S; Pelliccione, F; Rossi, A	1
Huang, YF; Wang, HY	1
Gittelman, M; Hellstrom, WJ; Jarow, J; McGill, JM; McMurray, J; Mitchell, CL; Steidle, C; Talley, D; Watts, S	1
Ahn, TY; Dwight, T; Dyachkova, Y; Kim, SW; Lee, MS; Lee, SW; Min, KS; Paick, JS; Park, K; Park, NC; Yang, DY	1
Ballanger, P; Calvet, C; Eftekhari, P; Farghal, H; Martin, K; Molimard, M; Moore, N; Robert, G	1
Andrade, E; Andrade, PM; Borra, RC; Claro, J; Srougi, M	1
Frajese, G; Frajese, GV; Pozzi, F	1
Hedelin, H; Ljunggren, C; Salomonsson, K; Ströberg, P	1
Canale, D; Francesca, F; Pomara, G; Turchi, P	1
Hop, WC; Incrocci, L; Slob, AK	1
Kieback, A; Kloner, RA; Reffelmann, T	1
El-Dakhly, M; Ghanem, H; Shamloul, R	1
Aversa, A; Bruzziches, R; Francomano, D; Greco, EA; Pili, M; Spera, G	1
Alexandre, L; Behr-Roussel, D; Charles Tremeaux, J; Combes, M; Giuliano, F; Gorny, D; Oger, S	1
Brock, GB; Buvat, J; Gambla, M; Hatzichristou, D; Liang, S; Lording, D; Rose, L; Rubio-Aurioles, E; Spera, G	1
Goldfischer, E; Hakim, LS; Natanegara, F; Sharlip, ID; Shumaker, BP; Wong, DG	1
Conaglen, HM; Conaglen, JV	1
Arver, S; Belger, M; Bitton, A; Roumeguère, T; Schmitt, H; Verheyden, B	1
Esposito, S; Galarza, M; Gazzeri, R; Neroni, M	1
Casabé, A; Filimon, I; Glina, S; Kopernicky, V; Leñero, E; Quinzaños, L; Rubio-Aurioles, E; Torres, LO	1
Liu, ZY; Sun, YH	1
Jung, F; Leithäuser, B; Park, JW	1
Ferguson, KM; McMurray, JG; Padma-Nathan, H; Pullman, WE; Rosen, RC; Saoud, JB; Whitaker, JS	1
Brock, G	1
Porst, H	1
Cartledge, J; Eardley, I	1

Reviews

133 review(s) available for tadalafil and Erectile Dysfunction

Article	Year
Recreational Use of Oral PDE5 Inhibitors: The Other Side of Midnight. Sexual medicine reviews, 2022, Volume: 10, Issue:3 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2022
Lodenafil. Profiles of drug substances, excipients, and related methodology, 2022, Volume: 47 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2022
Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives. International journal of molecular sciences, 2022, Apr-11, Volume: 23, Issue:8 Topics: Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Hormones; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Steroids; Tadalafil; Treatment Outcome	2022
Prostaglandins as a Topical Therapy for Erectile Dysfunction: A Comprehensive Review. Sexual medicine reviews, 2022, Volume: 10, Issue:4 Topics: Alprostadil; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Prostaglandins; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2022
Discontinuation Rates of Tadalafil Alone and in Combination with a-Blockers in the Treatment of Male Lower Urinary Tract Symptoms with or without Coexisting Erectile Dysfunction: A Systematic Review and Meta-Analysis. International journal of clinical practice, 2022, Volume: 2022 Topics: Combined Modality Therapy; Erectile Dysfunction; Health Care Costs; Humans; Lower Urinary Tract Symptoms; Male; Tadalafil	2022
An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review. Sexual medicine reviews, 2023, 06-27, Volume: 11, Issue:3 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Quality of Life; Sildenafil Citrate; Tadalafil; United States	2023
Chinese herbal medicine combined with tadalafil for erectile dysfunction: a systematic review and meta-analysis. Andrology, 2020, Volume: 8, Issue:2 Topics: Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2020
Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration? Acta medica Indonesiana, 2019, Volume: 51, Issue:3 Topics: Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome	2019
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease. British journal of pharmacology, 2020, Volume: 177, Issue:24 Topics: Cardiovascular Diseases; Erectile Dysfunction; Humans; Hypertension; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil	2020
[Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction]. Urologiia (Moscow, Russia : 1999), 2019, 12-31, Issue:6 Topics: Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Treatment Outcome; Vasodilator Agents	2019
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis. BioMed research international, 2020, Volume: 2020 Topics: Bayes Theorem; Databases, Factual; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Safety; Sildenafil Citrate; Tadalafil; Tamsulosin; Treatment Outcome	2020
Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors? The journal of sexual medicine, 2020, Volume: 17, Issue:8 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Priapism; Sildenafil Citrate; Tadalafil	2020
Phosphodiesterases 5 Inhibitors and Erectile Dysfunction Recovery after Pelvic Surgery: Future Perspectives for New Drugs and New Formulations. Current drug targets, 2021, Volume: 22, Issue:1 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostatectomy; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2021
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED. Current urology reports, 2020, Oct-27, Volume: 21, Issue:12 Topics: Combined Modality Therapy; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2020
Drug adulteration of sexual enhancement supplements: a worldwide insidious public health threat. Fundamental & clinical pharmacology, 2021, Volume: 35, Issue:5 Topics: Dietary Supplements; Drug Contamination; Erectile Dysfunction; Global Health; Humans; Male; Marketing; Public Health; Tadalafil	2021
Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis. JAMA network open, 2021, 02-01, Volume: 4, Issue:2 Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Combined Modality Therapy; Drug Therapy, Combination; Equipment and Supplies; Erectile Dysfunction; Extracorporeal Shockwave Therapy; Folic Acid; Humans; Hypoglycemic Agents; Male; Metformin; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Treatment Outcome; Vitamin B Complex	2021
[Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future]. Urologiia (Moscow, Russia : 1999), 2017, Issue:1 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2017
Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses. Urologia internationalis, 2017, Volume: 99, Issue:3 Topics: Chi-Square Distribution; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Odds Ratio; Penile Erection; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Recovery of Function; Risk Factors; Tadalafil; Time Factors; Treatment Outcome; Urological Agents	2017
Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. International urology and nephrology, 2017, Volume: 49, Issue:10 Topics: Back Pain; Controlled Clinical Trials as Topic; Erectile Dysfunction; Flushing; Humans; Male; Myalgia; Patient Preference; Phosphodiesterase 5 Inhibitors; Self Efficacy; Sildenafil Citrate; Tadalafil	2017
The Efficacy of Tadalafil Daily vs on Demand in the Treatment of Erectile Dysfunction: A Systematic Review and Meta-analysis. Urology, 2018, Volume: 112 Topics: Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Observational Studies as Topic; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome	2018
Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis. Lower urinary tract symptoms, 2018, Volume: 10, Issue:1 Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Severity of Illness Index; Tadalafil	2018
Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The aging male : the official journal of the International Society for the Study of the Aging Male, 2018, Volume: 21, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2018
Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails. Sexual medicine reviews, 2019, Volume: 7, Issue:3 Topics: Administration, Oral; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Treatment Failure; Treatment Outcome; Vasodilator Agents	2019
Tadalafil for the treatment of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:8 Topics: 5-alpha Reductase Inhibitors; Animals; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Tadalafil; Treatment Outcome	2019
The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue. Andrology, 2019, Volume: 7, Issue:6 Topics: Administration, Mucosal; Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Male; Middle Aged; Mouth Mucosa; Patient Compliance; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Quality of Life; Sexual Behavior; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2019
[Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors]. Der Urologe. Ausg. A, 2013, Volume: 52, Issue:2 Topics: Carbolines; Controlled Clinical Trials as Topic; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostatic Hyperplasia; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Urodynamics; Vardenafil Dihydrochloride	2013
Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia. Pharmacotherapy, 2013, Volume: 33, Issue:6 Topics: Carbolines; Drug Approval; Erectile Dysfunction; Half-Life; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; United States; United States Food and Drug Administration	2013
Daily dosing of PDE5 inhibitors: where does it fit in? Current urology reports, 2013, Volume: 14, Issue:4 Topics: Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil	2013
Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a meta-analysis. Urologia internationalis, 2013, Volume: 91, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Patient Safety; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Risk; Tadalafil; Treatment Outcome; Urinary Tract; Urologic Diseases; Urological Agents	2013
Pharmacologic therapy for erectile dysfunction and its interaction with the cardiovascular system. Journal of cardiovascular pharmacology and therapeutics, 2014, Volume: 19, Issue:1 Topics: Animals; Carbolines; Cardiovascular Diseases; Cardiovascular System; Erectile Dysfunction; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2014
Tadalafil - a therapeutic option in the management of BPH-LUTS. International journal of clinical practice, 2014, Volume: 68, Issue:1 Topics: Aged; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Multicenter Studies as Topic; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome; Urodynamics; Urological Agents	2014
[Tadalafil for erectile dysfunction associated with cardiovascular diseases]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:9 Topics: Carbolines; Cardiovascular Diseases; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2013
PDE-5 inhibitors: clinical points. Current drug targets, 2015, Volume: 16, Issue:5 Topics: Cardiovascular Diseases; Drug Incompatibility; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; Vasodilator Agents	2015
Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Andrologia, 2016, Volume: 48, Issue:1 Topics: Erectile Dysfunction; Humans; Male; Organ Sparing Treatments; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prostatectomy; Pyrimidines; Sildenafil Citrate; Tadalafil; Treatment Outcome; Vardenafil Dihydrochloride	2016
Erectile function post robotic radical prostatectomy: technical tips to improve outcomes? Journal of robotic surgery, 2016, Volume: 10, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Intraoperative Complications; Libido; Lithotripsy; Male; Middle Aged; Organ Sparing Treatments; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Robotic Surgical Procedures; Tadalafil; Trauma, Nervous System; Treatment Outcome; Young Adult	2016
Effectiveness of Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction in Patients with Spinal Cord Trauma: Systematic Review and Meta-Analysis. Urologia internationalis, 2017, Volume: 98, Issue:2 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Sildenafil Citrate; Spinal Cord Injuries; Tadalafil; Treatment Outcome; Vardenafil Dihydrochloride; Young Adult	2017
Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer. Scientific reports, 2016, 09-09, Volume: 6 Topics: Adolescent; Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Sildenafil Citrate; Tadalafil; Treatment Outcome; Young Adult	2016
Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors. Sexual medicine reviews, 2016, Volume: 4, Issue:3 Topics: Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Treatment Outcome; Vardenafil Dihydrochloride	2016
[Pharmacological, pharmacokinetic, and clinical profile of tadalafil (Cialis)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 131, Issue:6 Topics: Blood Pressure; Carbolines; Cyclic GMP; Erectile Dysfunction; Food-Drug Interactions; Humans; Male; Muscle Relaxation; Muscle, Smooth; Penis; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil	2008
Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Current medical research and opinion, 2008, Volume: 24, Issue:12 Topics: Adult; Aged; Carbolines; Clinical Trials as Topic; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Safety; Tadalafil	2008
Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies. BJU international, 2009, Volume: 103, Issue:9 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Quality of Life; Self Concept; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2009
Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. The journal of sexual medicine, 2009, Volume: 6, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Reproduction; Sildenafil Citrate; Spinal Cord Injuries; Sulfones; Surveys and Questionnaires; Tadalafil; Triazines; Vardenafil Dihydrochloride; Young Adult	2009
Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia? BJU international, 2009, Volume: 104, Issue:4 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Prostatic Hyperplasia; Prostatism; Purines; Quality of Life; Quinazolines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2009
[Tadalafil for erectile dysfunction: excellent safety and tolerance]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:1 Topics: Carbolines; Drug Tolerance; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2009
[Tadalafil for erectile dysfunction: efficacy evaluation]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:4 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2009
Five-year experience with tadalafil in the UK: an effective treatment for erectile dysfunction. International journal of clinical practice, 2009, Volume: 63, Issue:8 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome; United Kingdom; Young Adult	2009
Penile rehabilitation. The American journal of nursing, 2009, Volume: 109, Issue:9 Topics: Alprostadil; Carbolines; Causality; Clinical Protocols; Erectile Dysfunction; Fibrosis; Humans; Male; Nurse's Role; Penile Prosthesis; Penis; Phosphodiesterase Inhibitors; Piperazines; Postoperative Care; Prostatectomy; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Vasodilator Agents	2009
Tadalafil for the treatment of pulmonary arterial hypertension. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:1 Topics: Carbolines; Erectile Dysfunction; Half-Life; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilator Agents	2010
[Efficacy and safety of tadalafil for erectile dysfunction: an updated review]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:10 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2009
Management of erectile dysfunction. American family physician, 2010, Feb-01, Volume: 81, Issue:3 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Factors; Risk Reduction Behavior; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2010
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition. BJU international, 2010, Volume: 105, Issue:12 Topics: Carbolines; Drug Administration Schedule; Epidemiologic Methods; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2010
A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy. Drug design, development and therapy, 2010, Sep-07, Volume: 4 Topics: Animals; Carbolines; Drug Administration Schedule; Drug Approval; Erectile Dysfunction; Humans; Male; Medication Adherence; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil; United States; United States Food and Drug Administration	2010
Prevalence and medical management of erectile dysfunction in Asia. Asian journal of andrology, 2011, Volume: 13, Issue:4 Topics: Adult; Aged; Asia; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prevalence; Purines; Pyrimidines; Pyrimidinones; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfonamides; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2011
Erectile dysfunction. BMJ clinical evidence, 2011, Jun-29, Volume: 2011 Topics: Double-Blind Method; Erectile Dysfunction; Humans; Phosphodiesterase Inhibitors; Prostatectomy; Sildenafil Citrate; Tadalafil	2011
Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil. BJU international, 2012, Volume: 109, Issue:7 Topics: Carbolines; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Sexual Dysfunctions, Psychological; Tadalafil	2012
Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men. The Urologic clinics of North America, 2012, Volume: 39, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Carbolines; Disease Progression; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Men's Health; Middle Aged; Neurotransmitter Agents; Piperazines; Prognosis; Prostatic Hyperplasia; Purines; Receptors, Neurotransmitter; Risk Assessment; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2012
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. European urology, 2012, Volume: 61, Issue:5 Topics: Adrenergic alpha-Antagonists; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostatic Hyperplasia; Purines; Pyrimidines; Sildenafil Citrate; Sulfonamides; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2012
Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks. Journal of pharmaceutical and biomedical analysis, 2012, Volume: 69 Topics: Carbolines; Chemistry Techniques, Analytical; Cyclic Nucleotide Phosphodiesterases, Type 5; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Imidazoles; Ions; Male; Models, Chemical; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2012
Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalafil once-daily. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:10 Topics: Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Tadalafil	2012
The role of initial success rates and other factors in determining reliability of outcomes of phosphodiesterase inhibitor therapy for erectile dysfunction: a pooled analysis of 17 placebo-controlled trials of tadalafil for use as needed. The journal of sexual medicine, 2013, Volume: 10, Issue:2 Topics: Adult; Aged; Carbolines; Coitus; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Reproducibility of Results; Tadalafil; Treatment Outcome	2013
Tadalafil: in the treatment of signs and symptoms of benign prostatic hyperplasia with or without erectile dysfunction. Drugs & aging, 2012, Volume: 29, Issue:9 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Safety; Tadalafil	2012
Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. The journal of sexual medicine, 2013, Volume: 10, Issue:3 Topics: Aged; Carbolines; Coitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Tadalafil	2013
Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management. The journal of sexual medicine, 2013, Volume: 10, Issue:2 Topics: 5-alpha Reductase Inhibitors; Affect; Antidepressive Agents; Antihypertensive Agents; Carbolines; Comorbidity; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Long-Term Care; Male; Medication Adherence; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Self Concept; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2013
[Tadalafil rehabilitation therapy for erectile dysfunction following prostatectomy]. Zhonghua nan ke xue = National journal of andrology, 2012, Volume: 18, Issue:10 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Prostatectomy; Prostatic Neoplasms; Tadalafil	2012
SOP conservative (medical and mechanical) treatment of erectile dysfunction. The journal of sexual medicine, 2013, Volume: 10, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alprostadil; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Pyrimidines; Risk Factors; Sulfonamides; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine	2013
Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:2 Topics: Adrenergic alpha-Antagonists; Carbolines; Drug Resistance; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostate; Prostatic Hyperplasia; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2013
Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. European urology, 2013, Volume: 63, Issue:5 Topics: Administration, Oral; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Odds Ratio; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Risk Assessment; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2013
[New medications for treatment of erectile dysfunction]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 6 Topics: alpha-MSH; Arginine; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Peptides, Cyclic; Phosphodiesterase Inhibitors; Pinacidil; Piperazines; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2002
Phosphodiesterase 5 inhibitors: current status and potential applications. Nature reviews. Drug discovery, 2002, Volume: 1, Issue:9 Topics: Carbolines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Structure-Activity Relationship; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2002
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature. European journal of medical research, 2002, Oct-29, Volume: 7, Issue:10 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Contraindications; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Prevalence; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2002
Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:11 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil	2002
Pharmacological management of erectile dysfunction. BJU international, 2003, Volume: 91, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combinations; Erectile Dysfunction; Humans; Imidazoles; Injections; Male; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2003
Tadalafil Lilly ICOS. Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil	2003
Tadalafil: a new agent for erectile dysfunction. The Canadian journal of urology, 2003, Volume: 10 Suppl 1 Topics: Administration, Oral; Aged; Carbolines; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2003
The phosphodiesterase inhibitor 'war'. BJU international, 2003, Volume: 91, Issue:6 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Patient Compliance; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2003
[How effective are PDE-5 inhibitors?]. Der Urologe. Ausg. A, 2003, Volume: 42, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Imidazoles; Male; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2003
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annual review of sex research, 2002, Volume: 13 Topics: Carbolines; Clinical Trials as Topic; Cyclic GMP; Erectile Dysfunction; Female; Humans; Imidazoles; Male; Muscle, Smooth; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2002
Phosphodiesterase 5 inhibitors in male sexual dysfunction. Current opinion in urology, 2003, Volume: 13, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2003
Tadalafil. Drugs, 2003, Volume: 63, Issue:20 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Dose-Response Relationship, Drug; Drug Interactions; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome	2003
Cialis (tadalafil): a new treatment for erectile dysfunction. Hospital medicine (London, England : 1998), 2003, Volume: 64, Issue:10 Topics: Carbolines; Clinical Trials, Phase III as Topic; Erectile Dysfunction; Humans; Male; Multicenter Studies as Topic; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil	2003
Review of tadalafil in the treatment of erectile dysfunction. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:11 Topics: Aged; Carbolines; Drug Interactions; Erectile Dysfunction; Humans; Male; Patient Compliance; Phosphodiesterase Inhibitors; Tadalafil	2003
Overview of phosphodiesterase 5 inhibition in erectile dysfunction. The American journal of cardiology, 2003, Nov-06, Volume: 92, Issue:9A Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2003
Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction. The American journal of cardiology, 2003, Nov-06, Volume: 92, Issue:9A Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Erectile Dysfunction; Humans; Male; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Tadalafil	2003
Cardiovascular effects of tadalafil. The American journal of cardiology, 2003, Nov-06, Volume: 92, Issue:9A Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cardiovascular Diseases; Cardiovascular System; Drug Interactions; Erectile Dysfunction; Hemodynamics; Humans; Male; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Tadalafil	2003
Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. The American journal of cardiology, 2003, Nov-06, Volume: 92, Issue:9A Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antihypertensive Agents; Carbolines; Cardiovascular System; Clinical Trials as Topic; Drug Interactions; Erectile Dysfunction; Hemodynamics; Humans; Hypertension; Male; Phosphodiesterase Inhibitors; Tadalafil	2003
Tadalafil in the treatment of erectile dysfunction. Current urology reports, 2003, Volume: 4, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Evaluation; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome	2003
Oral drug treatment of erectile dysfunction. International journal of impotence research, 2003, Volume: 15 Suppl 7 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Apomorphine; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2003
[Pleasure and pain in sexual relations. The basis and reasons for sex counseling by the general practitioner]. MMW Fortschritte der Medizin, 2003, Nov-13, Volume: 145, Issue:46 Topics: Adult; Carbolines; Erectile Dysfunction; Family Practice; Female; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Physician-Patient Relations; Piperazines; Purines; Risk Factors; Sex Counseling; Sex Factors; Sexual Dysfunction, Physiological; Sexuality; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilator Agents	2003
Treatment of erectile dysfunction. International journal of STD & AIDS, 2004, Volume: 15, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Molecular Structure; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vacuum; Vardenafil Dihydrochloride; Vasodilator Agents	2004
[Treatment of erectile dysfunction]. Orvosi hetilap, 2004, Feb-29, Volume: 145, Issue:9 Topics: Adrenergic alpha-Antagonists; Androgens; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phytotherapy; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents; Yohimbine	2004
Emerging oral drugs for erectile dysfunction. Expert opinion on emerging drugs, 2004, Volume: 9, Issue:1 Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Apomorphine; Carbolines; Comorbidity; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dopamine Agonists; Double-Blind Method; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Multicenter Studies as Topic; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Second Messenger Systems; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2004
The efficacy and safety of tadalafil: an update. BJU international, 2004, Volume: 93, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome	2004
[Old and new treatments of erectile dysfunction]. Duodecim; laaketieteellinen aikakauskirja, 2004, Volume: 120, Issue:10 Topics: Administration, Oral; Adult; Carbolines; Combined Modality Therapy; Erectile Dysfunction; Finland; Follow-Up Studies; Humans; Injections, Intralesional; Male; Middle Aged; Piperazines; Purines; Risk Assessment; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome	2004
New oral drugs for erectile dysfunction. Drug and therapeutics bulletin, 2004, Volume: 42, Issue:7 Topics: Apomorphine; Carbolines; Dopamine Agonists; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Randomized Controlled Trials as Topic; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation, 2004, Nov-09, Volume: 110, Issue:19 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents	2004
Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies. Current urology reports, 2004, Volume: 5, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
Erectile dysfunction. RN, 2004, Volume: 67, Issue:10 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Patient Selection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:1 Topics: Carbolines; Controlled Clinical Trials as Topic; Cross-Over Studies; Erectile Dysfunction; Humans; Imidazoles; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Clinical monograph for drug formulary review: erectile dysfunction agents. Journal of managed care pharmacy : JMCP, 2005, Volume: 11, Issue:2 Topics: Carbolines; Drug Information Services; Erectile Dysfunction; Formularies as Topic; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
[Erectile dysfunction (ED) and diabetes mellitus]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Diabetic Neuropathies; Diagnosis, Differential; Erectile Dysfunction; Humans; Imidazoles; Male; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2005
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs, 2005, Volume: 65, Issue:12 Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamine Agonists; Drug Combinations; Enzyme Inhibitors; Erectile Dysfunction; Humans; Imidazoles; Male; Papaverine; Patient Satisfaction; Penile Prosthesis; Penis; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2005
The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction. Journal of clinical pharmacology, 2005, Volume: 45, Issue:9 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Biological Availability; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Cytochrome P-450 CYP3A; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Metabolic Clearance Rate; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. BJU international, 2005, Volume: 96, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Time Factors; Treatment Outcome	2005
Patient preferences in treatment of erectile dysfunction: the continuing importance of patient education. Clinical cornerstone, 2005, Volume: 7, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Patient Education as Topic; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Safety; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2005
[Treatment of erectile dysfunction after radical retropubic prostatectomy with PDE5 inhibitor]. Zhonghua nan ke xue = National journal of andrology, 2005, Volume: 11, Issue:9 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Prostatectomy; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
The therapeutic dilemma: how to use tadalafil. International journal of andrology, 2005, Volume: 28 Suppl 2 Topics: Carbolines; Diabetes Complications; Endothelium, Vascular; Erectile Dysfunction; Half-Life; Humans; Male; Nervous System Diseases; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil; Vasodilator Agents	2005
Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. World journal of urology, 2005, Volume: 23, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
PDE-5 inhibitors: current status and future trends. The Urologic clinics of North America, 2005, Volume: 32, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Forecasting; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship? Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2005, Volume: 25, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Optic Disk; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterases. Current pharmaceutical design, 2005, Volume: 11, Issue:31 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions. The American journal of cardiology, 2005, Dec-26, Volume: 96, Issue:12B Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2005
Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors. The American journal of cardiology, 2005, Dec-26, Volume: 96, Issue:12B Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Blood Pressure; Carbolines; Clinical Trials as Topic; Coronary Artery Disease; Cyclic Nucleotide Phosphodiesterases, Type 5; Electrophysiology; Erectile Dysfunction; Heart Rate; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
The efficacy of tadalafil in clinical populations. The journal of sexual medicine, 2005, Volume: 2, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Comorbidity; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2005
Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention. The journal of sexual medicine, 2004, Volume: 1, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Ejaculation; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; RNA, Messenger; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Triazines; Urogenital System; Vardenafil Dihydrochloride	2004
Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. The journal of sexual medicine, 2004, Volume: 1, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Cardiovascular Diseases; Erectile Dysfunction; Humans; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Tadalafil	2004
Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Nature clinical practice. Urology, 2005, Volume: 2, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. Drugs & aging, 2006, Volume: 23, Issue:2 Topics: Administration, Oral; Aged; Algorithms; Alprostadil; Carbolines; Combined Modality Therapy; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Penile Prosthesis; Phosphodiesterase Inhibitors; Piperazines; Practice Guidelines as Topic; Prostatectomy; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2006
Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing. The American journal of cardiology, 2006, Jun-15, Volume: 97, Issue:12 Topics: Aged; Carbolines; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Retrospective Studies; Tadalafil	2006
Phosphodiesterase-5 inhibitors and their hemodynamic effects. Current hypertension reports, 2006, Volume: 8, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antihypertensive Agents; Blood Pressure; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Hypotension; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vascular Resistance	2006
[Phosphodiesterase inhibitors: effectiveness and new applications]. Nederlands tijdschrift voor geneeskunde, 2006, Jul-22, Volume: 150, Issue:29 Topics: Carbolines; Coronary Disease; Erectile Dysfunction; Humans; Hypertension; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Prostatic Hyperplasia; Pulmonary Disease, Chronic Obstructive; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2006
Phosphodiesterase type 5 inhibitors: the day after. European urology, 2007, Volume: 51, Issue:1 Topics: Animals; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2007
Erectile dysfunction. Clinical evidence, 2006, Issue:15 Topics: Adult; Alprostadil; Apomorphine; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Penile Prosthesis; Piperazines; Purines; Sex Counseling; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine	2006
Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction. Urology, 2006, Volume: 68, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2006
Tadalafil for treatment of erectile dysfunction in men on antidepressants. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1 Topics: Adult; Aged; Antidepressive Agents; Carbolines; Controlled Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2007
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetic Angiopathies; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2007
[Advances in the studies on the safety of tadalafil in treating erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2007, Volume: 13, Issue:3 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Tadalafil	2007
[Efficacy of tadalafil for erectile dysfunction: an updated review]. Zhonghua nan ke xue = National journal of andrology, 2007, Volume: 13, Issue:6 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Tadalafil	2007
[The safety of tadalafil in the treatment of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2007, Volume: 13, Issue:8 Topics: Back Pain; Carbolines; Erectile Dysfunction; Headache; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2007
Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence. Clinical interventions in aging, 2006, Volume: 1, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aging; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Sexual Behavior; Tadalafil	2006
The cardiovascular safety of tadalafil. Expert opinion on drug safety, 2008, Volume: 7, Issue:1 Topics: Animals; Carbolines; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Erectile Dysfunction; Humans; Male; Tadalafil	2008
Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of diabetic erectile dysfunction. Current diabetes reviews, 2008, Volume: 4, Issue:1 Topics: Carbolines; Diabetes Complications; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Retrospective Studies; Safety; Tadalafil; United States; United States Food and Drug Administration	2008
[Evaluation of tadalafil for the treatment of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2008, Volume: 14, Issue:4 Topics: Carbolines; Diabetes Mellitus; Erectile Dysfunction; Humans; Hypertension; Male; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2008
IC351 (tadalafil, Cialis): update on clinical experience. International journal of impotence research, 2002, Volume: 14 Suppl 1 Topics: Carbolines; Clinical Trials as Topic; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2002

Trials

187 trial(s) available for tadalafil and Erectile Dysfunction

Article	Year
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial. Hepatology international, 2023, Volume: 17, Issue:2 Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Liver Cirrhosis; Male; Quality of Life; Tadalafil; Treatment Outcome	2023
The Effect of Combination Treatment With Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. The journal of sexual medicine, 2022, Volume: 19, Issue:1 Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; High-Energy Shock Waves; Humans; Male; Penile Erection; Tadalafil; Treatment Outcome	2022
[Tadalafil combined with behavioral therapy and psychological counseling for erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2021, Volume: 27, Issue:4 Topics: Behavior Therapy; Combined Modality Therapy; Counseling; Erectile Dysfunction; Humans; Male; Tadalafil	2021
Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow- Investigative and clinical urology, 2022, Volume: 63, Issue:1 Topics: Adult; Arginine; Combined Modality Therapy; Drug Administration Schedule; Erectile Dysfunction; Extracorporeal Shockwave Therapy; Follow-Up Studies; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Single-Blind Method; Tadalafil; Time Factors; Treatment Outcome	2022
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial. Science translational medicine, 2022, 06-15, Volume: 14, Issue:649 Topics: Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Female; Humans; Kinetics; Male; MicroRNAs; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome; Ventricular Remodeling	2022
Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. World journal of urology, 2022, Volume: 40, Issue:8 Topics: Erectile Dysfunction; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Tadalafil; Treatment Outcome	2022
Efficacy of Adjusted Dose Tadalafil for Treating Erectile Dysfunction in Patients on Chronic Hemodialysis. Archivos espanoles de urologia, 2022, Volume: 75, Issue:5 Topics: Adult; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Renal Dialysis; Tadalafil; Treatment Outcome	2022
Comparison of three different tadalafil regimens for erectile dysfunction treatment in patients with diabetes mellitus microvascular complications. Andrologia, 2022, Volume: 54, Issue:10 Topics: Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Humans; Male; Reproducibility of Results; Tadalafil; Treatment Outcome	2022
Clinical study of comprehensive TCM therapy in the treatment of damp and hot stasis erectile dysfunction. Medicine, 2022, Oct-28, Volume: 101, Issue:43 Topics: Double-Blind Method; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Medicine, Chinese Traditional; Penile Erection; Tadalafil; Treatment Outcome	2022
Sildenafil Vs. Tadalafil for The Treatment of Benign Prostatic Hyperplasia: A Single-arm Self-controlled Clinical Trial. Urology journal, 2023, Jul-26, Volume: 20, Issue:4 Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Sildenafil Citrate; Tadalafil; Treatment Outcome; Urinary Retention	2023
[Dumai moxibustion combined with low-dose tadalafil for erectile dysfunction: Evaluation of therapeutic effect]. Zhonghua nan ke xue = National journal of andrology, 2023, Volume: 29, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Moxibustion; Penile Erection; Penis; Tadalafil; Treatment Outcome	2023
The efficacy of Tadalafil 5mg in the treatment of lower urinary tract symptoms in patients where alpha blocker treatments have failed in terms of lower urinary tract symptoms. Archivos espanoles de urologia, 2019, Volume: 72, Issue:7 Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2019
Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study. Neurourology and urodynamics, 2020, Volume: 39, Issue:1 Topics: Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2020
Effects of Chaihu-Shugan-San capsule for psychogenic erectile dysfunction: Study protocol of a randomized placebo-controlled trial. Medicine, 2019, Volume: 98, Issue:46 Topics: Adult; Double-Blind Method; Erectile Dysfunction; Humans; Male; Plant Extracts; Tadalafil; Vasodilator Agents; Young Adult	2019
The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial. The journal of sexual medicine, 2020, Volume: 17, Issue:4 Topics: Aged; Erectile Dysfunction; Extracorporeal Shockwave Therapy; Humans; Male; Middle Aged; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Prostate; Prostatectomy; Prostatic Neoplasms; Tadalafil; Treatment Outcome	2020
[Therapeutic effect of tadalafil on lower urinary tract symptoms with erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2019, Volume: 25, Issue:6 Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome	2019
[Efficacy and safety of regular use of sildenafil in the treatment of penile erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2019, Volume: 25, Issue:7 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Sildenafil Citrate; Tablets; Tadalafil; Treatment Outcome	2019
Comparison of the clinical efficacy of daily use of L-arginine, tadalafil and combined L-arginine with tadalafil in the treatment of elderly patients with erectile dysfunction. Andrologia, 2020, Volume: 52, Issue:7 Topics: Aged; Arginine; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Single-Blind Method; Tadalafil; Treatment Outcome	2020
Efficacy of testosterone replacement therapy plus alternate-day tadalafil for patients with late-onset hypogonadism: An open-label, randomized, crossover study. International journal of urology : official journal of the Japanese Urological Association, 2021, Volume: 28, Issue:4 Topics: Cross-Over Studies; Erectile Dysfunction; Humans; Hypogonadism; Male; Tadalafil; Testosterone	2021
A new original nutraceutical formulation ameliorates the effect of Tadalafil on clinical score and cGMP accumulation. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2021, Jun-28, Volume: 93, Issue:2 Topics: Adult; Aged; Dietary Supplements; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Tadalafil; Treatment Outcome	2021
Chitosan membranes applied on the prostatic neurovascular bundles after nerve-sparing robot-assisted radical prostatectomy: a phase II study. BJU international, 2018, Volume: 121, Issue:3 Topics: Aged; Biocompatible Materials; Blood Vessels; Chitosan; Erectile Dysfunction; Feasibility Studies; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Robotic Surgical Procedures; Tadalafil	2018
The efficacy of low-dose tadalafil in patients undergoing hemodialysis with end-stage renal disease. Renal failure, 2017, Volume: 39, Issue:1 Topics: Adult; Aged; Ejaculation; Erectile Dysfunction; Evidence-Based Medicine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penile Erection; Renal Dialysis; Retrospective Studies; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents	2017
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial. The journal of sexual medicine, 2017, Volume: 14, Issue:8 Topics: Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2017
[Kangle Decoction for erectile dysfunction with liver-qi stagnation and kidney deficiency]. Zhonghua nan ke xue = National journal of andrology, 2016, Volume: 22, Issue:6 Topics: Adult; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Qi; Self Concept; Sexual Behavior; Tadalafil; Treatment Outcome	2016
[Effects of different medications with tadalafil on erectile dysfunction in males with primary sexual failure]. Zhonghua nan ke xue = National journal of andrology, 2017, Volume: 23, Issue:6 Topics: Adult; Coitus; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Orgasm; Patient Satisfaction; Penile Erection; Tadalafil; Treatment Outcome; Urological Agents; Vasodilator Agents; Young Adult	2017
Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction. International journal of impotence research, 2018, Volume: 30, Issue:3 Topics: Aged; Diabetic Angiopathies; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Retrospective Studies; Tadalafil; Treatment Outcome	2018
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:2 Topics: Aged; China; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Republic of Korea; Severity of Illness Index; Tadalafil; Taiwan; Tamsulosin; Treatment Outcome	2019
Daily Oral l-Arginine Plus Tadalafil in Diabetic Patients with Erectile Dysfunction: A Double-Blinded, Randomized, Controlled Clinical Trial. The journal of sexual medicine, 2019, Volume: 16, Issue:9 Topics: Adult; Arginine; Diabetes Complications; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2019
Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. The journal of sexual medicine, 2013, Volume: 10, Issue:6 Topics: Adult; Aged; Carbolines; Drug Administration Schedule; Drug Substitution; Erectile Dysfunction; Europe; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Proportional Hazards Models; Prospective Studies; Purines; Recovery of Function; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome	2013
[Low-dose daily de-escalatory administration of tadalafil for psychological erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:3 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil; Young Adult	2013
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical stu The journal of sexual medicine, 2013, Volume: 10, Issue:8 Topics: Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostate-Specific Antigen; Prostatic Hyperplasia; Tadalafil; Urination	2013
A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy. The journal of sexual medicine, 2014, Volume: 11, Issue:3 Topics: Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2014
[Low-dose tadalafil for erectile dysfunction following pelvic fracture-induced urethral injury: clinical observation of 42 cases]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:6 Topics: Adult; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Fractures, Bone; Humans; Male; Pelvis; Tadalafil; Treatment Outcome; Urethra	2013
[Clinical efficacy of daily low-dose tadalafil on erectile dysfunction-no sexual life]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:6 Topics: Adolescent; Adult; Carbolines; Erectile Dysfunction; Humans; Male; Sexual Behavior; Tadalafil; Treatment Outcome; Young Adult	2013
Evaluation of the efficacy of once-daily use of tadalafil vs. on-demand use. Is there a cumulative effect? JPMA. The Journal of the Pakistan Medical Association, 2012, Volume: 62, Issue:11 Topics: Adult; Aged; Carbolines; Case-Control Studies; Double-Blind Method; Erectile Dysfunction; Humans; Iran; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2012
[Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:7 Topics: Adult; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Tadalafil; Testosterone; Treatment Outcome	2013
Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction. BJU international, 2013, Volume: 112, Issue:7 Topics: Carbolines; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil	2013
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. The journal of sexual medicine, 2014, Volume: 11, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention	2014
Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). European urology, 2014, Volume: 65, Issue:3 Topics: Adenocarcinoma; Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil	2014
Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andrologia, 2015, Volume: 47, Issue:1 Topics: Adult; Carbolines; Drug Therapy, Combination; Early Medical Intervention; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Tadalafil; Treatment Outcome; Young Adult	2015
[Safety and efficacy of L-carnitine and tadalafil for late-onset hypogonadism with ED: a randomized controlled multicenter clinical trial]. Zhonghua nan ke xue = National journal of andrology, 2014, Volume: 20, Issue:2 Topics: Adult; Aged; Carbolines; Carnitine; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Tadalafil; Treatment Outcome	2014
[On-demand versus on-time dosing of tadalafil for erectile dysfunction: a prospective multi-center study]. Zhonghua nan ke xue = National journal of andrology, 2014, Volume: 20, Issue:1 Topics: Adult; Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Tadalafil; Treatment Outcome	2014
Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. JAMA, 2014, Apr-02, Volume: 311, Issue:13 Topics: Adaptation, Psychological; Aged; Aged, 80 and over; Brachytherapy; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Marriage; Middle Aged; Patient Satisfaction; Prostatic Neoplasms; Radiation Injuries; Sexual Behavior; Tadalafil; Treatment Outcome; Vasodilator Agents	2014
Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction. Urology, 2014, Volume: 83, Issue:6 Topics: Administration, Oral; Adult; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Reference Values; Risk Assessment; Tadalafil; Testosterone; Treatment Outcome; Young Adult	2014
[Low-dose tadalafil combined with Shuganyiyang capsules for mild-to-moderate erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2014, Volume: 20, Issue:3 Topics: Adult; Carbolines; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Tadalafil; Treatment Outcome	2014
Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind, placebo-controlled, crossover pilot study. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:3 Topics: Adult; Antipsychotic Agents; Carbolines; Cross-Over Studies; Double-Blind Method; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Pilot Projects; Schizophrenia; Tadalafil; Treatment Outcome	2014
Exercise training improves erectile dysfunction (ED) in patients with metabolic syndrome on phosphodiesterase-5 (PDE-5) inhibitors. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013, Volume: 80, Issue:4 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Exercise; Humans; Male; Metabolic Syndrome; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2013
Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study. International journal of clinical practice, 2014, Volume: 68, Issue:9 Topics: Aged; Double-Blind Method; Drug Monitoring; Erectile Dysfunction; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Observational Studies as Topic; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2014
Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy. World journal of urology, 2015, Volume: 33, Issue:7 Topics: Aged; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Recovery of Function; Tadalafil; Treatment Outcome	2015
Regional cerebral blood flow following single-dose and continuous-dose tadalafil after stroke. Acta neurologica Scandinavica, 2014, Volume: 130, Issue:6 Topics: Adult; Aged; Carbolines; Cerebrovascular Circulation; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Radiopharmaceuticals; Stroke; Tadalafil; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2014
Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride. The journal of sexual medicine, 2015, Volume: 12, Issue:1 Topics: Carbolines; Coitus; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2015
Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil. Current medical research and opinion, 2015, Volume: 31, Issue:2 Topics: Adult; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Preference; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2015
Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo. BJU international, 2015, Volume: 116, Issue:2 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil; Urological Agents	2015
Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily. The journal of sexual medicine, 2015, Volume: 12, Issue:3 Topics: Adult; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Sexual Partners; Tadalafil; Treatment Outcome	2015
Effects of three-times-per-week versus on-demand tadalafil treatment on erectile function and continence recovery following bilateral nerve sparing radical prostatectomy: results of a prospective, randomized, and single-center study. The Kaohsiung journal of medical sciences, 2015, Volume: 31, Issue:2 Topics: Aged; Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Postoperative Period; Preoperative Period; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil; Treatment Outcome; Urinary Incontinence	2015
The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome. The journal of sexual medicine, 2015, Volume: 12, Issue:4 Topics: Adult; Aged; Carbolines; Delayed-Action Preparations; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Syndrome; Tadalafil; Testosterone	2015
Combination Therapy Of Tadalafil And Pentoxifylline In Severe Erectile Dysfunction; A Prospective Randomized Trial. Polski przeglad chirurgiczny, 2015, Volume: 87, Issue:8 Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Pentoxifylline; Prospective Studies; Severity of Illness Index; Tadalafil; Treatment Outcome; Vasodilator Agents	2015
Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment. BJU international, 2016, Volume: 118, Issue:1 Topics: Aged; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Time Factors; Treatment Outcome	2016
Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy. European urology, 2016, Volume: 70, Issue:3 Topics: Adenocarcinoma; Aged; Coitus; Decision Trees; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Phosphodiesterase 5 Inhibitors; Preoperative Period; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Robotic Surgical Procedures; Self Efficacy; Severity of Illness Index; Sexuality; Tadalafil	2016
Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Tria The journal of sexual medicine, 2016, Volume: 13, Issue:5 Topics: Adult; Aged; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Testosterone; Treatment Outcome; Vasodilator Agents	2016
Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT). The journal of sexual medicine, 2016, Volume: 13, Issue:4 Topics: Aged; Canada; Double-Blind Method; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil	2016
Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2016, Mar-31, Volume: 88, Issue:1 Topics: Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil; Treatment Outcome	2016
Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study. The aging male : the official journal of the International Society for the Study of the Aging Male, 2016, Volume: 19, Issue:3 Topics: Combined Modality Therapy; Erectile Dysfunction; Eunuchism; Exercise Therapy; Humans; Luteinizing Hormone; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Testosterone	2016
Efficacy of Tadalafil De-Escalation in the Treatment of Psychogenic Erectile Dysfunction. Urologia internationalis, 2017, Volume: 98, Issue:2 Topics: Adult; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Severity of Illness Index; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Urological Agents; Young Adult	2017
Evaluation of arterial stiffness and cardiac function in patients with vascular erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil. International journal of impotence research, 2017, Volume: 29, Issue:3 Topics: Adult; Case-Control Studies; Diastole; Endothelium, Vascular; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Systole; Tadalafil; Vascular Stiffness; Ventricular Function, Left	2017
Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial. Urology journal, 2016, 12-08, Volume: 13, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tadalafil; Tamsulosin	2016
Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization. Endocrine, 2017, Volume: 56, Issue:3 Topics: Abdominal Fat; Absorptiometry, Photon; Adult; Body Composition; Endothelium, Vascular; Erectile Dysfunction; Estradiol; Humans; Insulin; Male; Middle Aged; Muscle Cells; Muscle, Skeletal; Myogenin; Phosphodiesterase 5 Inhibitors; Receptors, Androgen; Tadalafil; Treatment Outcome	2017
Effects of taking tadalafil 5 mg once daily on erectile function and total testosterone levels in patients with metabolic syndrome. Andrologia, 2017, Volume: 49, Issue:9 Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Metabolic Syndrome; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil; Testosterone	2017
Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice. Pakistan journal of pharmaceutical sciences, 2008, Volume: 21, Issue:3 Topics: Administration, Oral; Adult; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Saudi Arabia; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2008
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study. The journal of sexual medicine, 2008, Volume: 5, Issue:9 Topics: Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention	2008
Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology, 2009, Volume: 112, Issue:3 Topics: Adrenergic beta-Antagonists; Carbolines; Cross-Over Studies; Drug Interactions; Effect Modifier, Epidemiologic; Erectile Dysfunction; Humans; Hypertension; Male; Metoprolol; Middle Aged; Patient Education as Topic; Phosphodiesterase Inhibitors; Placebo Effect; Tadalafil	2009
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. The Journal of urology, 2008, Volume: 180, Issue:4 Topics: Administration, Oral; Aged; Carbolines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Multivariate Analysis; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Reference Values; Severity of Illness Index; Tadalafil; Treatment Outcome; Urination Disorders; Urodynamics	2008
Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report. The journal of sexual medicine, 2009, Volume: 6, Issue:2 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Quinazolines; Tadalafil; Treatment Outcome; Urologic Diseases	2009
Aspects of sexual satisfaction in men with erectile dysfunction: a factor analytic and logistic regression approach. The journal of sexual medicine, 2009, Volume: 6, Issue:1 Topics: Adult; Carbolines; Erectile Dysfunction; Factor Analysis, Statistical; Humans; Logistic Models; Male; Middle Aged; Personal Satisfaction; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil	2009
Evaluation of patient expectations and treatment satisfaction after 1-year tadalafil therapy for erectile dysfunction: the DETECT study. The journal of sexual medicine, 2009, Volume: 6, Issue:1 Topics: Attitude to Health; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Prospective Studies; Surveys and Questionnaires; Tadalafil	2009
Effects of once-daily tadalafil on erectile function in men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia. European urology, 2009, Volume: 56, Issue:4 Topics: Aged; Carbolines; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Tadalafil	2009
Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. The journal of sexual medicine, 2009, Volume: 6, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carbolines; Double-Blind Method; Erectile Dysfunction; Health Status Indicators; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Time Factors	2009
Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. The journal of sexual medicine, 2009, Volume: 6, Issue:5 Topics: Adult; Carbolines; Double-Blind Method; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Quality of Life; Sexual Behavior; Sexual Partners; Tadalafil; Treatment Outcome	2009
Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment. BJU international, 2010, Volume: 105, Issue:4 Topics: Aged; Carbolines; Dose-Response Relationship, Drug; Epidemiologic Methods; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Prostatism; Tadalafil; Treatment Outcome; Urination; Urodynamics	2010
Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT study. The journal of sexual medicine, 2009, Volume: 6, Issue:12 Topics: Awareness; Carbolines; Erectile Dysfunction; Female; Health Status; Humans; Interpersonal Relations; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Sexual Partners; Surveys and Questionnaires; Tadalafil; Time Factors	2009
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Urology, 2010, Volume: 75, Issue:6 Topics: Aged; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Phosphodiesterase Inhibitors; Probability; Prostatic Hyperplasia; Prostatism; Quality of Life; Reference Values; Risk Assessment; Severity of Illness Index; Tadalafil; Treatment Outcome; Urination Disorders; Urodynamics	2010
[Low-dose tadalafil improves arterial erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:11 Topics: Adult; Aged; Arteries; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil	2009
Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. The journal of sexual medicine, 2010, Volume: 7, Issue:6 Topics: Adult; Carbolines; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Phosphodiesterase 5 Inhibitors; Quality of Life; Tadalafil; Treatment Outcome	2010
The effects of phosphodiesterase type 5 inhibitors on penile rigidity variables during a period with no sexual stimulation: a laboratory setting double-blind study. BJU international, 2011, Volume: 107, Issue:2 Topics: Adolescent; Adult; Carbolines; Double-Blind Method; Ejaculation; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Photic Stimulation; Piperazines; Purines; Quality of Life; Sexual Behavior; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Triazines; Vardenafil Dihydrochloride; Young Adult	2011
Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction. The journal of sexual medicine, 2010, Volume: 7, Issue:10 Topics: Carbolines; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Retrospective Studies; Tadalafil; Time Factors; Treatment Outcome	2010
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). The journal of sexual medicine, 2011, Volume: 8, Issue:1 Topics: Administration, Topical; Aged; Aged, 80 and over; Analysis of Variance; Carbolines; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hydrogels; Hypogonadism; Intention to Treat Analysis; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Testosterone	2011
Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU international, 2011, Volume: 107, Issue:12 Topics: Aged; Carbolines; Erectile Dysfunction; Feasibility Studies; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Pyrimidines; Sulfonamides; Tadalafil; Treatment Outcome	2011
Onset of efficacy of tadalafil once daily in men with erectile dysfunction: a randomized, double-blind, placebo controlled trial. The Journal of urology, 2011, Volume: 185, Issue:1 Topics: Carbolines; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil	2011
Comparison of the first intake of vardenafil and tadalafil in patients with diabetic neuropathy and diabetic erectile dysfunction. The journal of sexual medicine, 2011, Volume: 8, Issue:3 Topics: Age Factors; Carbolines; Diabetic Neuropathies; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Risk Factors; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2011
[Standard doses of tadalafil for different ED patients]. Zhonghua nan ke xue = National journal of andrology, 2010, Volume: 16, Issue:9 Topics: Adult; Aged; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Tadalafil; Treatment Outcome; Vasodilator Agents	2010
[Daily medication of low-dose tadalafil improves endothelial function and erectile hardness of ED patients]. Zhonghua nan ke xue = National journal of andrology, 2010, Volume: 16, Issue:11 Topics: Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2010
[Nocturnal penile tumescence and the effect of tadalafil on erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2010, Volume: 16, Issue:10 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Tadalafil	2010
Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology, 2011, Volume: 77, Issue:5 Topics: Adult; Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tadalafil; Young Adult	2011
[Efficacy of low-dose tadalafil on ED assessed by Self-Esteem and Relationship Questionnaire]. Zhonghua nan ke xue = National journal of andrology, 2010, Volume: 16, Issue:12 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Self Concept; Surveys and Questionnaires; Tadalafil; Vasodilator Agents	2010
Oral tadalafil administration plus low dose vasodilator injection: a novel approach to erection induction for penile color duplex ultrasound. The Journal of urology, 2011, Volume: 186, Issue:1 Topics: Administration, Oral; Adult; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Penis; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil; Ultrasonography, Doppler, Color; Vasodilator Agents; Young Adult	2011
Tadalafil versus solifenacin for persistent storage symptoms after prostate surgery in patients with erectile dysfunction: a prospective randomized study. International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:7 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Muscarinic Antagonists; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Surveys and Questionnaires; Tadalafil; Tetrahydroisoquinolines; Therapeutics; Urination Disorders; Urodynamics	2011
Effect on sexual function of a vacuum erection device post-prostatectomy. The Canadian journal of urology, 2011, Volume: 18, Issue:3 Topics: Adult; Carbolines; Combined Modality Therapy; Equipment and Supplies; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Compliance; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Sexual Behavior; Sexuality; Tadalafil; Treatment Outcome; Vacuum	2011
A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors. The journal of sexual medicine, 2011, Volume: 8, Issue:9 Topics: Age Factors; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2011
Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial. The journal of sexual medicine, 2010, Volume: 7, Issue:8 Topics: Aged; Aged, 80 and over; Carbolines; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Medication Adherence; Middle Aged; Neoplasm Staging; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Tadalafil	2010
[Efficacy and safety of long-term small-dose tadalafil in the treatment of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2011, Volume: 17, Issue:6 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2011
Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study. The journal of sexual medicine, 2012, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2012
[Tadalafil for ED after transurethral resection of the prostate: a report of 113 cases]. Zhonghua nan ke xue = National journal of andrology, 2011, Volume: 17, Issue:10 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Transurethral Resection of Prostate; Treatment Outcome	2011
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial. International journal of andrology, 2012, Volume: 35, Issue:2 Topics: Adult; Aged; Carbolines; Combined Modality Therapy; Erectile Dysfunction; High-Energy Shock Waves; Humans; Male; Middle Aged; Pain; Penile Erection; Penile Induration; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tadalafil	2012
Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study. International urology and nephrology, 2012, Volume: 44, Issue:3 Topics: Adult; Aged; Atorvastatin; Carbolines; Erectile Dysfunction; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Pyrroles; Single-Blind Method; Tadalafil	2012
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. European urology, 2012, Volume: 61, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Vasodilator Agents	2012
A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction. The journal of sexual medicine, 2012, Volume: 9, Issue:5 Topics: Administration, Oral; Carbolines; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome	2012
[Effects of tadalafil on erectile dysfunction: on-demand versus once-daily dosing]. Zhonghua nan ke xue = National journal of andrology, 2012, Volume: 18, Issue:5 Topics: Adult; Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2012
[Tadalafil improves total testosterone, IIEF score and SEP in old and middle-aged males with late-onset hypogonadism]. Zhonghua nan ke xue = National journal of andrology, 2012, Volume: 18, Issue:5 Topics: Carbolines; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Sexual Behavior; Tadalafil; Testosterone; Treatment Outcome	2012
Evaluation of erectile function after laparoscopic radical prostatectomy in a single center. The Canadian journal of urology, 2012, Volume: 19, Issue:4 Topics: Adult; Aged; Alprostadil; Carbolines; Coitus; Erectile Dysfunction; Humans; Laparoscopy; Male; Medication Adherence; Middle Aged; Organ Sparing Treatments; Orgasm; Penile Erection; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Care; Prostate; Prostatectomy; Prostatic Neoplasms; Severity of Illness Index; Surveys and Questionnaires; Tadalafil; Vasodilator Agents	2012
Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily. BMC surgery, 2012, Volume: 12 Suppl 1 Topics: Acetylglucosamine; Aged; Aged, 80 and over; Androgens; Biomarkers; Carbolines; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Erectile Dysfunction; Glucosamine; Humans; Libido; Male; Phaeophyceae; Phosphodiesterase 5 Inhibitors; Phytotherapy; Plant Extracts; Plant Preparations; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Tadalafil; Testosterone; Treatment Outcome; Tribulus	2012
Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years. International journal of impotence research, 2013, Volume: 25, Issue:3 Topics: Age Factors; Aged; Carbolines; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Retrospective Studies; Tadalafil; Treatment Outcome	2013
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin The journal of sexual medicine, 2013, Volume: 10, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tadalafil; Tamsulosin	2013
Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus. The journal of sexual medicine, 2013, Volume: 10, Issue:4 Topics: Adult; Aged; Carbolines; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Folic Acid; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Vitamin B Complex	2013
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. The Journal of urology, 2002, Volume: 168, Issue:4 Pt 1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Aged, 80 and over; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome	2002
Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes care, 2002, Volume: 25, Issue:12 Topics: Antihypertensive Agents; Carbolines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Glycated Hemoglobin; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Tadalafil; Treatment Outcome	2002
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology, 2003, Volume: 62, Issue:1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Aged, 80 and over; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Erectile Dysfunction; Half-Life; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Time Factors; Treatment Outcome	2003
Tadalafil. Drugs, 2003, Volume: 63, Issue:20 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Dose-Response Relationship, Drug; Drug Interactions; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome	2003
Time course of the interaction between tadalafil and nitrates. Journal of the American College of Cardiology, 2003, Nov-19, Volume: 42, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carbolines; Contraindications; Cross-Over Studies; Double-Blind Method; Drug Synergism; Erectile Dysfunction; Humans; Hypotension; Male; Middle Aged; Nitrates; Phosphodiesterase Inhibitors; Tadalafil; Time Factors	2003
A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. Clinical therapeutics, 2003, Volume: 25, Issue:11 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2003
Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference. Clinical therapeutics, 2003, Volume: 25, Issue:11 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aged; Carbolines; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Italy; Male; Middle Aged; Patient Satisfaction; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Sulfones; Sweden; Tadalafil	2003
Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. European urology, 2004, Volume: 45, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Comorbidity; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2004
A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. European urology, 2004, Volume: 45, Issue:4 Topics: Adult; Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2004
Nocturnal electrobioimpedance volumetric assessment in diabetic men with erectile dysfunction before and after tadalafil intake. International journal of impotence research, 2004, Volume: 16, Issue:5 Topics: Arterial Occlusive Diseases; Blood Volume; Carbolines; Diabetes Mellitus; Electric Impedance; Erectile Dysfunction; Humans; Male; Middle Aged; Tadalafil	2004
The efficacy and safety of tadalafil: an update. BJU international, 2004, Volume: 93, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome	2004
The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction. The Journal of urology, 2004, Volume: 172, Issue:2 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aged; Carbolines; Coitus; Comorbidity; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prospective Studies; Puerto Rico; Tadalafil; United States	2004
Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal cord, 2004, Volume: 42, Issue:11 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Piperazines; Purines; Quality of Life; Sildenafil Citrate; Spinal Cord Injuries; Sulfones; Tadalafil; Time Factors; Vasodilator Agents	2004
Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction. European urology, 2004, Volume: 46, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index; Tadalafil; Treatment Outcome; Vasodilator Agents	2004
Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. The Journal of urology, 2004, Volume: 172, Issue:3 Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Prostatectomy; Tadalafil	2004
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clinical endocrinology, 2004, Volume: 61, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Luteinizing Hormone; Male; Middle Aged; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil; Testosterone	2004
Population dose-response model for tadalafil in the treatment of male erectile dysfunction. Pharmaceutical research, 2004, Volume: 21, Issue:8 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Canada; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Self Administration; Severity of Illness Index; Surveys and Questionnaires; Tadalafil	2004
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU international, 2004, Volume: 94, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Analysis of Variance; Carbolines; Coitus; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome	2004
Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction. Urology, 2004, Volume: 64, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Comorbidity; Diabetes Complications; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Patient Satisfaction; Tadalafil; Treatment Outcome	2004
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia, 2004, Volume: 47, Issue:11 Topics: Blood Glucose; Carbolines; Diabetes Mellitus; Double-Blind Method; Erectile Dysfunction; Glycated Hemoglobin; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Placebos; Tadalafil	2004
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. European urology, 2005, Volume: 47, Issue:2 Topics: Aged; Brachial Artery; Carbolines; Cardiovascular Diseases; Endothelium, Vascular; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Risk; Tadalafil; Time Factors; Treatment Outcome; Vasodilation	2005
Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers. Urology, 2005, Volume: 65, Issue:2 Topics: Aged; Carbolines; Cardiovascular Diseases; Comorbidity; Diabetes Complications; Double-Blind Method; Erectile Dysfunction; Female; Humans; Hyperlipidemias; Male; Middle Aged; Personal Satisfaction; Phosphodiesterase Inhibitors; Postoperative Complications; Prostatectomy; Sexual Partners; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents	2005
A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men. International journal of clinical practice, 2005, Volume: 59, Issue:2 Topics: Adult; Aged; Australia; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2005
An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries. European urology, 2005, Volume: 47, Issue:6 Topics: Carbolines; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Europe; Follow-Up Studies; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Retrospective Studies; Safety; Tadalafil; Treatment Outcome	2005
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. Journal of the American College of Cardiology, 2005, Aug-16, Volume: 46, Issue:4 Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Carbolines; Case-Control Studies; Electrocardiography; Electrophysiology; Erectile Dysfunction; Humans; Long QT Syndrome; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Sulfonamides; Tadalafil; Time Factors; Ventricular Function	2005
An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. BJU international, 2005, Volume: 96, Issue:9 Topics: Adolescent; Adult; Aged; Carbolines; Cross-Over Studies; Erectile Dysfunction; Humans; Italy; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; United Kingdom	2005
Sexual intercourse attempt patterns with two dosing regimens of tadalafil in men with erectile dysfunction: results from the SURE study in 14 European countries. The journal of sexual medicine, 2005, Volume: 2, Issue:5 Topics: Carbolines; Coitus; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; International Cooperation; Male; Middle Aged; Tadalafil; Vasodilator Agents	2005
Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. The journal of sexual medicine, 2005, Volume: 2, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Adult; Aged; Canada; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphoric Diester Hydrolases; Severity of Illness Index; Tadalafil; Treatment Outcome; Vasodilator Agents	2005
Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. The journal of sexual medicine, 2005, Volume: 2, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Cross-Over Studies; Drug Administration Schedule; Drug Tolerance; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil	2005
Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. The journal of sexual medicine, 2004, Volume: 1, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2004
Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study. The journal of sexual medicine, 2004, Volume: 1, Issue:2 Topics: Adult; Aged; Carbolines; Coitus; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Headache; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Sexual Behavior; Tadalafil; Time Factors; Treatment Outcome	2004
Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. The journal of sexual medicine, 2004, Volume: 1, Issue:2 Topics: Administration, Oral; Aged; Back Pain; Carbolines; Double-Blind Method; Dyspepsia; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Tadalafil; Taiwan; Treatment Outcome	2004
Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil. The journal of sexual medicine, 2006, Volume: 3, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Coitus; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Vasodilator Agents	2006
Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study. Andrologia, 2006, Volume: 38, Issue:2 Topics: Adult; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Tadalafil; Testosterone	2006
Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design. The journal of sexual medicine, 2006, Volume: 3, Issue:3 Topics: Adult; Aged; Back Pain; Black or African American; Carbolines; Dose-Response Relationship, Drug; Dyspepsia; Erectile Dysfunction; Ethnicity; Flushing; Headache; Hispanic or Latino; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Rhinitis; Surveys and Questionnaires; Tadalafil; Vasodilator Agents; White People	2006
Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction. The journal of sexual medicine, 2006, Volume: 3, Issue:3 Topics: Adult; Aged; Carbolines; Coitus; Dose-Response Relationship, Drug; Drug Tolerance; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents	2006
Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. The journal of sexual medicine, 2006, Volume: 3, Issue:3 Topics: Adult; Aged; Carbolines; Comorbidity; Cross-Over Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Sexual Behavior; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents	2006
[Tadalafil vs sildenafil patient preference in Spanish men with erectile dysfunction: results from an International Multicentric Study]. Actas urologicas espanolas, 2006, Volume: 30, Issue:1 Topics: Adult; Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; United States	2006
Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. European urology, 2006, Volume: 50, Issue:2 Topics: Adult; Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Logistic Models; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Tadalafil; Treatment Outcome	2006
Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal cord, 2007, Volume: 45, Issue:2 Topics: Adult; Analysis of Variance; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Reaction Time; Retrospective Studies; Sildenafil Citrate; Spinal Cord Injuries; Sulfones; Surveys and Questionnaires; Tadalafil; Triazines; Vardenafil Dihydrochloride	2007
Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Asia, Southeastern; Carbolines; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil	2006
Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study. The journal of sexual medicine, 2006, Volume: 3, Issue:4 Topics: Adult; Aged; Analysis of Variance; Carbolines; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Self Concept; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Vasodilator Agents	2006
Testosterone:estradiol ratio changes associated with long-term tadalafil administration: a pilot study. The journal of sexual medicine, 2006, Volume: 3, Issue:4 Topics: Adult; Aged; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Estradiol; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Pilot Projects; Tadalafil; Testosterone; Treatment Outcome	2006
Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction. International journal of clinical practice, 2006, Volume: 60, Issue:7 Topics: Adolescent; Adult; Aged; Carbolines; Double-Blind Method; Egypt; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Quality of Life; Tadalafil; Treatment Outcome; Turkey	2006
Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study. Asian journal of andrology, 2006, Volume: 8, Issue:6 Topics: Adolescent; Adult; Aged; Asia, Southeastern; Carbolines; China; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2006
Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors. The journal of sexual medicine, 2006, Volume: 3, Issue:5 Topics: Aged; Carbolines; Coitus; Cross-Over Studies; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Quality of Life; Severity of Illness Index; Sexual Behavior; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2006
A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. International journal of radiation oncology, biology, physics, 2006, Oct-01, Volume: 66, Issue:2 Topics: Aged; Aged, 80 and over; Carbolines; Coitus; Cross-Over Studies; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Prostatic Neoplasms; Radiotherapy, Conformal; Tadalafil; Treatment Outcome	2006
Through the eyes of women: the partners' perspective on tadalafil. Urology, 2006, Volume: 68, Issue:3 Topics: Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Spouses; Tadalafil	2006
Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study. Urology, 2006, Volume: 68, Issue:4 Topics: Asian People; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2006
The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study. International journal of clinical practice, 2006, Volume: 60, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Interpersonal Relations; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Quality of Life; Surveys and Questionnaires; Sweden; Tadalafil; Treatment Outcome	2006
[Efficacy and safety of two dosing regimens with Tadalafil in Spanish men with erectile dysfunction: results from the SURE study in 14 European countries]. Actas urologicas espanolas, 2006, Volume: 30, Issue:8 Topics: Adult; Aged; Carbolines; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Spain; Tadalafil	2006
Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS). European urology, 2007, Volume: 51, Issue:2 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Remission Induction; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Time Factors; Triazines; Vardenafil Dihydrochloride	2007
A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction. The journal of sexual medicine, 2007, Volume: 4, Issue:3 Topics: Adult; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Japan; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Research Design; Severity of Illness Index; Tadalafil; Treatment Outcome; Vasodilator Agents	2007
Predictors of tadalafil efficacy in men with erectile dysfunction: the SURE study comparing two dosing regimens. The journal of sexual medicine, 2006, Volume: 3, Issue:6 Topics: Adult; Carbolines; Coitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Single-Blind Method; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2006
Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. Atherosclerosis, 2008, Volume: 196, Issue:1 Topics: Adult; Aged; Brachial Artery; Carbolines; Cardiovascular Diseases; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelial Cells; Erectile Dysfunction; Humans; Male; Middle Aged; Neovascularization, Physiologic; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Risk Factors; Tadalafil; Ultrasonography; Vasodilation	2008
Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment. Minerva endocrinologica, 2006, Volume: 31, Issue:4 Topics: Aged; Alprostadil; Arteries; Attitude to Health; Blood Flow Velocity; Carbolines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Erectile Dysfunction; Humans; Injections; Luteinizing Hormone; Male; Middle Aged; Nitric Oxide; Penis; Prolactin; Surveys and Questionnaires; Tadalafil; Testosterone; Treatment Outcome; Vasodilator Agents	2006
The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study. BJU international, 2007, Volume: 99, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Carbolines; Cross-Over Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Sexual Behavior; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2007
Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US. The journal of sexual medicine, 2007, Volume: 4, Issue:1 Topics: Age Distribution; Aged; Carbolines; Comorbidity; Depression; Diabetes Mellitus; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Prevalence; Tadalafil; Treatment Outcome; United States	2007
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. Asian journal of andrology, 2007, Volume: 9, Issue:3 Topics: Carbolines; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; Italy; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2007
Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study. BJU international, 2007, Volume: 100, Issue:1 Topics: Adolescent; Adult; Aged; Carbolines; Cross-Over Studies; Erectile Dysfunction; Humans; Logistic Models; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2007
Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. The Journal of rheumatology, 2007, Volume: 34, Issue:8 Topics: Adult; Carbolines; Disease Progression; Endothelin-1; Erectile Dysfunction; Health Surveys; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Scleroderma, Systemic; Tadalafil	2007
Effect of tadalafil on erectile dysfunction in male patients with diabetes mellitus. Vojnosanitetski pregled, 2007, Volume: 64, Issue:6 Topics: Adult; Carbolines; Diabetes Complications; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil	2007
Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Archives of neurology, 2007, Volume: 64, Issue:11 Topics: Adolescent; Adult; Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Severity of Illness Index; Spinal Cord Injuries; Tadalafil; Treatment Outcome	2007
Treatment of erectile dysfunction reduces psychological distress. International journal of andrology, 2009, Volume: 32, Issue:1 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Personal Satisfaction; Phosphodiesterase Inhibitors; Placebos; Quality of Life; Stress, Psychological; Tadalafil	2009
An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study. European urology, 2008, Volume: 53, Issue:5 Topics: Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Middle Aged; Phosphodiesterase Inhibitors; Semen; Spermatogenesis; Tadalafil; Testosterone; Time Factors; Treatment Outcome	2008
Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil. Asian journal of andrology, 2007, Volume: 9, Issue:6 Topics: Adult; Aged; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Korea; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Psychology; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome	2007
Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial. Urology, 2007, Volume: 70, Issue:6 Topics: Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prostatic Neoplasms; Radiotherapy, Conformal; Tadalafil	2007
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:2 Topics: Adult; Aged; Carbolines; Coitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Severity of Illness Index; Tadalafil; Treatment Outcome	2008
Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States. The journal of sexual medicine, 2008, Volume: 5, Issue:3 Topics: Aged; Aged, 80 and over; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Research Design; Severity of Illness Index; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2008
Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study. The journal of sexual medicine, 2008, Volume: 5, Issue:5 Topics: Carbolines; Cross-Over Studies; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Personal Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sexual Partners; Sildenafil Citrate; Sulfones; Tadalafil	2008
Therapeutic response after first month of tadalafil treatment predicts 12 months treatment continuation in patients with erectile dysfunction: results from the DETECT study. The journal of sexual medicine, 2008, Volume: 5, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Health Status Indicators; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome	2008
Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses. The journal of sexual medicine, 2008, Volume: 5, Issue:8 Topics: Adult; Aged; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Humans; Latin America; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2008
Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition. Clinical hemorheology and microcirculation, 2008, Volume: 39, Issue:1-4 Topics: Administration, Sublingual; Adult; Angina Pectoris; Blood Pressure; Carbolines; Cardiovascular Diseases; Dosage Forms; Drug Interactions; Erectile Dysfunction; Humans; Hypotension; Male; Nitrendipine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil	2008
On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. International journal of impotence research, 2001, Volume: 13, Issue:1 Topics: Adult; Aged; Carbolines; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Placebos; Tadalafil	2001

Other Studies

315 other study(ies) available for tadalafil and Erectile Dysfunction

Article	Year
Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction. Journal of medicinal chemistry, 2003, Feb-13, Volume: 46, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Animals; Biological Availability; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Enzyme Inhibitors; Erectile Dysfunction; Female; Male; Penis; Pyridazines; Rabbits; Rats; Structure-Activity Relationship	2003
Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction. Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Biological Availability; Blood Pressure; Cell Line; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Electric Stimulation; Erectile Dysfunction; Macaca mulatta; Male; Penis; Pyrroles; Quinolones; Rats; Rats, Sprague-Dawley; Solubility; Stereoisomerism; Structure-Activity Relationship	2005
Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED. Bioorganic & medicinal chemistry letters, 2005, May-02, Volume: 15, Issue:9 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Models, Molecular; Molecular Structure; Phosphodiesterase I; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Rats; Sildenafil Citrate; Structure-Activity Relationship; Sulfones; Vasodilator Agents	2005
Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction. Bioorganic & medicinal chemistry letters, 2008, Dec-01, Volume: 18, Issue:23 Topics: Combinatorial Chemistry Techniques; Erectile Dysfunction; Humans; Male; Molecular Structure; Penile Erection; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Quinazolines; Structure-Activity Relationship	2008
Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533). Bioorganic & medicinal chemistry letters, 2010, Jan-01, Volume: 20, Issue:1 Topics: Administration, Oral; Animals; Carbamates; Catalytic Domain; Computer Simulation; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Microsomes, Liver; Phosphodiesterase 5 Inhibitors; Quinazolines; Rabbits; Rats	2010
The discovery of avanafil for the treatment of erectile dysfunction: a novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor. Bioorganic & medicinal chemistry letters, 2014, Dec-01, Volume: 24, Issue:23 Topics: Animals; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Pyrimidines; Rabbits	2014
Retrospective Observational Real-World Outcome Study to Evaluate Safety Among Patients With Erectile Dysfunction (ED) With Co-Possession of Tadalafil and Anti-Hypertensive Medications (anti-HTN). The journal of sexual medicine, 2022, Volume: 19, Issue:1 Topics: Adult; Antihypertensive Agents; Carbolines; Cohort Studies; Erectile Dysfunction; Humans; Hypertension; Male; Outcome Assessment, Health Care; Retrospective Studies; Tadalafil; Treatment Outcome	2022
[Effect of Shanhaidan Granules combined with tadalafil on erectile dysfunction: A multi-center clinical trial]. Zhonghua nan ke xue = National journal of andrology, 2021, Volume: 27, Issue:9 Topics: Erectile Dysfunction; Humans; Male; Medicine, Chinese Traditional; Penile Erection; Syndrome; Tadalafil	2021
Role of shear wave elastography (SWE) in erectile dysfunction patients for evaluation of daily tadalafil treatment outcome. Andrologia, 2022, Volume: 54, Issue:4 Topics: Carbolines; Elasticity Imaging Techniques; Erectile Dysfunction; Humans; Male; Penis; Tadalafil; Treatment Outcome	2022
Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications. Journal of clinical hypertension (Greenwich, Conn.), 2022, Volume: 24, Issue:2 Topics: Antihypertensive Agents; Double-Blind Method; Erectile Dysfunction; Humans; Hypertension; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2022
The role of tadalafil in treated hypertensive patients with erectile dysfunction. Journal of clinical hypertension (Greenwich, Conn.), 2022, Volume: 24, Issue:2 Topics: Erectile Dysfunction; Humans; Hypertension; Male; Patient Satisfaction; Tadalafil; Treatment Outcome	2022
Assessment of the intracavernosal injection platelet-rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non-responding to on-demand oral PDE5 inhibitors. Andrologia, 2022, Volume: 54, Issue:6 Topics: Carbolines; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Platelet-Rich Plasma; Sulfones; Tadalafil; Treatment Outcome	2022
Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction. International journal of impotence research, 2023, Volume: 35, Issue:5 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatectomy; Tadalafil; Treatment Outcome	2023
Is tadalafil associated with decreased risk of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms? World journal of urology, 2022, Volume: 40, Issue:7 Topics: Adrenergic alpha-Antagonists; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Treatment Outcome; Venous Thromboembolism	2022
The effect of vitamin D replacement in patients with lower urinary tract complaint/erectile dysfunction resistant to Tadalafil 5 mg treatment: A pilot clinical study. Andrologia, 2022, Volume: 54, Issue:8 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Treatment Outcome; Urinary Tract; Vitamin D; Vitamins	2022
Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats. PeerJ, 2022, Volume: 10 Topics: Animals; Aphrodisiacs; Erectile Dysfunction; Humans; Male; Polymers; Povidone; Rats; Solubility; Tadalafil	2022
Comment on: Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction. International journal of impotence research, 2023, Volume: 35, Issue:5 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Tadalafil; Treatment Outcome	2023
Current trends in erectile rehabilitation after radical prostatectomy: Results from a worldwide survey. Andrologia, 2022, Volume: 54, Issue:9 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase Inhibitors; Prostatectomy; Tadalafil	2022
Response to Comment on 'Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction'. International journal of impotence research, 2023, Volume: 35, Issue:5 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Tadalafil	2023
Selecting an Individualized Treatment Approach: The Predictive Value of Erotic Stimulation and Nocturnal Erections for Efficacy of Tadalafil and Cure in Patients With Erectile Dysfunction. Frontiers in endocrinology, 2022, Volume: 13 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Tadalafil	2022
Is there a relationship between mean platelet volume and response to treatment with daily tadalafil in patients with erectile dysfunction? Andrologia, 2022, Volume: 54, Issue:11 Topics: Adult; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Mean Platelet Volume; Middle Aged; Retrospective Studies; Tadalafil; Treatment Outcome	2022
Cytochrome P450 3A4-mediated pharmacokinetic interaction study between tadalafil and canagliflozin using high-performance thin-layer chromatography. Journal of separation science, 2022, Volume: 45, Issue:23 Topics: Canagliflozin; Chromatography, Thin Layer; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Tadalafil	2022
Inhibition of multidrug resistance proteins by MK571 restored the erectile function in obese mice through cGMP accumulation. Andrology, 2023, Volume: 11, Issue:3 Topics: Acetylcholine; Animals; ATP Binding Cassette Transporter, Subfamily B; Cyclic GMP; Erectile Dysfunction; Humans; Male; Mice; Mice, Obese; Nitroprusside; Obesity; Tadalafil	2023
Phosphodiesterase-5 inhibitors for Alzheimer's disease? The Medical letter on drugs and therapeutics, 2022, 10-31, Volume: 64, Issue:1662 Topics: Alzheimer Disease; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Sulfones; Tadalafil	2022
Isolation and characterization of a novel tadalafil analogue adulterant, N-cyclohexyl nortadalafil, in a dietary supplement. Journal of pharmaceutical and biomedical analysis, 2023, Apr-01, Volume: 227 Topics: Chromatography, High Pressure Liquid; Dietary Supplements; Erectile Dysfunction; Humans; Male; Mass Spectrometry; Spectroscopy, Fourier Transform Infrared; Tadalafil	2023
Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database. Andrology, 2023, Volume: 11, Issue:7 Topics: Adolescent; Adult; Erectile Dysfunction; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Pharmacovigilance; Phosphodiesterase 5 Inhibitors; Priapism; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; World Health Organization	2023
Re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focus 2022;8:794-802. European urology focus, 2023, Volume: 9, Issue:5 Topics: Erectile Dysfunction; Humans; Male; Patient Preference; Sildenafil Citrate; Tadalafil	2023
Reply to Eugenio Ventimiglia, Andrea Salonia, and Francesco Montorsi's Letter to the Editor re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients wit European urology focus, 2023, Volume: 9, Issue:5 Topics: Erectile Dysfunction; Humans; Male; Patient Preference; Sildenafil Citrate; Tadalafil	2023
Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction. European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:9 Topics: Ejaculation; Erectile Dysfunction; Female; Humans; Male; Paroxetine; Phosphodiesterase 5 Inhibitors; Premature Ejaculation; Retrospective Studies; Tadalafil; Treatment Outcome	2023
Effects of continuous use of Tadalafil on male sexual function after posterior urethroplasty: A clinical trial. Urologia, 2023, Volume: 90, Issue:4 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2023
[Efficacy of leech powder on hyperlipidaemia-associated erectile dysfunction in male rats]. Zhonghua nan ke xue = National journal of andrology, 2022, Volume: 28, Issue:4 Topics: Animals; Erectile Dysfunction; Humans; Hyperlipidemias; Lipids; Male; NF-kappa B; Penile Erection; Powders; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tadalafil	2022
Improvement in Endothelial Function in Men Taking Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction. The American journal of medicine, 2023, Volume: 136, Issue:10 Topics: C-Reactive Protein; Carbolines; Erectile Dysfunction; Humans; Male; Myocardial Infarction; Phosphodiesterase 5 Inhibitors; Pilot Projects; Tadalafil; Treatment Outcome	2023
Role of penile rehabilitation through daily intake of 5 mg tadalafil on erectile dysfunction after different presentations of penile fracture: a prospective case-control study. International urology and nephrology, 2023, Volume: 55, Issue:11 Topics: Carbolines; Case-Control Studies; Erectile Dysfunction; Humans; Male; Penile Erection; Penis; Rupture; Tadalafil; Treatment Outcome	2023
[RigiScan monitoring assists tadalafil medication in the treatment of penile ED]. Zhonghua nan ke xue = National journal of andrology, 2022, Volume: 28, Issue:12 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Penis; Tadalafil; Ultrasonography, Doppler, Color	2022
Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2024, Jan-15, Volume: 305 Topics: Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2024
Non-invasive alternative for phosphodiesterase inhibitor-refractory erectile dysfunction: Real-life experience with low-intensity extracorporeal shockwave therapy. Medicine, 2023, Nov-10, Volume: 102, Issue:45 Topics: Adult; Erectile Dysfunction; Extracorporeal Shockwave Therapy; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Retrospective Studies; Tadalafil; Treatment Outcome	2023
[Efficiency of phosphodiesterase-5 inhibitors for treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia and concomitant erectile dysfunction]. Urologiia (Moscow, Russia : 1999), 2019, Issue:4 Topics: Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Moscow; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Treatment Outcome	2019
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial. European urology focus, 2021, Volume: 7, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Urological Agents	2021
Role of Serum High-Sensitivity C-Reactive Protein as a Predictor of Therapeutic Response to Tadalafil in Patients With Erectile Dysfunction: A Prospective Observational Study. The journal of sexual medicine, 2019, Volume: 16, Issue:12 Topics: Adult; C-Reactive Protein; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil; Treatment Outcome; Vasodilator Agents	2019
Smart spectrophotometric assessment of tamsulosin hydrochloride and tadalafil in their new pharmaceutical formulation for treatment of benign prostatic hyperplasia and erectile dysfunction. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2020, Feb-15, Volume: 227 Topics: Adrenergic alpha-1 Receptor Antagonists; Capsules; Drug Combinations; Drug Compounding; Erectile Dysfunction; Humans; Limit of Detection; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Spectrophotometry; Tadalafil; Tamsulosin	2020
Acute pancreatitis induced by Tadalafil: a case report. Clinical journal of gastroenterology, 2020, Volume: 13, Issue:3 Topics: Adult; Erectile Dysfunction; Humans; Male; Pancreatitis; Phosphodiesterase 5 Inhibitors; Tadalafil; Tomography, X-Ray Computed	2020
Effects of tadalafil to prevent injury on corpus cavernosum after vascular or nervous peri-prostatic bundle injury. Experimental model in rats. Acta cirurgica brasileira, 2019, Volume: 34, Issue:9 Topics: Animals; Collagen; Elastic Tissue; Erectile Dysfunction; Immunohistochemistry; Male; Penis; Peripheral Nerve Injuries; Phosphodiesterase 5 Inhibitors; Prostatectomy; Protective Agents; Random Allocation; Rats, Wistar; Reproducibility of Results; Tadalafil	2019
Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction. Investigative and clinical urology, 2020, Volume: 61, Issue:1 Topics: Age Factors; Aged; Drug Combinations; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tadalafil; Tamsulosin; Treatment Failure; Urological Agents	2020
Phosphodiesterase Type-5 Inhibitor Prescription Patterns in the United States Among Men With Erectile Dysfunction: An Update. The journal of sexual medicine, 2020, Volume: 17, Issue:5 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Medicare; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Prescriptions; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride	2020
Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model. Neurourology and urodynamics, 2020, Volume: 39, Issue:4 Topics: Animals; Disease Models, Animal; Erectile Dysfunction; Hydrogen; Hydrogen Sulfide; Male; Muscle, Smooth; Penile Erection; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Tadalafil; Treatment Outcome; Urinary Bladder Neck Obstruction	2020
Can subfoveal choroidal thickness replace subjective tests in patients using tadalafil to treat erectile dysfunction? Andrologia, 2020, Volume: 52, Issue:6 Topics: Adult; Choroid; Erectile Dysfunction; Fovea Centralis; Humans; Male; Middle Aged; Organ Size; Phosphodiesterase 5 Inhibitors; Tadalafil; Tomography, Optical Coherence	2020
[Low-dose PDE5 inhibitors for erectile dysfunction with subclinical metabolic syndrome]. Zhonghua nan ke xue = National journal of andrology, 2019, Volume: 25, Issue:6 Topics: Adult; Erectile Dysfunction; Humans; Male; Metabolic Syndrome; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Young Adult	2019
Simultaneous analysis of 31 anti-impotence compounds potentially illegally added to herbal-based dietary supplements by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, May-01, Volume: 1144 Topics: Chromatography, High Pressure Liquid; Dietary Supplements; Drug Contamination; Drugs, Chinese Herbal; Erectile Dysfunction; Food Safety; Humans; Limit of Detection; Male; Molecular Structure; Sildenafil Citrate; Tadalafil; Tandem Mass Spectrometry	2020
Identification of Erectile Dysfunction Drugs in Dietary Supplements by Liquid Chromatography Ion Trap Mass Spectrometry. Journal of dietary supplements, 2021, Volume: 18, Issue:3 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Dietary Supplements; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Tandem Mass Spectrometry; Vardenafil Dihydrochloride	2021
Effect of daily tadalafil on reported outcomes in patients with erectile dysfunction and depressive symptoms: STROBE, a case-control study. Medicine, 2020, Jun-05, Volume: 99, Issue:23 Topics: Adult; Aged; Case-Control Studies; Depression; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Tadalafil; Young Adult	2020
Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass. Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-23, Volume: 117, Issue:25 Topics: Aging; Animals; Bone and Bones; Bone Density; Brain; Cell Differentiation; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Repositioning; Erectile Dysfunction; Humans; Male; Mice; Middle Aged; Models, Animal; Models, Molecular; Neurons; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporotic Fractures; Phosphodiesterase 5 Inhibitors; Primary Cell Culture; Tadalafil; Vardenafil Dihydrochloride	2020
The Association Between Phosphodiesterase-5 Inhibitors and Colorectal Cancer in a National Cohort of Patients. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:6 Topics: Aged; Colorectal Neoplasms; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Incidence; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Proportional Hazards Models; Retrospective Studies; Sildenafil Citrate; Tadalafil; United States; United States Department of Veterans Affairs; Veterans Health Services	2020
[Combination of 1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study]. Urologiia (Moscow, Russia : 1999), 2020, Issue:3 Topics: Adult; Aged; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Moscow; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2020
[Effects of Tadalafil 5 mg Once-Daily on Serum Testosterone Level, Erectile Function, and Highly Sensitive C-Reactive Protein Value in Hypogonadal Patients with Lower Urinary Tract Symptoms]. Hinyokika kiyo. Acta urologica Japonica, 2020, Volume: 66, Issue:8 Topics: C-Reactive Protein; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Testosterone; Treatment Outcome	2020
Erectile dysfunction drugs altered the activities of antioxidant enzymes, oxidative stress and the protein expressions of some cytochrome P450 isozymes involved in the steroidogenesis of steroid hormones. PloS one, 2020, Volume: 15, Issue:11 Topics: Animals; Antioxidants; Cytochrome P-450 Enzyme System; Erectile Dysfunction; Glutathione; Isoenzymes; Liver; Male; Oxidative Stress; Rabbits; Sildenafil Citrate; Steroids; Tadalafil; Testis; Thiobarbituric Acid Reactive Substances; Vardenafil Dihydrochloride	2020
Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction. International journal of clinical pharmacy, 2021, Volume: 43, Issue:4 Topics: Cross-Sectional Studies; Drug Prescriptions; Erectile Dysfunction; Humans; Inappropriate Prescribing; Male; Middle Aged; Tadalafil; Treatment Outcome	2021
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome. Minerva urology and nephrology, 2021, Volume: 73, Issue:6 Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin	2021
The effect of cardiovascular morbidity on clinical response provided by tadalafil in patients with erectile dysfunction. Andrologia, 2021, Volume: 53, Issue:2 Topics: Carbolines; Cardiovascular Diseases; Double-Blind Method; Erectile Dysfunction; Humans; Male; Tadalafil; Treatment Outcome	2021
Association between sexual activity-related death and non-prescription use of phosphodiesterase type 5 inhibitors. Legal medicine (Tokyo, Japan), 2021, Volume: 48 Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contraindications, Drug; Death, Sudden, Cardiac; Erectile Dysfunction; Forensic Medicine; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Risk; Sexual Behavior; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2021
[PDE-5i combined with RigiScan-based audiovisual sexual stimulation test versus nocturnal penile tumescence test in evaluation of erectile function]. Zhonghua nan ke xue = National journal of andrology, 2020, Volume: 26, Issue:7 Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Young Adult	2020
Editorial Comment to Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial. International journal of urology : official journal of the Japanese Urological Association, 2021, Volume: 28, Issue:4 Topics: Brachytherapy; Erectile Dysfunction; Humans; Male; Prostatic Neoplasms; Tadalafil	2021
Whether Adding Vitamin D to Tadalafil 5 mg Treatment Is Useful in Patients with Erectile Dysfunction and Vitamin D Deficiency? Urologia internationalis, 2021, Volume: 105, Issue:5-6 Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Retrospective Studies; Tadalafil; Vitamin D; Vitamin D Deficiency; Vitamins	2021
[Effect of Tadalafil SZ on endothelial function in patients with erectile dysfunction]. Urologiia (Moscow, Russia : 1999), 2021, Issue:1 Topics: Adult; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2021
[Phosphodesterase type 5 inhibitors clinical efficiency and role in therapy for erectile dysfunction]. Urologiia (Moscow, Russia : 1999), 2021, Issue:2 Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2021
Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. European urology focus, 2022, Volume: 8, Issue:3 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Patient Preference; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil	2022
Comment on "Role of Serum High-Sensitivity C-Reactive Protein as a Predictor of Therapeutic Response to Tadalafil in Patients With Erectile Dysfunction: A Prospective Observational Study". The journal of sexual medicine, 2021, Volume: 18, Issue:6 Topics: C-Reactive Protein; Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil	2021
Influencing Factors for Erectile Dysfunction of Young Adults with No Response to PDE5i. Current medical science, 2021, Volume: 41, Issue:3 Topics: Adolescent; Adult; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Treatment Outcome; Young Adult	2021
Technological Device for Manufacturing Transdermal Films: Possible Applications to the Individualized Treatment for Erectile Dysfunction. AAPS PharmSciTech, 2017, Volume: 18, Issue:7 Topics: Administration, Cutaneous; Drug Delivery Systems; Epidermis; Erectile Dysfunction; Humans; Male; Skin Absorption; Tadalafil; Technology, Pharmaceutical	2017
Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia. The aging male : the official journal of the International Society for the Study of the Aging Male, 2018, Volume: 21, Issue:1 Topics: Aged; Ankle Brachial Index; Endothelium, Vascular; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostate; Prostatic Hyperplasia; Pulse Wave Analysis; Tadalafil	2018
[Oral-appliance combined with tadalafil for erectile dysfunction induced by severe obstructive sleep apneahypopnea syndrome]. Zhonghua nan ke xue = National journal of andrology, 2016, Volume: 22, Issue:9 Topics: Adult; Coitus; Combined Modality Therapy; Erectile Dysfunction; Female; Humans; Male; Orthodontic Appliances; Penile Erection; Personal Satisfaction; Sexual Partners; Sleep Apnea, Obstructive; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents	2016
Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries. International journal of clinical practice, 2018, Volume: 72, Issue:4 Topics: Adult; Aged; Brazil; China; Coitus; Drug Administration Schedule; Erectile Dysfunction; Habits; Humans; Italy; Japan; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Russia; Sildenafil Citrate; Surveys and Questionnaires; Tadalafil; Taiwan; Time Factors; Turkey; Vardenafil Dihydrochloride	2018
[The role of tadalafil in the management of sexual dysfunctions]. Urologiia (Moscow, Russia : 1999), 2018, Issue:2 Topics: Erectile Dysfunction; Humans; Male; Premature Ejaculation; Tadalafil	2018
Interval importance index to select relevant ATR-FTIR wavenumber Intervals for falsified drug classification. Journal of pharmaceutical and biomedical analysis, 2018, Sep-05, Volume: 158 Topics: Brazil; Counterfeit Drugs; Erectile Dysfunction; Fraud; Humans; Male; Models, Chemical; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Spectroscopy, Fourier Transform Infrared; Statistics, Nonparametric; Tadalafil; Urological Agents	2018
Association of Transient Colorblindness With Sildenafil and Tadalafil. JAMA ophthalmology, 2019, Jan-01, Volume: 137, Issue:1 Topics: Color Perception Tests; Color Vision; Color Vision Defects; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil	2019
Accurate and sensitive determination of sildenafil, tadalafil, vardenafil, and avanafil in illicit erectile dysfunction medications and human urine by LC with quadrupole-TOF-MS/MS and their behaviors in simulated gastric conditions. Journal of separation science, 2019, Volume: 42, Issue:2 Topics: Chromatography, Liquid; Erectile Dysfunction; Humans; Illicit Drugs; Male; Pyrimidines; Sildenafil Citrate; Stomach; Tadalafil; Tandem Mass Spectrometry; Vardenafil Dihydrochloride	2019
Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial. The Journal of urology, 2018, Volume: 200, Issue:5 Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin	2018
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and ta International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:2 Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin	2019
Low-intensity shock wave therapy ameliorates erectile dysfunction in men with pelvic fractures associated with urethral injury. International journal of impotence research, 2019, Volume: 31, Issue:3 Topics: Adult; Erectile Dysfunction; Fractures, Bone; Humans; Male; Pelvic Bones; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Tadalafil; Taiwan; Treatment Outcome; Ultrasonic Therapy; Urethra; Young Adult	2019
Effects on sexual function in Japanese patients with benign prostatic hyperplasia upon switching from combination therapy with α1 blocker and dutasteride to combination therapy with tadalafil and dutasteride. The aging male : the official journal of the International Society for the Study of the Aging Male, 2020, Volume: 23, Issue:5 Topics: Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Japan; Male; Prostatic Hyperplasia; Quality of Life; Retrospective Studies; Tadalafil; Treatment Outcome	2020
Evaluation of the effectiveness and safety of a daily dose of 5 mg of tadalafil, over an 8-week period, for improving quality of life among Korean men with andropause symptoms, including erectile dysfunction: A pilot study. Medicine, 2018, Volume: 97, Issue:51 Topics: Adult; Aged; Andropause; Controlled Before-After Studies; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pilot Projects; Quality of Life; Republic of Korea; Self Report; Tadalafil; Testosterone	2018
Comparison between counterfeit and authentic medicines: A novel approach using differential scanning calorimetry and hierarchical cluster analysis. Journal of pharmaceutical and biomedical analysis, 2019, Mar-20, Volume: 166 Topics: Brazil; Calorimetry, Differential Scanning; Cluster Analysis; Counterfeit Drugs; Erectile Dysfunction; Excipients; Humans; Male; Phosphodiesterase 5 Inhibitors; Principal Component Analysis; Sildenafil Citrate; Tadalafil	2019
[Safety of tadalafil in patients with cardiovascular comorbidities]. Urologiia (Moscow, Russia : 1999), 2019, Issue:1 Topics: Cardiovascular Diseases; Cardiovascular System; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2019
Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials. Journal of health politics, policy and law, 2019, 10-01, Volume: 44, Issue:5 Topics: Adolescent; Child; Direct-to-Consumer Advertising; Drug Industry; Erectile Dysfunction; Guideline Adherence; Guidelines as Topic; Humans; Male; Prescription Drugs; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; Vasodilator Agents	2019
The effect of using tadalafil 5 mg/day on neutrophil-lymphocyte and platelet-lymphocyte ratios in mild-medium and severe erectile dysfunction patients; and comparison of clinical response. Andrologia, 2019, Volume: 51, Issue:9 Topics: Adult; Blood Cell Count; Blood Platelets; Case-Control Studies; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Lymphocytes; Male; Middle Aged; Neutrophils; Penile Erection; Retrospective Studies; Severity of Illness Index; Tadalafil; Treatment Outcome	2019
Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase-5 inhibitor. Andrology, 2013, Volume: 1, Issue:2 Topics: Adult; Carbolines; Diabetes Mellitus; Diabetic Neuropathies; Ejaculation; Erectile Dysfunction; Humans; Infertility, Male; Male; Phosphodiesterase 5 Inhibitors; Semen Analysis; Seminal Vesicles; Sperm Count; Sperm Motility; Tadalafil; Ultrasonography	2013
Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction. British journal of pharmacology, 2013, Volume: 169, Issue:2 Topics: Adult; Aged; Animals; Benzimidazoles; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation Therapy; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Potassium Channels, Calcium-Activated; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilation; Vasodilator Agents	2013
Prescription opioids for back pain and use of medications for erectile dysfunction. Spine, 2013, May-15, Volume: 38, Issue:11 Topics: Adult; Age Factors; Aged; Analgesics, Opioid; Androgens; Back Pain; Carbolines; Comorbidity; Cross-Sectional Studies; Depression; Drug Prescriptions; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Imidazoles; Insurance, Health; Logistic Models; Male; Middle Aged; Piperazines; Prevalence; Purines; Sildenafil Citrate; Smoking; Sulfones; Tadalafil; Testosterone; Triazines; United States; Urological Agents; Vardenafil Dihydrochloride	2013
[Non-arteritic anterior ischemic optic neuropathy associated with erectile dysfunction medications]. Harefuah, 2013, Volume: 152, Issue:2 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2013
A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction. Current medical research and opinion, 2013, Volume: 29, Issue:6 Topics: Carbolines; Carbonates; Erectile Dysfunction; Humans; Imidazoles; Latin America; Male; Medication Adherence; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Purines; Pyrimidines; Self Concept; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2013
A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction. Current medical research and opinion, 2013, Volume: 29, Issue:6 Topics: Carbolines; Egypt; Erectile Dysfunction; Humans; Imidazoles; Male; Medication Adherence; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Purines; Saudi Arabia; Self Concept; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Triazines; United Arab Emirates; Vardenafil Dihydrochloride	2013
Hearing loss with phosphodiesterase-5 inhibitors: a prospective and objective analysis with tadalafil. The Laryngoscope, 2013, Volume: 123, Issue:6 Topics: Adult; Audiometry, Pure-Tone; Carbolines; Erectile Dysfunction; Evoked Potentials, Auditory, Brain Stem; Female; Follow-Up Studies; Hearing; Hearing Loss, Sensorineural; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil	2013
[Intracavernous injection: a treatment modality for erectile dysfunction]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2013, Volume: 64, Issue:4 Topics: Alprostadil; Carbolines; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Penis; Piperazines; Purines; Self Administration; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Vasodilator Agents	2013
[Medico legal considerations on prosthesis surgery of the erectile dysfunction in a La Peyronie disease case]. Minerva chirurgica, 2013, Volume: 68, Issue:2 Topics: Adult; Carbolines; Diabetes Mellitus, Type 1; Erectile Dysfunction; Foreign-Body Migration; General Surgery; Humans; Hypertension; Intraoperative Complications; Male; Malpractice; Panic Disorder; Penile Implantation; Penile Induration; Penile Prosthesis; Penis; Prosthesis Failure; Tadalafil; Urology	2013
Condom attitudes of heterosexual men ages 50 and older using prescribed drugs (Viagra, Cialis, Levitra) to treat erectile dysfunction. American journal of men's health, 2013, Volume: 7, Issue:6 Topics: Carbolines; Condoms; Erectile Dysfunction; Female; Health Behavior; Health Promotion; Heterosexuality; Humans; Imidazoles; Male; Middle Aged; Piperazines; Purines; Safe Sex; Sexual Partners; Sexually Transmitted Diseases; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2013
Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. The journal of sexual medicine, 2013, Volume: 10, Issue:7 Topics: Carbolines; Chromatography, Liquid; Dietary Supplements; Drug Labeling; Erectile Dysfunction; Humans; Male; Mass Spectrometry; Nonprescription Drugs; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; United States	2013
[Oral tadalafil on alternate days for erectile dysfunction that fails to respond to on-demand sildenafil: a report of 15 cases]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:4 Topics: Administration, Oral; Adult; Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Treatment Outcome	2013
[Tadalafil for erectile dysfunction: an overview]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:4 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2013
[Daily low-dose tadalafil for erectile dysfunction induced by pelvic fracture urethral disruption]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:5 Topics: Adult; Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Fractures, Bone; Humans; Male; Middle Aged; Pelvis; Penile Erection; Tadalafil; Treatment Outcome; Urethra	2013
The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model. Spinal cord, 2013, Volume: 51, Issue:9 Topics: Acetylcholine; Animals; Arginine; Carbolines; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Erectile Dysfunction; In Vitro Techniques; Isometric Contraction; Male; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penis; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Spinal Cord Injuries; Tadalafil; Vasodilator Agents	2013
Stress management and erectile dysfunction: a pilot comparative study. Andrologia, 2014, Volume: 46, Issue:6 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pilot Projects; Relaxation Therapy; Stress, Psychological; Tadalafil	2014
Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil. International journal of impotence research, 2014, Volume: 26, Issue:1 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Models, Theoretical; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Self Concept; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2014
The daily intake of Tadalafil 5 mg improves the symptoms of chronic anal fissure. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:10 Topics: Carbolines; Chronic Disease; Erectile Dysfunction; Fissure in Ano; Humans; Male; Phosphodiesterase 5 Inhibitors; Tadalafil	2013
Assisted semen collection using two phosphodiesterase type 5 inhibitors (Tadalafil and Sildenafil) in infertile men with mild erectile dysfunction. Chinese medical journal, 2013, Volume: 126, Issue:14 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Semen; Sildenafil Citrate; Specimen Handling; Sulfones; Tadalafil	2013
The selectivity and potency of the new PDE5 inhibitor TPN729MA. The journal of sexual medicine, 2013, Volume: 10, Issue:11 Topics: Animals; Blood Pressure; Carbolines; Dogs; Erectile Dysfunction; Humans; Inhibitory Concentration 50; Isoenzymes; Male; Nitroprusside; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil	2013
Tadalafil for benign prostatic hyperplasia. Drug and therapeutics bulletin, 2013, Volume: 51, Issue:8 Topics: Adult; Carbolines; Drug Approval; Erectile Dysfunction; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil	2013
Should you take an erectile dysfunction drug to also ease urinary woes? We think not. Standard medications to treat the symptoms of an enlarged prostate are still the best first choice for men. Harvard men's health watch, 2013, Volume: 17, Issue:11 Topics: Aged; Aged, 80 and over; Carbolines; Ejaculation; Erectile Dysfunction; Evidence-Based Medicine; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2013
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies. The Journal of urology, 2014, Volume: 191, Issue:2 Topics: Aged; Carbolines; Comorbidity; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2014
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies. European urology, 2014, Volume: 65, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Severity of Illness Index; Tadalafil; Time Factors; Treatment Outcome; Young Adult	2014
Nonresponders, partial responders, and complete responders to PDE5 inhibitors therapy according to IIEF criteria: validation of an anchor-based treatment responder classification. The journal of sexual medicine, 2013, Volume: 10, Issue:12 Topics: Adolescent; Adult; Aged; Carbolines; Classification; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome; Young Adult	2013
The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study. Journal of chemical information and modeling, 2013, Nov-25, Volume: 53, Issue:11 Topics: Binding Sites; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclic Nucleotide Phosphodiesterases, Type 6; Erectile Dysfunction; Humans; Imidazoles; Ligands; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Phosphodiesterase 5 Inhibitors; Piperazines; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Purines; Sildenafil Citrate; Structural Homology, Protein; Sulfones; Tadalafil; Thermodynamics; Triazines; Urological Agents; Vardenafil Dihydrochloride	2013
Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study. The journal of sexual medicine, 2014, Volume: 11, Issue:2 Topics: Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2014
Lower urinary tract symptoms in the elderly male: choosing wisely. The Journal of urology, 2014, Volume: 191, Issue:2 Topics: Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Tadalafil	2014
Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy. European urology, 2014, Volume: 65, Issue:3 Topics: Adenocarcinoma; Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil	2014
Reply from authors re: Arthur L. Burnett. Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy. Eur Urol 2014;65:597-8: although erection rehabilitation after prostatectomy remains indefinite, the most effective treat European urology, 2014, Volume: 65, Issue:3 Topics: Adenocarcinoma; Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil	2014
Management of ED under the "severe distress" criteria in the NHS: a real-life study. The journal of sexual medicine, 2014, Volume: 11, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Carbolines; Drug Costs; Erectile Dysfunction; Humans; Imidazoles; Longitudinal Studies; Male; Middle Aged; Patient Compliance; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; State Medicine; Sulfones; Tadalafil; Triazines; United Kingdom; Vardenafil Dihydrochloride; Young Adult	2014
[Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:12 Topics: Carbolines; Cardiovascular Diseases; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Tadalafil	2013
Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats. Clinical and experimental pharmacology & physiology, 2014, Volume: 41, Issue:4 Topics: Animals; Antioxidants; Carbolines; Erectile Dysfunction; Gene Expression Regulation, Enzymologic; Glutathione; Male; Melatonin; Nitric Oxide Synthase Type III; Peroxidase; Rats; Rats, Wistar; Spinal Cord Injuries; Tadalafil; Vasodilator Agents	2014
A broad-spectrum approach to daily tadalafil: making the big picture even bigger. European urology, 2014, Volume: 65, Issue:2 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil	2014
Central serous chorioretinopathy following oral tadalafil intake. Clinical & experimental optometry, 2014, Volume: 97, Issue:5 Topics: Administration, Oral; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Retina; Tadalafil; Tomography, Optical Coherence	2014
Effect of once-daily tadalafil on confidence and perceived difficulty in performing sexual intercourse in men who were incomplete responders to as-needed PDE5 inhibitor treatment. International journal of clinical practice, 2014, Volume: 68, Issue:7 Topics: Aged; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Perception; Performance Anxiety; Phosphodiesterase 5 Inhibitors; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2014
The effect of methamphetamine on an animal model of erectile function. Andrology, 2014, Volume: 2, Issue:4 Topics: Animals; Carbolines; Disease Models, Animal; Erectile Dysfunction; Male; Methamphetamine; Penile Erection; Phosphodiesterase 5 Inhibitors; Rats, Sprague-Dawley; Tadalafil	2014
Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway. The journal of sexual medicine, 2014, Volume: 11, Issue:5 Topics: Arteries; Benzopyrans; Carbolines; Cyclic GMP; Diabetes Mellitus, Type 2; Drug Synergism; Erectile Dysfunction; Ethanolamines; Humans; Imidazoles; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Nebivolol; Nitric Oxide; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2014
Molecular signalling of a novel curcumin derivative versus Tadalafil in erectile dysfunction. Andrologia, 2015, Volume: 47, Issue:6 Topics: Animals; Curcumin; Cyclic GMP; Diabetes Mellitus, Experimental; Erectile Dysfunction; Heme Oxygenase-1; Male; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase; p38 Mitogen-Activated Protein Kinases; Penis; Phosphodiesterase 5 Inhibitors; Rats; Tadalafil	2015
Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active. Harvard health letter, 2014, Volume: 39, Issue:7 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Life Style; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyrimidines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2014
Chromatographic analysis of some drugs employed in erectile dysfunction therapy: qualitative and quantitative studies using calixarene stationary phase. Journal of separation science, 2014, Volume: 37, Issue:20 Topics: Apomorphine; Buffers; Calixarenes; Carbolines; Chromatography, High Pressure Liquid; Erectile Dysfunction; Humans; Hydrogen-Ion Concentration; Limit of Detection; Male; Pharmaceutical Preparations; Piperazines; Purines; Reproducibility of Results; Sildenafil Citrate; Sulfonamides; Tadalafil	2014
ED drugs after cancer treatment don't protect erectile function. Harvard men's health watch, 2014, Volume: 18, Issue:12 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil	2014
Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates. European journal of pharmacology, 2014, Dec-05, Volume: 744 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Animals; Carbolines; Drug Synergism; Electric Stimulation; Erectile Dysfunction; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Muscle Contraction; Phenylephrine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Tadalafil	2014
Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis. International journal of clinical practice, 2015, Volume: 69, Issue:4 Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Risk Assessment; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2015
Detection of a tadalafil analogue as an adulterant in a dietary supplement for erectile dysfunction. The journal of sexual medicine, 2015, Volume: 12, Issue:1 Topics: Argentina; Benzodioxoles; Carbolines; Chromatography, High Pressure Liquid; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Male; Pharmaceutical Preparations; Phosphodiesterase 5 Inhibitors; Plant Preparations; Spectrometry, Mass, Electrospray Ionization; Tadalafil	2015
Use of phosphodiesterase type 5 inhibitors in assistive living and home care settings. Applied nursing research : ANR, 2015, Volume: 28, Issue:3 Topics: Drug Prescriptions; Erectile Dysfunction; Home Care Services; Housing for the Elderly; Humans; Male; Phosphodiesterase 5 Inhibitors; Retrospective Studies; Sildenafil Citrate; Tadalafil	2015
Once-a-day Tadalafil administration improves the spermogram parameters in fertile patients. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2015, Sep-30, Volume: 87, Issue:3 Topics: Adult; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Spermatozoa; Tadalafil; Time Factors; Treatment Outcome	2015
Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC urology, 2015, Nov-12, Volume: 15 Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prospective Studies; Risk Factors; Tadalafil; Treatment Outcome; Urological Agents; Young Adult	2015
A Case Report: Consecutive Cranial Neuropathies Following the Use of Phosphodiesterase-5 Inhibitors. The American orthoptic journal, 2015, Volume: 65 Topics: Aged; Cranial Nerve Diseases; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil	2015
Bilateral visual loss recovering after tadalafil withdrawal. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2016, Volume: 37, Issue:5 Topics: Aged; Blindness; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Substance Withdrawal Syndrome; Tadalafil	2016
[Rapid screening and confirmation of illegally added anti- impotence preparations in health care products by high performance liquid chromatography-high resolution mass spectrometry]. Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:8 Topics: Benzylamines; Chromatography, High Pressure Liquid; Drug Contamination; Erectile Dysfunction; Humans; Indole Alkaloids; Male; Mass Spectrometry; Naphthalenes; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; Vasodilator Agents	2015
Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats. The journal of sexual medicine, 2016, Volume: 13, Issue:1 Topics: Animals; Combined Modality Therapy; Disease Models, Animal; Erectile Dysfunction; Male; Mesenchymal Stem Cells; Nerve Crush; Penile Erection; Penis; Peripheral Nerve Injuries; Phosphodiesterase 5 Inhibitors; Prostatectomy; Rats; Tadalafil	2016
Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases. The journal of sexual medicine, 2016, Volume: 13, Issue:5 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Preference; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2016
Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments. Andrology, 2016, Volume: 4, Issue:5 Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Implantation; Sexual Partners; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents	2016
Re: Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction during a 6-Month Observational Study (EDATE): Impact of Patient Characteristics and Comorbidities. The Journal of urology, 2016, Volume: 196, Issue:2 Topics: Carbolines; Comorbidity; Double-Blind Method; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome	2016
Re: Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil versus Placebo to Predict Recovery of Erectile Function after Bilateral Nerve-Sparing Radical Prostatectomy. The Journal of urology, 2016, Volume: 196, Issue:3 Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil	2016
Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. Journal of endocrinological investigation, 2017, Volume: 40, Issue:3 Topics: Adult; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Multiple Sclerosis; Phosphodiesterase 5 Inhibitors; Pilot Projects; Prognosis; Prospective Studies; Single-Blind Method; Tadalafil	2017
Erectile Dysfunction Drugs Changed the Protein Expressions and Activities of Drug-Metabolising Enzymes in the Liver of Male Rats. Oxidative medicine and cellular longevity, 2016, Volume: 2016 Topics: Animals; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Erectile Dysfunction; Isoenzymes; Liver; Male; Metabolic Detoxication, Phase I; Phosphodiesterase 5 Inhibitors; Rats; Risk Assessment; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride	2016
Prevalence of use of erectile dysfunction medication by Dutch military personnel between 2003 and 2012. International journal of impotence research, 2017, Volume: 29, Issue:2 Topics: Adult; Clinical Pharmacy Information Systems; Erectile Dysfunction; Humans; Male; Military Personnel; Netherlands; Psychotropic Drugs; Risk Factors; Sildenafil Citrate; Surveys and Questionnaires; Tadalafil	2017
α The journal of sexual medicine, 2016, Volume: 13, Issue:12 Topics: Adrenergic alpha-Antagonists; Animals; Erectile Dysfunction; Humans; Male; Middle Aged; Nerve Crush; Nitric Oxide Synthase Type I; Penile Erection; Penis; Peripheral Nerve Injuries; Prostatectomy; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Tadalafil; Trauma, Nervous System	2016
Paroxysmal Hemicrania-Like Headache Secondary to Phosphodiesterase Inhibitors Administration: A Case Report. Headache, 2017, Volume: 57, Issue:4 Topics: Adult; Erectile Dysfunction; Headache; Humans; Male; Paroxysmal Hemicrania; Phosphodiesterase Inhibitors; Pudendal Neuralgia; Tadalafil	2017
[New data on the effectiveness of Tadalafil alone and in combination with NeyroDoz in treating erectile dysfunction associated with secondary premature ejaculation]. Urologiia (Moscow, Russia : 1999), 2016, Issue:5 Topics: Adult; Biological Products; Drug Combinations; Drug Therapy, Combination; Erectile Dysfunction; Glutamine; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Premature Ejaculation; Prospective Studies; Tadalafil; Tryptophan	2016
Erectile dysfunction in a murine model of sleep apnea. American journal of respiratory and critical care medicine, 2008, Sep-15, Volume: 178, Issue:6 Topics: Animals; Blotting, Western; Carbolines; Comorbidity; Disease Models, Animal; Erectile Dysfunction; Estradiol; Hypoxia; Immunohistochemistry; Libido; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Penis; Phosphodiesterase Inhibitors; Sleep Apnea, Obstructive; Tadalafil; Testosterone	2008
Psychosocial impact and effectiveness of tadalafil among treatment-naïve and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Kuwait; Male; Middle Aged; Phosphodiesterase Inhibitors; Saudi Arabia; Sexuality; Tadalafil; Treatment Outcome; United Arab Emirates	2008
Pulmonary embolism after tadalafil ingestion. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:5 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Protein C; Pulmonary Embolism; Tadalafil	2008
[Treatment of male erectile dysfunction following spinal cord injuries using PDE5 inhibitors]. Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti, 2008, Volume: 87, Issue:5 Topics: Adult; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Spinal Cord Injuries; Tadalafil	2008
Daily tadalafil prevents erectile dysfunction in diabetic men. Medscape journal of medicine, 2008, May-29, Volume: 10, Issue:5 Topics: Carbolines; Diabetes Complications; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2008
Use of phosphodiesterase-5 inhibitors by college students. Revista de saude publica, 2008, Volume: 42, Issue:5 Topics: Adolescent; Adult; Brazil; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Self Medication; Sildenafil Citrate; Students; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents; Young Adult	2008
The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients. BJU international, 2009, Volume: 103, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Cohort Studies; England; Erectile Dysfunction; Humans; Male; Middle Aged; Myocardial Ischemia; Phosphodiesterase Inhibitors; Product Surveillance, Postmarketing; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires; Tadalafil	2009
[Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours]. Zhonghua nan ke xue = National journal of andrology, 2008, Volume: 14, Issue:9 Topics: Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Tadalafil; Treatment Outcome	2008
EEG abnormalities during treatment with tadalafil, a phosphodiesterase type 5 inhibitor. Neurological research, 2009, Volume: 31, Issue:3 Topics: Carbolines; Cohort Studies; Electroencephalography; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil; Time Factors	2009
Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction. The journal of sexual medicine, 2009, Volume: 6, Issue:2 Topics: Adult; Aged; Carbolines; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Severity of Illness Index; Spinal Cord Injuries; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Young Adult	2009
Management of erectile dysfunction in general practice. The journal of sexual medicine, 2009, Volume: 6, Issue:4 Topics: Attitude of Health Personnel; Carbolines; Cardiovascular Diseases; Drug Prescriptions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Physician-Patient Relations; Piperazines; Practice Patterns, Physicians'; Primary Health Care; Purines; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Triazines; Vardenafil Dihydrochloride	2009
Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry. Journal of pharmaceutical and biomedical analysis, 2009, Apr-05, Volume: 49, Issue:3 Topics: Adult; Amines; Carbolines; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Imidazoles; Ions; Male; Piperazines; Plant Preparations; Purines; Reference Standards; Sildenafil Citrate; Spectrum Analysis; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2009
Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors. BJU international, 2009, Volume: 103, Issue:10 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Time Factors; Triazines; Vardenafil Dihydrochloride	2009
Isolation and structural elucidation of cyclopentynafil and N-octylnortadalafil found in a dietary supplement. Chemical & pharmaceutical bulletin, 2009, Volume: 57, Issue:2 Topics: Carbolines; Chromatography, High Pressure Liquid; Circular Dichroism; Dietary Supplements; Erectile Dysfunction; Humans; Illicit Drugs; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Phosphodiesterase Inhibitors; Piperazines; Spectrometry, Mass, Electrospray Ionization; Sulfones; Tadalafil	2009
Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction. Urology, 2009, Volume: 73, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Databases, Factual; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Young Adult	2009
Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. The journal of sexual medicine, 2009, Volume: 6, Issue:5 Topics: Animals; Carbolines; Disease Models, Animal; Erectile Dysfunction; Humans; Hypogonadism; In Vitro Techniques; Male; Penis; Phosphodiesterase Inhibitors; Prostatectomy; Rats; Rats, Sprague-Dawley; Tadalafil	2009
An unusual outbreak of hypoglycemia. The New England journal of medicine, 2009, Feb-12, Volume: 360, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Chromatography, High Pressure Liquid; Disease Outbreaks; Drug Contamination; Erectile Dysfunction; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Illicit Drugs; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Plant Extracts; Purines; Sildenafil Citrate; Singapore; Sulfones; Tadalafil; Young Adult	2009
Vcsa1 acts as a marker of erectile function recovery after gene therapeutic and pharmacological interventions. The Journal of urology, 2009, Volume: 181, Issue:6 Topics: Animals; Carbolines; Erectile Dysfunction; Gene Expression; Genetic Therapy; Male; Penile Erection; Phosphodiesterase Inhibitors; Protein Precursors; Rats; Rats, Sprague-Dawley; Salivary Proteins and Peptides; Tadalafil	2009
Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis. Asian journal of andrology, 2009, Volume: 11, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Asia; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Randomized Controlled Trials as Topic; Tadalafil	2009
Editorial comment on: Effects of once-daily tadalafil on erectile function in men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia. European urology, 2009, Volume: 56, Issue:4 Topics: Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Tadalafil	2009
Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU international, 2009, Volume: 103, Issue:10 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Prostatectomy; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2009
Tadalafil and purpura. The journal of sexual medicine, 2009, Volume: 6, Issue:6 Topics: Aged; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Purpura; Tadalafil; Vasculitis	2009
[Safety and tolerance of tadalafil in the treatment of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:6 Topics: Carbolines; Drug Tolerance; Erectile Dysfunction; Humans; Male; Tadalafil; Treatment Outcome	2009
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study. Asian journal of andrology, 2009, Volume: 11, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Practice Patterns, Physicians'; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2009
Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency. BJU international, 2010, Volume: 105, Issue:3 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Purines; Robotics; Sildenafil Citrate; Sulfones; Tadalafil; Trauma, Nervous System; Treatment Outcome	2010
[Minute dose of tadalafil for nocturnal penile tumescence]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:8 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Tadalafil	2009
[Therapy of erectile dysfunction can help man and woman. Improving the sexual quality of life of couples]. MMW Fortschritte der Medizin, 2009, Nov-05, Volume: 151, Issue:45 Topics: Carbolines; Erectile Dysfunction; Female; Humans; Male; Marriage; Patient Satisfaction; Phosphodiesterase Inhibitors; Tadalafil	2009
[Interview with Dr. Heinz-Jürgen Notz, established urologist, Düsseldorf. Creating love life without time pressure]. MMW Fortschritte der Medizin, 2009, Nov-05, Volume: 151, Issue:45 Topics: Carbolines; Erectile Dysfunction; Female; Half-Life; Humans; Male; Marriage; Metabolic Clearance Rate; Phosphodiesterase Inhibitors; Tadalafil; Time Factors	2009
Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:2 Topics: Adolescent; Adult; Carbolines; Case-Control Studies; Central Serous Chorioretinopathy; Databases, Factual; Drug Prescriptions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Product Surveillance, Postmarketing; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; United States Department of Veterans Affairs; Vardenafil Dihydrochloride; Young Adult	2010
Sildenafil or vardenafil nonresponders' erectile response to tadalafil. Urology journal, 2009,Fall, Volume: 6, Issue:4 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Triazines; Vardenafil Dihydrochloride	2009
Erectile dysfunction. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Mar-09, Volume: 182, Issue:4 Topics: Blood Glucose; Carbolines; Cardiovascular Diseases; Cholesterol; Erectile Dysfunction; Humans; Imidazoles; Impotence, Vasculogenic; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Triazines; Vardenafil Dihydrochloride	2010
[Therapy of erectile dysfunction]. Orvosi hetilap, 2010, Feb-28, Volume: 151, Issue:9 Topics: Adrenergic alpha-Antagonists; Androgens; Carbolines; Diagnosis, Differential; Erectile Dysfunction; Humans; Imidazoles; Injections; Male; Penile Implantation; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vacuum; Vardenafil Dihydrochloride; Vasodilator Agents	2010
Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation. Urology, 2010, Volume: 75, Issue:6 Topics: Adult; Carbolines; Cohort Studies; Coitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Patient Satisfaction; Penis; Phosphodiesterase Inhibitors; Probability; Randomized Controlled Trials as Topic; Retrospective Studies; Sexual Partners; Tadalafil; Treatment Outcome	2010
Identification of counterfeit medicines for erectile dysfunction from an illegal supply chain. Arhiv za higijenu rada i toksikologiju, 2010, Volume: 61, Issue:1 Topics: Carbolines; Chromatography, High Pressure Liquid; Croatia; Erectile Dysfunction; Fraud; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2010
Evaluation of therapeutic response of patients with erectile dysfunction. Medicinski arhiv, 2009, Volume: 63, Issue:5 Topics: Adolescent; Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Preference; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Young Adult	2009
Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitrates. Current medical research and opinion, 2010, Volume: 26, Issue:6 Topics: Adolescent; Adult; Aged; Carbolines; Databases, Factual; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Nitrates; Pharmaceutical Services; Phosphodiesterase Inhibitors; Piperazines; Practice Patterns, Physicians'; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Young Adult	2010
Effects of tadalafil on platelets and endothelium in patients with erectile dysfunction and cardiovascular risk factors: a pilot study. Angiology, 2010, Volume: 61, Issue:6 Topics: Analysis of Variance; Blood Platelets; Carbolines; Cyclic AMP; Cyclic GMP; Dyslipidemias; E-Selectin; Endothelium, Vascular; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; P-Selectin; Phosphodiesterase Inhibitors; Pilot Projects; Risk Factors; Smoking; Tadalafil	2010
Editorial comment. Urology, 2010, Volume: 75, Issue:6 Topics: Carbolines; Erectile Dysfunction; Female; Humans; Male; Patient Satisfaction; Phosphodiesterase Inhibitors; Sexual Partners; Tadalafil; Treatment Outcome	2010
Editorial comment. Urology, 2010, Volume: 75, Issue:6 Topics: Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Prostatism; Quality of Life; Risk Assessment; Tadalafil; Treatment Outcome; Urination Disorders	2010
Editorial comment. Urology, 2010, Volume: 75, Issue:6 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Prostatism; Quality of Life; Tadalafil; Treatment Outcome; Urination Disorders	2010
Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry. Journal of separation science, 2010, Volume: 33, Issue:14 Topics: Adrenergic alpha-Antagonists; Carbolines; Chromatography, High Pressure Liquid; Dietary Supplements; Erectile Dysfunction; Humans; Imidazoles; Male; Molecular Structure; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Tandem Mass Spectrometry; Triazines; Vardenafil Dihydrochloride; Yohimbine	2010
[Benefits of tadalafil in sexual activity-related time concerns]. Zhonghua nan ke xue = National journal of andrology, 2010, Volume: 16, Issue:6 Topics: Carbolines; Erectile Dysfunction; Female; Humans; Imidazoles; Interpersonal Relations; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2010
Tadalafil-induced transient global amnesia. The Journal of neuropsychiatry and clinical neurosciences, 2010,Summer, Volume: 22, Issue:3 Topics: Amnesia, Transient Global; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil	2010
[Dietary supplements on the domestic market adulterated with sildenafil and tadalafil]. Orvosi hetilap, 2010, Oct-24, Volume: 151, Issue:43 Topics: Aphrodisiacs; Carbolines; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Hungary; Male; Phosphodiesterase Inhibitors; Piperazines; Plant Preparations; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilator Agents	2010
Separation and structural elucidation of a novel analogue of vardenafil included as an adulterant in a dietary supplement by liquid chromatography-electrospray ionization mass spectrometry, infrared spectroscopy and nuclear magnetic resonance spectroscopy Journal of pharmaceutical and biomedical analysis, 2011, Feb-20, Volume: 54, Issue:3 Topics: Carbolines; Chromatography, Liquid; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Imidazoles; Magnetic Resonance Spectroscopy; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Saccharomyces cerevisiae; Sildenafil Citrate; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2011
The impact of oral ED medication on female partners' relationship satisfaction. The journal of sexual medicine, 2011, Volume: 8, Issue:2 Topics: Adult; Aged; Carbolines; Communication; Emotions; Erectile Dysfunction; Female; Humans; Interpersonal Relations; Interviews as Topic; Male; Middle Aged; Personal Satisfaction; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilator Agents	2011
Brachial artery flow mediated assessment: a tool to predict the response to chronic PDE5 inhibition with tadalafil in patients with erectile dysfunction. International journal of cardiology, 2011, Feb-03, Volume: 146, Issue:3 Topics: Brachial Artery; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Predictive Value of Tests; Regional Blood Flow; Tadalafil	2011
Leber's hereditary optic neuropathy precipitated by tadalafil use for erectile dysfunction. Seminars in ophthalmology, 2011, Volume: 26, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Optic Atrophy, Hereditary, Leber; Phosphodiesterase 5 Inhibitors; Tadalafil; Visual Acuity; Visual Field Tests; Visual Fields	2011
Complementary medicine and erectile dysfunction: will you accept the charges? International journal of clinical practice, 2011, Volume: 65, Issue:3 Topics: Carbolines; Complementary Therapies; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prescription Fees; Tadalafil	2011
Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction. Clinics (Sao Paulo, Brazil), 2010, Volume: 65, Issue:12 Topics: Adult; Carbolines; Case-Control Studies; Dipeptidases; Erectile Dysfunction; Humans; Male; Middle Aged; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Tadalafil	2010
[Benefits of tadalafil to ED patients]. Zhonghua nan ke xue = National journal of andrology, 2011, Volume: 17, Issue:1 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2011
Effect of tadalafil in chronic renal failure rabbits: relevance to erectile dysfunction. Journal of Zhejiang University. Science. B, 2011, Volume: 12, Issue:6 Topics: Animals; Carbolines; Cyclic GMP; Erectile Dysfunction; Kidney Failure, Chronic; Male; Nitroprusside; Phosphodiesterase 5 Inhibitors; Rabbits; Tadalafil; Vasodilator Agents	2011
[Serous central chorioretinopathy and tadalafil: a case report]. Journal francais d'ophtalmologie, 2012, Volume: 35, Issue:2 Topics: Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Vasodilator Agents	2012
[ED patients and their female partners prefer tadalafil]. Zhonghua nan ke xue = National journal of andrology, 2011, Volume: 17, Issue:6 Topics: Carbolines; Erectile Dysfunction; Female; Humans; Male; Patient Preference; Phosphodiesterase Inhibitors; Sexual Partners; Tadalafil	2011
Dysfunction of the endothelial-platelet pathway in patients with erectile dysfunction before and after daily treatment with tadalafil. Andrologia, 2012, Volume: 44, Issue:3 Topics: Carbolines; Cell-Derived Microparticles; Endothelium, Vascular; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Integrin alphaVbeta3; Male; Middle Aged; Tadalafil	2012
Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. European urology, 2011, Volume: 60, Issue:5 Topics: Aged; Analysis of Variance; Asia; Australia; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Multicenter Studies as Topic; North America; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Predictive Value of Tests; Randomized Controlled Trials as Topic; Recovery of Function; Reproducibility of Results; ROC Curve; Severity of Illness Index; South America; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome	2011
[Psychosomatic treatment: a key to the improvement of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2011, Volume: 17, Issue:9 Topics: Carbolines; Combined Modality Therapy; Erectile Dysfunction; Humans; Interpersonal Relations; Male; Psychotherapy; Tadalafil	2011
Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profile. The journal of sexual medicine, 2012, Volume: 9, Issue:1 Topics: Aged; Carbolines; Coitus; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Sexual Behavior; Surveys and Questionnaires; Tadalafil; Treatment Outcome	2012
Sexual dysfunction: MCID provides new perspective on erectile function research. Nature reviews. Urology, 2011, 10-18, Volume: 8, Issue:11 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Randomized Controlled Trials as Topic; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Tadalafil	2011
10-Year analysis of adverse event reports to the Food and Drug Administration for phosphodiesterase type-5 inhibitors. The journal of sexual medicine, 2012, Volume: 9, Issue:1 Topics: Carbolines; Cardiovascular Diseases; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Product Surveillance, Postmarketing; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride	2012
Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series. European urology, 2012, Volume: 61, Issue:5 Topics: Adult; Aged; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Neoplasm Grading; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Urinary Incontinence	2012
Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors? Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2012, Volume: 227, Issue:2 Topics: Aged; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Fluorescein Angiography; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Sulfones; Tadalafil; Tomography, Optical Coherence; Triazines; Vardenafil Dihydrochloride; Vision Disorders	2012
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors. The journal of sexual medicine, 2012, Volume: 9, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2012
Type B aortic dissection after the use of tadalafil. The Annals of thoracic surgery, 2012, Volume: 93, Issue:2 Topics: Acute Disease; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Rupture; Blood Vessel Prosthesis Implantation; Carbolines; Emergencies; Endovascular Procedures; Erectile Dysfunction; Hemothorax; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Shock; Stents; Tadalafil; Tomography, X-Ray Computed	2012
[Alternate-day oral tadalafil for erectile dysfunction with no successful intercourse at the baseline]. Zhonghua nan ke xue = National journal of andrology, 2012, Volume: 18, Issue:1 Topics: Adult; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Retrospective Studies; Tadalafil; Treatment Outcome; Young Adult	2012
Monotherapy for comorbid erectile dysfunction and lower urinary tract symptoms: phosphodiesterase inhibitor or α-adrenoceptor antagonist? BJU international, 2012, Volume: 109, Issue:7 Topics: Adrenergic alpha-Antagonists; Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil	2012
Effect of testosterone and frequent low-dose sildenafil/tadalafil on cavernous tissue oxidative stress of aged diabetic rats. Andrologia, 2012, Volume: 44, Issue:6 Topics: Aging; Animals; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Erectile Dysfunction; Glutathione Peroxidase; Male; Malondialdehyde; Oxidative Stress; Penile Erection; Penis; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Testosterone; Vasodilator Agents	2012
The effects of long-term administration of tadalafil on STZ-induced diabetic rats with erectile dysfunction via a local antioxidative mechanism. Asian journal of andrology, 2012, Volume: 14, Issue:4 Topics: Animals; Antioxidants; Blood Pressure; Carbolines; Diabetes Mellitus, Experimental; Erectile Dysfunction; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria, Muscle; Penis; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Tadalafil	2012
PDEI-5 for erectile dysfunction: a potential role in seizure susceptibility. The journal of sexual medicine, 2012, Volume: 9, Issue:8 Topics: Aged; Animals; Carbolines; Disease Susceptibility; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prevalence; Purines; Rats; Seizures; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2012
Erectile dysfunction drug approved to treat BPH symptoms. Mayo Clinic health letter (English ed.), 2012, Volume: 30, Issue:4 Topics: Carbolines; Drug Approval; Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Tadalafil; United States; United States Food and Drug Administration; Vasodilator Agents	2012
Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction. The Journal of urology, 2012, Volume: 188, Issue:2 Topics: Animals; Carbolines; Dogs; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Imidazoles; Infusions, Intravenous; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyrimidines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2012
Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability. The journal of sexual medicine, 2012, Volume: 9, Issue:8 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyrimidines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2012
Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency. International journal of impotence research, 2013, Volume: 25, Issue:1 Topics: Adult; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Retreatment; Tadalafil; Testosterone; Treatment Outcome; Vasodilator Agents	2013
Central serous chorioretinopathy due to tadalafil use. International ophthalmology, 2013, Volume: 33, Issue:2 Topics: Adult; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Tadalafil; Tomography, Optical Coherence	2013
The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers. The journal of sexual medicine, 2013, Volume: 10, Issue:2 Topics: Adult; Aged; Carbolines; Comorbidity; Coronary Artery Disease; Cross-Sectional Studies; Drug Administration Schedule; Drug Utilization; Erectile Dysfunction; Health Surveys; Humans; Illicit Drugs; Imidazoles; Internet; Male; Middle Aged; Nonprescription Drugs; Phosphodiesterase Inhibitors; Piperazines; Prescription Drugs; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride	2013
Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction. BJU international, 2013, Volume: 112, Issue:2 Topics: Administration, Oral; Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Organ Sparing Treatments; Patient Satisfaction; Penile Implantation; Penile Prosthesis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Tadalafil; Treatment Outcome	2013
Comprehensive analysis of clinical trials data shows unequivocally that Phosphodiesterase Inhibitors (PDEi) improve orgasm. The power of meta-analysis? BJU international, 2013, Volume: 111, Issue:2 Topics: Carbolines; Ejaculation; Erectile Dysfunction; Humans; Male; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Sexual Dysfunctions, Psychological; Tadalafil	2013
Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies. BJU international, 2013, Volume: 111, Issue:2 Topics: Carbolines; Coitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Sexual Dysfunctions, Psychological; Tadalafil	2013
Family complains that "love drug'"will smear their name. BMJ (Clinical research ed.), 2002, Sep-07, Volume: 325, Issue:7363 Topics: Carbolines; Drug Industry; Erectile Dysfunction; Humans; Male; Names; Phosphodiesterase Inhibitors; Tadalafil	2002
Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. International journal of impotence research, 2002, Volume: 14, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials, Phase III as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Erectile Dysfunction; Humans; Imidazoles; Male; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2002
Tadalafil: a new treatment for erectile dysfunction. BJU international, 2003, Volume: 91, Issue:6 Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Half-Life; Humans; Male; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil	2003
[Good sex inspite of erectile dysfunction. A new PDE-5 inhibitor gives more latitude]. MMW Fortschritte der Medizin, 2003, Feb-20, Volume: 145, Issue:8 Topics: Carbolines; Clinical Trials, Phase III as Topic; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Placebos; Tadalafil; Time Factors	2003
[PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality]. MMW Fortschritte der Medizin, 2003, Mar-13, Volume: 145, Issue:11 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Half-Life; Humans; Male; Metabolic Clearance Rate; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Sexual Behavior; Tadalafil	2003
New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction. The journal of the Royal Society for the Promotion of Health, 2003, Volume: 123, Issue:2 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United Kingdom; Vardenafil Dihydrochloride	2003
US advertising campaign begins for alternative to sildenafil. BMJ (Clinical research ed.), 2003, Aug-30, Volume: 327, Issue:7413 Topics: Advertising; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2003
[Erectile dysfunction to be taken seriously. Otherwise, the psyche becomes limp, too]. MMW Fortschritte der Medizin, 2003, Aug-07, Volume: 145, Issue:31-32 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil	2003
Coming attractions! New medications on the horizon for erectile dysfunction. Urologic nursing, 2003, Volume: 23, Issue:4 Topics: Alprostadil; Apomorphine; Carbolines; Drug Approval; Erectile Dysfunction; Genetic Therapy; Global Health; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil; United States; United States Food and Drug Administration	2003
Roundtable discussion: tadalafil study group. The American journal of cardiology, 2003, Nov-06, Volume: 92, Issue:9A Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cardiovascular System; Drug Interactions; Erectile Dysfunction; Humans; Male; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Tadalafil	2003
Tadalafil (cialis) for erectile dysfunction. The Medical letter on drugs and therapeutics, 2003, Dec-22, Volume: 45, Issue:1172 Topics: Carbolines; Coitus; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Humans; Male; Penile Erection; Placebos; Tadalafil; Treatment Outcome	2003
Are they better than Viagra? Two new drugs for erectile dysfunction work like Viagra and carry similar risks and benefits. Their subtle differences, however, may make a difference for some men. Harvard health letter, 2004, Volume: 29, Issue:3 Topics: Carbolines; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2004
Cialis is here. The soft sell. Newsweek, 2004, Feb-02, Volume: 143, Issue:5 Topics: Carbolines; Commerce; Drug Industry; Erectile Dysfunction; Humans; Imidazoles; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride	2004
Tadalafil (Cialis) and vardenafil (Levitra) recently approved drugs for erectile dysfunction. Urologic nursing, 2004, Volume: 24, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
Pills for erectile dysfunction: now there are three. Harvard men's health watch, 2004, Volume: 8, Issue:9 Topics: Carbolines; Drug Interactions; Erectile Dysfunction; Food-Drug Interactions; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
Tadalafil and vardenafil. Nature reviews. Drug discovery, 2004, Volume: 3, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Approval; Erectile Dysfunction; Forecasting; Humans; Imidazoles; Legislation, Drug; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
Time course of the interaction between tadalafil and nitrates. Journal of the American College of Cardiology, 2004, Jun-02, Volume: 43, Issue:11 Topics: Angina Pectoris; Carbolines; Drug Interactions; Erectile Dysfunction; Humans; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Research Design; Tadalafil; Time Factors; Vasodilator Agents	2004
A consumer's guide to impotence drugs. The Johns Hopkins medical letter health after 50, 2004, Volume: 17, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Enzyme Inhibitors; Erectile Dysfunction; Humans; Imidazoles; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2004
[ED (erectile dysfunction) therapy in general practice. Increased patient satisfaction]. MMW Fortschritte der Medizin, 2004, Apr-15, Volume: 146, Issue:16 Topics: Carbolines; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Patient Satisfaction; Physician-Patient Relations; Tadalafil	2004
[Phosphodiesterase-5 inhibitor with broad temporal effectiveness window]. MMW Fortschritte der Medizin, 2004, Apr-15, Volume: 146, Issue:16 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Delayed-Action Preparations; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome	2004
Tadalafil (Cialis) for erectile dysfunction. American family physician, 2004, Jul-15, Volume: 70, Issue:2 Topics: Carbolines; Consumer Product Safety; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil	2004
Counterfeits of impotence drug appear in the United Kingdom. BMJ (Clinical research ed.), 2004, Sep-04, Volume: 329, Issue:7465 Topics: Carbolines; Drugs, Generic; Erectile Dysfunction; Humans; Male; Tadalafil; United Kingdom; Vasodilator Agents	2004
[After taking the table, immediate sex? New potency pill allows more time for love life]. MMW Fortschritte der Medizin, 2004, May-06, Volume: 146, Issue:19 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Coitus; Cyclic Nucleotide Phosphodiesterases, Type 5; Delayed-Action Preparations; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil	2004
Tadalafil-associated anterior ischaemic optic neuropathy. Eye (London, England), 2005, Volume: 19, Issue:6 Topics: Adenocarcinoma; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Optic Disk; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil	2005
Development of a Micellar electrokinetic capillary chromatography method for the determination of three drugs employed in the erectile dysfunction therapy. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004, Nov-25, Volume: 811, Issue:2 Topics: Carbolines; Chromatography, Micellar Electrokinetic Capillary; Erectile Dysfunction; Humans; Imidazoles; Male; Piperazines; Purines; Reproducibility of Results; Sensitivity and Specificity; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2004
[Birthday of a "potency pill". Helmut Newton celebrates posthumously likewise]. MMW Fortschritte der Medizin, 2004, Jul-22, Volume: 146, Issue:29-30 Topics: Carbolines; Contraceptives, Oral; Erectile Dysfunction; Erotica; Female; Germany; History, 20th Century; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Photography; Piperazines; Purines; Sexual Behavior; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2004
My doctor prescribed Cialis [tadalafil] for erectile dysfunction. Anything I need to watch out for? I have a heart condition. Heart advisor, 2004, Volume: 7, Issue:7 Topics: Adrenergic alpha-Antagonists; Carbolines; Contraindications; Drug Interactions; Erectile Dysfunction; Humans; Male; Nitrates; Tadalafil; Vasodilator Agents	2004
Erectile dysfunction and cardiovascular disease. Mayo Clinic proceedings, 2005, Volume: 80, Issue:2 Topics: Adrenergic Antagonists; Carbolines; Cardiovascular Diseases; Contraindications; Erectile Dysfunction; Humans; Male; Nitrates; Nitric Oxide Donors; Tadalafil	2005
Patient education series. Erectile dysfunction. Nursing, 2005, Volume: 35, Issue:2 Topics: Carbolines; Contraindications; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Tadalafil in a patient with treatment-resistant depression and antidepressant polypharmacy. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:2 Topics: Antidepressive Agents; Carbolines; Depressive Disorder, Major; Erectile Dysfunction; Humans; Male; Middle Aged; Tadalafil	2005
Tadalafil associated with anterior ischemic optic neuropathy. Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:3 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Tadalafil; Visual Field Tests; Visual Fields	2005
Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:3 Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Recurrence; Tadalafil; Visual Fields	2005
ED drugs covered, but managed care unmoved. Managed care (Langhorne, Pa.), 2005, Volume: 14, Issue:3 Topics: Carbolines; Erectile Dysfunction; Formularies as Topic; Humans; Imidazoles; Insurance Coverage; Insurance, Pharmaceutical Services; Male; Managed Care Programs; Medicare; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride	2005
Viagra, Levitra, and Cialis: what's the difference? South Dakota journal of medicine, 2005, Volume: 58, Issue:4 Topics: Adult; Age Factors; Aged; Carbolines; Contraindications; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2005
Resumption of spontaneous erections in selected patients affected by erectile dysfunction and various degrees of carotid wall alteration: role of tadalafil. European urology, 2005, Volume: 48, Issue:2 Topics: Adolescent; Adult; Aged; Carbolines; Carotid Stenosis; Case-Control Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil; Tunica Intima; Tunica Media; Ultrasonography, Doppler, Color	2005
Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors. The Journal of urology, 2005, Volume: 174, Issue:2 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Chromatography, High Pressure Liquid; Drug Contamination; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phytotherapy; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Tadalafil-associated priapism. Urology, 2005, Volume: 66, Issue:2 Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Priapism; Tadalafil	2005
Effect of tadalafil on sexual timing behavior patterns in men with erectile dysfunction: integrated analysis of randomized, placebo controlled trials. The Journal of urology, 2005, Volume: 174, Issue:4 Pt 1 Topics: Adult; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Time Factors	2005
Efficacy and safety of tadalafil in men with severe erectile dysfunction in tertiary care academic centers. Current urology reports, 2005, Volume: 6, Issue:6 Topics: Carbolines; Erectile Dysfunction; Health Facilities; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Severity of Illness Index; Tadalafil	2005
The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Current medical research and opinion, 2005, Volume: 21, Issue:11 Topics: Adult; Aged; Carbolines; Coitus; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Personal Satisfaction; Phosphodiesterase Inhibitors; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Surveys and Questionnaires; Tadalafil	2005
How new drugs help treat erectile dysfunction. Nursing, 2006, Volume: 36, Issue:1 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Nursing Assessment; Patient Education as Topic; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2006
Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction. The journal of sexual medicine, 2005, Volume: 2, Issue:6 Topics: Adult; Carbolines; Drug Prescriptions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Acceptance of Health Care; Phosphodiesterase Inhibitors; Piperazines; Purines; Self Administration; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2005
Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction. The journal of sexual medicine, 2005, Volume: 2, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Clinical Trials as Topic; Erectile Dysfunction; Humans; Interpersonal Relations; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Psychometrics; Purines; Research; Self Efficacy; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome	2005
Can erectile dysfunction drug use lead to ischaemic optic neuropathy? The British journal of ophthalmology, 2006, Volume: 90, Issue:2 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2006
Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. The British journal of ophthalmology, 2006, Volume: 90, Issue:2 Topics: Carbolines; Case-Control Studies; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilator Agents	2006
Beyond Viagra. What are your options? Mayo Clinic health letter (English ed.), 2006, Volume: 24, Issue:1 Topics: Carbolines; Contraindications; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Testosterone; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2006
Ophthalmic aspects of erectile dysfunction drugs. American journal of ophthalmology, 2006, Volume: 141, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adverse Drug Reaction Reporting Systems; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vision Disorders	2006
Prescribing all phosphodiesterase 5 inhibitors to a patient with erectile dysfunction--a realistic and feasible option in everyday clinical practice--outcomes of a simple treatment regime. European urology, 2006, Volume: 49, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Adult; Aged; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Prescriptions; Drug Therapy, Combination; Erectile Dysfunction; Feasibility Studies; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2006
Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study. European urology, 2006, Volume: 50, Issue:1 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2006
In that case. Journal of bioethical inquiry, 2005, Volume: 2, Issue:3 Topics: Advertising; Carbolines; Confidentiality; Depression; Erectile Dysfunction; Female; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Professional-Family Relations; Purines; Sildenafil Citrate; Spouses; Sulfones; Tadalafil	2005
There have been inadequate warnings that erectile dysfunction drugs can cause blindness. MedGenMed : Medscape general medicine, 2005, Dec-05, Volume: 7, Issue:4 Topics: Blindness; Carbolines; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Humans; Imidazoles; Incidence; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Assessment; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride; Vasodilator Agents; Video Recording	2005
Structural elucidation of a tadalafil analogue found as an adulterant of a herbal product. Food additives and contaminants, 2006, Volume: 23, Issue:5 Topics: Carbolines; Chromatography, High Pressure Liquid; Dietary Supplements; Erectile Dysfunction; Food Contamination; Humans; Magnetic Resonance Spectroscopy; Male; Phosphodiesterase Inhibitors; Plant Extracts; Spectrometry, Mass, Electrospray Ionization; Tadalafil	2006
Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. The journal of sexual medicine, 2006, Volume: 3, Issue:3 Topics: Animals; Carbolines; Cell Hypoxia; Disease Models, Animal; Endothelins; Erectile Dysfunction; Male; Nitric Oxide Donors; Nitroprusside; Penile Erection; Penis; Peptide Fragments; Phosphodiesterase Inhibitors; Prostatectomy; Rats; Rats, Sprague-Dawley; Tadalafil; Vasodilator Agents	2006
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology, 2006, Volume: 67, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Anemia, Sickle Cell; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Nitric Oxide; Penile Erection; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Priapism; Purines; Recurrence; Signal Transduction; Sildenafil Citrate; Sulfones; Tadalafil	2006
[Observation of safety and efficacy of tadalafil for men with erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2006, Volume: 12, Issue:5 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil	2006
NAION and treatment of erectile dysfunction: reply from Pfizer. The British journal of ophthalmology, 2006, Volume: 90, Issue:7 Topics: Carbolines; Case-Control Studies; Data Interpretation, Statistical; Erectile Dysfunction; Humans; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2006
Tadalafil-induced subretinal and choroidal hemorrhage in a patient with an unsuspected uveal (choroidal and ciliary body) melanoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:7 Topics: Carbolines; Choroid Hemorrhage; Erectile Dysfunction; Eye Enucleation; Humans; Male; Melanoma; Middle Aged; Phosphodiesterase Inhibitors; Retinal Hemorrhage; Tadalafil; Ultrasonography; Uveal Neoplasms	2006
Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate. The journal of sexual medicine, 2006, Volume: 3, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Vasodilator Agents	2006
Treatment of erectile dysfunction with chronic dosing of tadalafil. European urology, 2006, Volume: 50, Issue:2 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tadalafil	2006
Regaining of morning erection and sexual confidence in patients with erectile dysfunction. Asian journal of andrology, 2006, Volume: 8, Issue:6 Topics: Aged; Carbolines; Circadian Rhythm; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Self Concept; Sildenafil Citrate; Sulfones; Tadalafil	2006
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. British journal of clinical pharmacology, 2007, Volume: 63, Issue:1 Topics: Adult; Age Factors; Belgium; Carbolines; Diabetes Mellitus; Erectile Dysfunction; Female; Germany; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Poland; Sex Factors; Tadalafil; United Kingdom	2007
Visual loss with erectile dysfunction medications. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Aug-15, Volume: 175, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Atherosclerosis; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vision Disorders	2006
[Effectiveness duration determines selection]. MMW Fortschritte der Medizin, 2006, Jul-20, Volume: 148, Issue:29-30 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Choice Behavior; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Treatment Outcome	2006
Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study. BJU international, 2006, Volume: 98, Issue:3 Topics: Aged; Attitude of Health Personnel; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Personal Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sexual Partners; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome	2006
Detection of sildenafil analogues in herbal products for erectile dysfunction. Journal of toxicology and environmental health. Part A, 2006, Volume: 69, Issue:21 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Molecular Structure; Phosphodiesterase Inhibitors; Piperazines; Plant Preparations; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2006
Erectile dysfunction. Harvard men's health watch, 2006, Volume: 11, Issue:1 Topics: Carbolines; Contraindications; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2006
The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners. BJU international, 2007, Volume: 99, Issue:2 Topics: Carbolines; Erectile Dysfunction; Female; Humans; Male; Patient Satisfaction; Personal Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sexual Partners; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome	2007
[Viagra -- patients stand by their treatment]. Praxis, 2006, Nov-22, Volume: 95, Issue:47 Topics: Adult; Aged; Carbolines; Clinical Trials as Topic; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2006
Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum. British journal of pharmacology, 2007, Volume: 150, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbolines; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth; Nitrergic Neurons; Nitric Oxide; Penis; Phosphodiesterase Inhibitors; Piperazines; Priapism; Purines; Rabbits; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2007
[Tadalafil and patients preference in the treatment of erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2006, Volume: 12, Issue:12 Topics: Carbolines; Erectile Dysfunction; Humans; Male; Patient Satisfaction; Phosphodiesterase Inhibitors; Psychotherapy; Tadalafil	2006
Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase. British journal of pharmacology, 2007, Volume: 150, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Carbolines; Cardiomyopathies; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Doxorubicin; Endothelium, Vascular; Enzyme Inhibitors; Erectile Dysfunction; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Imidazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents; Ventricular Remodeling	2007
An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease. BJU international, 2007, Volume: 99, Issue:2 Topics: Aged; Carbolines; Cohort Studies; England; Erectile Dysfunction; Family Practice; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil	2007
Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK. BJU international, 2007, Volume: 99, Issue:4 Topics: Adolescent; Adult; Aged; Carbolines; Cohort Studies; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2007
Confusion still reigns in premature ejaculation management. International journal of clinical practice, 2007, Volume: 61, Issue:6 Topics: Carbolines; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Fluoxetine; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome	2007
[Drug counterfeiting--the risk to the public health]. Przeglad lekarski, 2007, Volume: 64, Issue:4-5 Topics: Carbolines; Drug Compounding; Drug Contamination; Drug Industry; Drug Labeling; Drug Packaging; Erectile Dysfunction; Fraud; Humans; Imidazoles; Legislation, Drug; Male; Phosphodiesterase Inhibitors; Piperazines; Poland; Public Health; Purines; Quality Control; Risk Assessment; Sildenafil Citrate; Spectrum Analysis, Raman; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2007
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. European urology, 2008, Volume: 53, Issue:3 Topics: Carbolines; Erectile Dysfunction; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Patient Compliance; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Postoperative Complications; Prostate; Prostatectomy; Prostatic Neoplasms; Purines; Quality of Life; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome; Treatment Refusal; Triazines; Vardenafil Dihydrochloride	2008
Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. International journal of clinical practice, 2007, Volume: 61, Issue:11 Topics: Adolescent; Adult; Aged; Carbolines; Cohort Studies; Erectile Dysfunction; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Regression Analysis; Severity of Illness Index; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2007
Analogues of erectile dysfunction drugs: an under-recognised threat. Hong Kong medical journal = Xianggang yi xue za zhi, 2007, Volume: 13, Issue:5 Topics: Adult; Ataxia; Carbolines; Data Collection; Drug Contamination; Erectile Dysfunction; Hong Kong; Humans; Imidazoles; Male; Nonprescription Drugs; Phosphodiesterase Inhibitors; Piperazines; Plant Preparations; Purines; Pyrimidinones; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2007
[Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2007, Volume: 17, Issue:5 Topics: Biopsy; Carbolines; Erectile Dysfunction; Humans; Male; Nervous System Diseases; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; United States; United States Food and Drug Administration	2007
cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil. BJU international, 2008, Volume: 101, Issue:4 Topics: Animals; Carbolines; Down-Regulation; Erectile Dysfunction; Gene Expression; Immunohistochemistry; Male; Oligonucleotide Array Sequence Analysis; Penile Erection; Penis; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; Rats; Rats, Wistar; Tadalafil	2008
Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance. The journal of sexual medicine, 2008, Volume: 5, Issue:2 Topics: Adult; Aged; Carbolines; Erectile Dysfunction; Follow-Up Studies; Humans; Imidazoles; Longitudinal Studies; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2008
Re: Wayne J.G. Hellstrom, Marc Gittelman, Jonathan Jarow, et al. an evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20 mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-mont European urology, 2008, Volume: 53, Issue:5 Topics: Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Semen; Spermatogenesis; Tadalafil; Time Factors; Treatment Outcome	2008
Alternate-day tadalafil in the management of honeymoon impotence. The journal of sexual medicine, 2008, Volume: 5, Issue:6 Topics: Adult; Carbolines; Coitus; Drug Administration Schedule; Egypt; Erectile Dysfunction; Health Knowledge, Attitudes, Practice; Humans; Male; Marriage; Patient Education as Topic; Phosphodiesterase Inhibitors; Psychotherapy; Tadalafil; Treatment Outcome	2008
Erectile dysfunction: the Viagra revolution. Harvard men's health watch, 2005, Volume: 9, Issue:9 Topics: Carbolines; Ejaculation; Erectile Dysfunction; Humans; Imidazoles; Male; Nitric Oxide; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2005
Combination of alfuzosin and tadalafil exerts in vitro an additive relaxant effect on human corpus cavernosum. The journal of sexual medicine, 2008, Volume: 5, Issue:4 Topics: Adrenergic alpha-Antagonists; Carbolines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Penile Erection; Phosphodiesterase Inhibitors; Quinazolines; Tadalafil	2008
Intracerebral hemorrhage associated with use of tadalafil (Cialis). Neurology, 2008, Apr-08, Volume: 70, Issue:15 Topics: Aged; Brain; Carbolines; Cerebral Arteries; Cerebral Hemorrhage; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Labeling; Drug Overdose; Erectile Dysfunction; Headache; Homeostasis; Humans; Magnetic Resonance Imaging; Male; Patient Compliance; Phosphodiesterase Inhibitors; Tadalafil; Time Factors; Tomography, X-Ray Computed	2008
Tadalafil (Cialis) once a day for erectile dysfunction. The Medical letter on drugs and therapeutics, 2008, Apr-07, Volume: 50, Issue:1283 Topics: Carbolines; Drug Interactions; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil	2008
Towards optimal ED management: educational forum - II. The Canadian journal of urology, 2001, Volume: 8, Issue:6 Topics: Canada; Carbolines; Diabetes Complications; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2001
Phosphodiesterase inhibition: erectile dysfunction is only part of the story. International journal of clinical practice, 2002, Volume: 56, Issue:4 Topics: Angiotensin II; Carbolines; Cardiovascular Diseases; Delayed-Action Preparations; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2002
Tadalafil (Cialis) for men with erectile dysfunction. International journal of clinical practice, 2002, Volume: 56, Issue:4 Topics: Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride	2002